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Current, influential theories of insomnia emphasise the role of cognitive and 
arousal factors in the development and maintenance of insomnia. Even though we know 
that insomnia is heritable, genetic influences have not been given enough attention in 
these models of insomnia. This thesis investigates the extent to which genes and the 
environment influence these cognitive and arousal variables (and their subscales) and 
their associations with insomnia symptoms. Furthermore, the theory that insomnia can 
be subtyped into insomnia with short sleep duration and insomnia with normal sleep 
duration (being distinguishable by for example differences in arousal) has not yet been 
tested. 
Data came from 862 individuals (aged 22 to 32, mean age 25, 34% males) of 
Wave 5 of the G1219 twin/sibling sample. The five studies reported in the current thesis 
investigated: 1) Mindfulness 2) Pre-sleep arousal 3) Dysfunctional beliefs about sleep 
(DBAS) and their associations with insomnia symptoms; 4) Non-shared environmental 
factors associated with DBAS; and 5) Self-reports of insomnia with short versus normal 
sleep duration.  
Mindfulness, pre-sleep arousal and DBAS (and their subscales) were all found to 
be associated with insomnia symptoms. Mindfulness was found to be familial, while 
DBAS had no familial influence. Pre-sleep arousal showed moderate, significant 
genetic influence. No genetic or shared environmental influence was found for the 
associations between mindfulness and symptoms of insomnia, depression and anxiety, 
nor was any found for the association between DBAS and insomnia symptoms. Genetic 
influences were important in the relationship between pre-sleep arousal and insomnia 
symptoms. Furthermore, for DBAS, drug use was a non-shared environmental influence 
un-confounded by genetic factors. The theory of subtypes of insomnia (short versus 
normal sleep duration) could not be confirmed. The findings provide novel insight into 
the concept and aetiology of insomnia, by integrating the behavioural genetics 
perspective into the current theories of insomnia.  
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CovMZ Covariance between MZ twin 1 and MZ twin 2 
D Non-additive genetic (dominance) influence 
d2 Non-additive genetic (dominance) influence 
DBAS Dysfunctional beliefs about sleep 






Beliefs about long-term consequences 
DBAS 
factor III 
Beliefs about the need for control over insomnia 
df Degrees of freedom 
DNA Deoxyribonucleic Acid  
DSM-5 Diagnostic and Statistical Manual of Mental Disorders 5th edition 
DSM-IV Diagnostic and Statistical Manual of Mental Disorders 5th edition 
DZ Dizygotic  
E Non-shared environmental influence 




FFMQ Five Facet Mindfulness Scale 
FIRST Ford Insomnia Response to Stress Test 
G1219 Genesis 12-19 years sample 
GWAS Genome Wide Association Studies  
ICD-10 International Classification of Mental and Behavioural Disorders (10th 
edition) 
ICD-11 International Classification of Mental and Behavioural Disorders (11th 
edition) 
ICSD-3 International Classification of Sleep Disorders (3rd edition) 
ISI Insomnia Severity Index 
ISQ Insomnia Symptoms Questionnaire 
MBCT Mindfulness-Based Cognitive Therapy 
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MBSR Mindfulness-Based Stress Reduction 
MBTI Mindfulness-Based Therapy for Insomnia 
MZ Monozygotic  
N Number of participants 
NREM Non-rapid eye movement sleep 
NHS National Health Service 
NSD Normal sleep duration 
r Correlation coefficient 
R A language and environment for statistical computing and graphics 
rA Additive genetic correlation 
rC Shared environmental correlation  
RCADS Revised Children Anxiety and Depression Scale 
rE Non-shared environmental correlation  
rDZ Dizygotic twins’ correlation 
rMZ  Monozygotic twins’ correlation 
RNA Ribonucleic acid 
OCT Over the counter 
p p-value 
PCT Pharmacotherapy  
PLA Placebo group 
PSAS Pre-sleep Arousal Scale 
PSG Polysomnography  
PSQI Pittsburgh Sleep Quality Index 
REM Rapid eye movement sleep 
SCI Sleep Condition Indicator 
SD Standard Deviation 
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SE Standard Error 
Sib Siblings 
SHI Sleep Hygiene Index 
SOL Sleep onset latency  
SPSS Statistical Package for the Social Sciences 
SSD Short sleep duration 
STATA A general-purpose statistical software package created in 1985 by 
StataCorp 
t t-statistic 
WASO Wake time after sleep onset 




CHAPTER 1: Introduction 
 
1.1 What is sleep? 
1.1.1 Definition of sleep 
Sleep is a distinct brain state involving partial or full unconsciousness which 
occurs periodically (usually every night) and is reversible. It is characterised by reduced 
sensitivity to stimuli, inactivity, reduced metabolism and by a lack of muscle tone 
(VandenBos, 2007; Carskadon & Dement, 2005). It can be differentiated from other 
forms of unconsciousness (for example, as a result of drug use or head injury) by unique 
patterns that are shown by brain imaging or electroencephalography which illustrate the 
different stages of sleep (VandenBos, 2007). 
1.1.2 Sleep stages 
During the night we periodically move through different stages of sleep. These 
can be measured using polysomnography (see 1.5.2.1 Polysomnography for more 
details). We differentiate between rapid eye movement sleep (REM) and non-rapid eye 
movement sleep (NREM, including the stages N1, N2 and N3). The main characteristic 
of rapid-eye-movement (REM) sleep is, as the name implies, a rapid movement of the 
eyeballs. The other sleep stages are also non-REM sleep as this was found to be such a 
crucial feature (Carskadon & Dement, 2005; Espie, 1991). The EEG pattern during 
REM sleep looks quite similar to wakefulness or the transient stage between sleep and 
wakefulness (stage 1) but the electromyograph shows that there is no muscle tone 
(Espie, 1991; Espie, 2006; Peigneux, Urbain & Schmitz, 2012). 
Stage N1 is the lightest form of sleep. It is a transitional stage between sleep and 
wakefulness when the muscles start to relax and eye movement slows down. The EEG 
waves are slower at this stage as well, disappearing of alpha waves and displaying theta 
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waves, getting slower in frequency and greater in amplitude compared to during sleep 
onset (Espie, 2006; Peigneux et al., 2012). Stage N2 is a light form of sleep, 
characterised by mixed frequencies in the EEG, highlighted by sleep spindles (rapid 
bursts of high-frequency waves) and K-complexes (rapid decline followed by a sharp 
rise in the wave) in the EEG data. Stage N3 represent deep sleep and is also called slow 
wave sleep because the EEG now shows lower frequencies of higher waves now 
(Carskadon & Dement, 2005; Espie, 2006; Peigneux et al., 2012). Measuring the sleep 
stages gives us an indication of the structure, quality and quantity of the sleep of the 
individual from an objective point of view, which can help us to better understand 
possible sleep disturbances (Espie, 2006). 
1.1.3 The function of sleep 
Even though there is a long history of sleep research, we are still not sure why 
we all have to sleep and a whole series of competing hypotheses exists (Krueger, Frank, 
Wisor, & Roy, 2016). The key theories of the function of sleep include the idea that we 
need to sleep for the following reasons: memory processing and learning, emotion 
regulation, protection, preservation, restoration and for ‘cleaning’ the brain. It is 
unlikely that there is just one reason why we need to sleep, it is much more likely that it 
is a combination of reasons. Sleep is a state in which learned information is processed 
and stored. It also correlates with structural reorganization of the brain and brain 
plasticity (Dinkelman & Born, 2010). During sleep recent emotional experiences are 
processed, our affective neural systems are modulated and REM sleep plays a role in 
emotional-memory processing (Walker & van Der Helm, 2009). Sleep may also have an 
adaptive function when viewed from an evolutionary perspective because staying 
indoors and sleeping when it is dark outside reduces the risk of being harmed - for 
example, by a predator (Meddis, 1983). Periods of sleep also help us to conserve energy 
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which is, for example, evident in a reduction of metabolic rate during sleep (Jung et al., 
2011; White, Weil, & Zwillich, 1985). It helps the restoration of the body by promoting 
healing and also helps the immune system (Ingiosi, Opp, & Krueger, 2013). 
Furthermore, during sleep, the brain is cleared of metabolic waste products much faster 
than during wake-times (Eugene & Masiak, 2015; Herculano-Houzel, 2013). There are 
various other theories of the function of sleep which are not mentioned here. It should 
be mentioned that some researchers consider that these theories compete with one 
another while others accept that there is more than one reason why we sleep (Krueger et 
al., 2016). In summary, it can be said that it is not yet clear what the main function of 
sleep actually is. However, what we do know is that sleep disturbances (particularly 
when they occur frequently as in insomnia) can have serious consequences for our 
physical and mental health (see Roth et al. 2011; Roth & Roehrs, 2003; Taylor et al., 
2014, for a more detailed outline of the consequences of insomnia see 1.4.4 
Comorbidities and associated negative factors). 
 
1.2 What is insomnia? 
1.2.1 Definition and prevalence of insomnia  
The key variable of interest for this PhD thesis is insomnia symptoms. When 
conducting research, it is of the highest importance to clearly characterise the phenotype 
of interest (Perlis, Corbitt, & Kloss, 2014). Insomnia is characterised by difficulties 
initiating sleep, maintaining sleep and/or early awakenings, resulting in an impairment 
in daytime functioning (Morin & Benca, 2012). According to the Diagnostic and 
Statistical Manual of Mental Disorders DSM-5 (APA, 2013), to meet criteria for 
diagnosis, the symptoms need to be present for at least 3 nights a week. There are three 
classifications of insomnia: acute insomnia (duration of symptoms < 1 month), sub-
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chronic insomnia (1 - 3 months) and chronic insomnia (duration > 3 months) (APA, 
2013). It is important to mention that this thesis focuses on insomnia symptoms found 
within the general population and not on insomnia diagnosis. In some cases (see 
Chapter 7: Self-reports of insomnia with short versus normal sleep duration), the 
term ‘insomnia’ is used but only when participants actually met the diagnostic criteria 
of the DSM-IV (APA, 2010), respectively the Research Diagnostic Criteria for 
insomnia (Edinger et al., 2004), as identified by a self-measure – the Insomnia 
Symptoms Questionnaire (ISQ, Okun et al., 2009 – which was based on the DSM 
version at the time). 
Insomnia is one of the most common health problems (Hublin & Partinen, 2002; 
Leger & Bayon, 2010; Ohayon, 2002). Prevalence rates vary but it has been estimated 
that approximately one-third of our society experience insomnia symptoms at any given 
time (Morin, LeBlanc, Daley, Grégoire, & Mérette, 2006; Ohayon, 2002). Worldwide, 
between 9% and 15% of the general adult population suffer from insomnia and 
experience the consequences of insomnia during the day and are therefore in substantial 
distress (Ohayon, 2002). Depending on the diagnostic criteria used, 10% to 30% of 
children and 3% to 12% of adolescents also experience insomnia (Roberts, Roberts, & 
Chan, 2008). It can be criticised that no common consensus exists about which criteria 
should be applied to define insomnia, which is one of the reasons why estimates vary 
across the different studies. 
In a more recent study, the America Insomnia Survey, it was found that up to 
30% of the adult population in the US experience insomnia symptoms, and 10% of the 
individual experience insomnia that affects their daytime functioning (Kessler et al., 
2011; Shahly et al., 2012). The survey also showed that among employed (or self-
employed) individuals, 20% of them experienced chronic insomnia symptoms of a 
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duration of 12 months or more (Shahly et al., 2012). However, it should be mentioned 
that the sample of this survey was limited to the US population while the earlier review 
by Ohayon (2002) included data from various countries world wide, which may be one 
possible explanation why estimates are higher in this review. 
In another recent review, it was pointed out that estimates of the prevalence of 
insomnia (summarised here to lie between 2% and 4% for primary insomnia as 
diagnosed by DSM-IV which is referring to ‘insomnia disorder’ in the DSM-5) in some 
studies and between 30% to 48% for insomnia symptoms experienced in the general 
population in others) vary largely because of the differences in how insomnia is defined 
according to the different diagnostic manuals currently in use (Grewal & Doghramji, 
2017). 
1.2.2 Classification and clinical diagnosis of insomnia 
Currently there are three main manuals in use for classifying or diagnosing 
insomnia, the International Classification of Sleep Disorders (ICSD-3, American 
Academy of Sleep Medicine, 2015), the Diagnostic and Statistic Manual of Mental 
Disorders from the American Psychiatric Association (DSM-5; APA, 2013) and the 
International Classification of Mental and Behavioural Disorders from the World Health 
Organization (ICD-10; WHO, 1992).  
The DSM-5 and the ICSD-3 largely overlap in terms of diagnostic criteria. They 
both include the following symptoms: difficulty initiating and/or maintaining sleep 
and/or early-morning awakenings and (in children) bedtime resistance/struggles. They 
also agree on the frequency (at least three nights per week), duration (lasting at least 
three months) and opportunity (having adequate opportunity for sleep). Both 
classification systems include fatigue, cognitive impairment (attention, concentration or 
memory), mood disturbance, impaired social, interpersonal, occupational or academic 
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functioning, and behavioural problems (for example, aggression). The differences here 
are that the DSM-5 includes negative impact on the caregiver and the functioning of the 
family, while the ICSD-3 also refers to daytime sleepiness, reduced motivation or 
energy, proneness to accidents and errors and dissatisfaction with sleep (or concerns 
about sleep). Dissatisfaction with sleep quality or quantity is also mentioned in the 
DSM-5. The ICSD-3 and the DSM-5 both allow for comorbidities to be added to the 
insomnia diagnosis (American Academy of Sleep Medicine, 2015; APA, 2013).  
The DSM-5 and the ICSD-3 both provide rough guidelines as to when latency to 
fall asleep, awakenings during the night and early awakenings can be considered 
clinically significant (American Academy of Sleep Medicine, 2015; APA, 2013). Adults 
who struggle for more than 30 minutes to fall asleep or who are awake for more than 30 
minutes during the night meet the criteria of “difficulty initiating sleep” or “difficulty 
maintaining sleep” respectively. The 30-minute-rule also applies to the “waking up 
earlier than desired” diagnostic criterion (American Academy of Sleep Medicine, 2015; 
Hood, Carney, & Harris, 2011). 
In contrast to the other two diagnostic manuals (DSM-5 and the ICSD-3), the 
ICD-10 has a more basic structure of classification for insomnia, comprising only four 
diagnostic criteria:  
1) Complaining about a disruption in sleep, problems with sleep disruption 
during the night, poor sleep quality or not feeling refreshed in the 
morning;  
2) A sleep disturbance that occurs at least three times a week for at least one 
month;  
3) The sleep problems cause distress or impair everyday functioning; and  
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4) Other organic causes, including somatic disorders and effects caused by 
psychotropic substances or medications can be excluded.  
This does not allow for the duration or intensity of the insomnia disorder to be 
specified (such as, for example, in the DSM-5 where episodic, persistent and recurrent 
can be added to the insomnia diagnosis), nor does it take into account other sleep 
disorders as a differential diagnosis (WHO, 1992).  
With the different classification systems available, the question arises as to 
which one to use. The American Insomnia Survey included diagnostic criteria in line 
with both the ICD-10 and the DSM-IV when assessing insomnia (10,094 participants 
were included). It was found that the prevalence rates vary greatly depending on which 
criteria are utilised (22% for the DSM; 4% for the ICD-10, 15% for the ICSD-2) (Roth 
et al., 2011). It was argued that the ICD-10 criteria might give a narrower diagnosis of 
insomnia and include the more severe cases but it was recommended that the DSM 
criteria should be applied as some cases may be missed by the ICD-10 criteria (Roth et 
al., 2011). Even though it can be criticised that not the most recent versions of the DSM 
and the ICSD were used (although they were in fact the most recent versions at the 
time), an important point has been made here about the ICD-10. In the ICD-11, which 
will be published shortly, it is likely that there will be a further sub-division of insomnia 
into the following subtypes: chronic insomnia, short-term insomnia and disorders of 
initiating and maintaining sleep (WHO, 2016).  
Preferences for using either the ICD or DSM diagnostic system vary across 
different countries but, in general, the ICD-10 was used more commonly within a 
clinical context (for diagnosis and training), while the DSM-IV was more frequently 
used for research in the past (Mezzich, 2002). With the newest version of the DSM, the 
DSM-5 and the newest version of the ICSD, the ICSD-3, more concordance has been 
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achieved between the two classification systems and both are frequently used within a 
research context (Wilson & Attarian, 2017). Discussing the differences between the 
various diagnostic systems and considering the differences in prevalence rates between 
the various epidemiological studies, it has become clear how important it is to outline 
how insomnia is defined when conducting research in this area. 
1.2.3 Subtypes of insomnia  
1.2.3.1 Duration 
The ICSD-3 only distinguishes between three subtypes of insomnia: chronic 
insomnia disorder, short-term insomnia disorder (also called acute insomnia) and ‘other’ 
insomnia disorder. The ‘other insomnia disorder’ can be used when not all the criteria 
have been met and can also be used as a preliminary diagnosis until enough information 
about the patient is available to decide on whether he/she has a short-term or chronic 
insomnia disorder (American Academy of Sleep Medicine, 2015). Short-term insomnia 
may be related to a stressor (for example, grief) and may improve over time or when the 
stressor is removed (American Academy of Sleep Medicine, 2015). The DSM-5 allows 
specification of whether the insomnia is episodic (meaning more than one month, but 
less than three months), persistent (more than three months) or recurrent (two or more 
occurrences within one year). The ICD-10 only classifies ‘nonorganic insomnia’ and no 
distinctions are made in terms of duration (such as short-term or chronic) but this is 
likely to change in the ICD-11 (WHO, 2016). 
1.2.3.2 Sleep length 
Previous research and theory suggests that insomnia with objective short sleep 
duration (SSD, typically < 6h of sleep per night; Vgontzas, Fernandez-Mendoza, Liao, 
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Edward & Bixler, 2013; American Academy of Sleep Medicine, 2014) differs 
importantly from insomnia with normal sleep duration (Vgontzas et al., 2013; NSD,  
>= 6h of sleep per night). For example, it was shown that those individuals with SSD 
insomnia have an increased risk of cardiometabolic morbidity and mortality as 
compared to those individuals with NSD insomnia. More recently, SSD insomnia 
(defined in that study as 5-6 hours of sleep) was also found to be associated with 
hypercholesterolemia (Lin, Tsai, & Yeh, 2016). This theory is discussed in the ICSD-3 
(American Academy of Sleep Medicine, 2015), and has also gained support from 
another recent study (Fernandez-Mendoza et al., 2016). Considering a sample of 
adolescents, insomnia symptoms with SSD (in that study defined as =< 7 hours of 
sleep) were found to be associated with rumination, depression, social isolation and 
problems with mood regulation, while NSD insomnia symptoms were found to be 
related to aggressive and rule-breaking behaviours (and, to a lesser extent, to 
rumination). One criticism that could be made here is that normal sleep length for the 
majority of the general population is about 7 hours (American Academy of Sleep 
Medicine, 2015; Markov & Goldman, 2006) but has been defined as SSD in this study. 
And, in general, there seems to be no consensus in the time period that should be used 
to define sleep length as being either normal or short. The definition of short sleep time 
varies from study to study. Sometimes a median split is used which will inevitably lead 
to differences in the definition of what is short or long sleep as it depends on the sample 
(Fernandez-Mendoza et al., 2016; Lin et al., 2016; Vgontzas et al., 2013). This theory is 
discussed in more detail in Chapter 4: Self-reports of insomnia with short versus 
normal sleep duration. 
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1.2.3.3 Paradoxical insomnia: A subtype unrelated to ‘normal’ insomnia 
The term ‘paradoxical insomnia’ (also called ‘sleep-state misperception’) is 
outdated. It was part of the primary insomnia classification and a distinctive subtype as 
outlined in the ICSD-2 but is no longer included in the ICSD-3 (American Academy of 
Sleep Medicine, 2015). However, it is still mentioned under chronic insomnia 
(American Academy of Sleep Medicine, 2015). This may be related to the issue that 
people with insomnia generally have a tendency to underestimate their sleep length and 
their complaint is subjectively measurable rather than objectively measurable 
(American Academy of Sleep Medicine, 2015; Feige et al., 2008). Therefore, in current 
clinical practice, insomnia patients are typically assessed using subjective measures 
(American Academy of Sleep Medicine, 2015, APA, 2013). 
1.2.4 Symptoms versus diagnosis 
In the past, there was a discussion about the terms ‘primary’ and ‘secondary’ 
insomnia, and the extent to which insomnia was just a symptom of another (secondary) 
disorder rather than being regarded as a ‘stand-alone’ (primary) disorder in itself. 
Insomnia was often considered to be a symptom of anxiety disorders, depression or 
substance use/abuse (Ford & Kamerow, 1989; see Harvey, 2001) which meant that 
insomnia was trivialised and the main treatment focused on the other (‘primary’) 
disorder (Kupfer, 1999). Harvey (2002) highlighted evidence showing that insomnia is 
more than just the symptom of another disorder. This issue is also highlighted in the 
ICD-10 where it is stated that insomnia is often a symptom or part of the diagnostic 
criteria of another disorder and should therefore only be diagnosed if the insomnia 
symptoms actually dominate the clinical picture (WHO, 1992).  
Even though insomnia can be a symptom of physical and mental disorders, this 
does not mean that it cannot be an entity on its own. According to Harvey (2002), it is 
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not useful to describe insomnia as ‘secondary’ as it often develops first. Plenty of 
research has shown that sleep problems precede or predict, for example, depression 
(Baglioni et al., 2011; Breslau, Roth, Rosenthal, & Andreski, 1997; Eaton, Baldawi, & 
Melton, 1995). It can be helpful to treat insomnia even without treating the comorbid 
disorder. Recently, it was found that treating insomnia also improves a comorbid 
depression or anxiety disorder (Bélanger et al., 2016). More specifically, after treating 
insomnia, 66% of the group with comorbid depression or anxiety disorder no longer met 
the diagnostic criteria for those illnesses. Furthermore, when only the insomnia is 
targeted, comorbid depression or anxiety does not impair the effectiveness of the 
treatment for the sleep problem (Bélanger et al., 2016). This is only to some extent in 
line with previous findings that showed that cancer patients treated with cognitive 
behavioural therapy for insomnia (CBT-I) because of their insomnia also improved in 
fatigue, but only 6% of all participants improved in anxiety symptoms as well and about 
9% of all participants also showed a remission in depression as a results of CBT-I. One 
criticism that could be made here is that the study by Bélanger and colleagues (2016) 
only focused on a particular population and had a relatively small sample size (n = 113) 
out of which only 20 showed comorbid fatigue, depression and anxiety at the same 
time. Therefore, it may not be possible to generalise these results to the general 
population (Fleming, Randell, Harvey, & Espie, 2014).   
Early research has also shown that insomnia can occur without any comorbidity 
(see, for example, Weissman, Greenwald, Nino-Murcia, & Dement, 1997). Harvey 
(2002) argues that in clinical practice, usually only one disorder is the focus of 
treatment. This means that if insomnia is diagnosed as the ‘primary’ disorder, it is 
treated while the other disorder is neglected. However, if insomnia was considered to be 
just a symptom of another disorder, then the treatment focuses mainly on the other 
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disorder. It has been suggested that it might be helpful to consider the two disorders as 
comorbid and treat both of them, rather than just focusing on one. This is also 
underlined in a comment about comorbidity of insomnia disorder in the DSM-5 where it 
states that the relationship between medical disorders (such as coronary heart disease or 
arthritis) as well as mental disorders (such as depression or anxiety) and insomnia is not 
just one-directional but bidirectional and possibly changes over time. Therefore, the 
term ‘comorbid insomnia’ should be used (APA, 2013). In the most recent version of 
the DSM, primary insomnia is no longer included (see, DSM-5, APA, 2013). It should 
be mentioned here that the terms ‘primary’ and ‘secondary’ insomnia are still being 
used by some researchers to date (see, for example, Chiu, Chang, Hsieh, & Tsai, 2016). 
However, the terms are used in the sense of ‘with (secondary) or without (primary) a 
comorbidity’ – they do not imply any particular order of occurrence of the insomnia. In 
a review of studies considering CBT-I and for comorbid insomnia (comorbid with 
depression, substance use disorders, post-traumatic stress disorder and anxiety) it was 
suggested that CBT-I may be useful, even if insomnia is not the primary mental health 
issue (Taylor & Pruiksma, 2014). However, the results were not conclusive and more 
research in this area is needed (Taylor & Pruiksma, 2014). It should be mentioned that 
some difficulties were encountered when conducting this meta-analysis because of the 
different types of analyses, the inconsistencies in reporting means, standard deviations 
and interaction effects across the various studies included (Taylor & Pruiksma, 2014). 
1.2.5 Differential diagnosis 
According to the DSM-5, insomnia can be diagnosed as a stand-alone disorder or 
may be comorbid with a sleep disorder (like sleep apnoea), a medical disorder (for 
example, diabetes) or any other psychological disorder (such as depression). For a 
differential diagnosis, variations in normal sleep should be taken into account (for 
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example, some people do not need as much sleep as others but this is no reason for 
concern) (Taylor, Gehrman, Dautovich, Lichstein, & McCrae, 2014). The individual’s 
personal situation should also be taken into account. If insomnia only occurs for a short 
period as a result of life events or problems related to the sleep schedule but still causes 
distress, a diagnosis of ‘other specified’ or ‘unspecified’ insomnia disorder should be 
given (APA, 2013). There are other disorders that also cause symptoms similar to those 
in insomnia which should be differentiated: advanced or delayed sleep phase syndrome 
and circadian rhythm sleep-wake disorders (including shift work type), restless legs 
syndrome, breathing-related sleep disorders (featuring, for example, long pauses in 
breathing which disturb normal sleep), narcolepsy, parasomnias and substance or 
medication induced sleep disorder (insomnia symptoms are caused by a substance or 
medication, for example caffeine-induced sleep disorder) (APA, 2013; WHO, 1992; 
Roth & Roehrs, 2003). It is important to be aware of these other disorders in order to 
make sure their symptoms are not mistaken for insomnia when conducting research in 
this area. 
According to the ICD-10, nonorganic insomnia should be distinguished from 
‘nonorganic disorder of the sleep-wake schedule’, sleep terrors, sleepwalking or 
nightmares which represent a separate diagnosis (WHO, 1992). 
Shift-work sleep disorder is caused by a disturbance of the circadian rhythm as a 
result of an irregular shift-work pattern (WHO, 1992). In a similar way, sleep 
disturbances can also be caused by jetlag (American Academy of Sleep Medicine, 
2015). There are two processes for regulating the wake- and sleep-times: the circadian 
rhythm and sleep homoeostasis (see two process model of sleep regulation for a detailed 
outline, Borbély, 1982). The circadian rhythm is usually somewhat longer than 24 hours 
and zeitgeber (environmental cues such as light/darkness, etc.) synchronise the 
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biological clock to the 24-hour rhythm (Berson, Dunn, & Takao, 2002; Guardiola-
Lemaitre & Quera-Salva, 2011). Sleep homeostasis is related to the need to sleep, 
meaning that the longer one is awake the greater is the need to sleep again, while the 
more sleep that one has had, the lower the sleep propensity (Borbély, 1982). 
In advanced sleep phase disorder (often occurring in elderly individuals), the 
individual falls asleep too early and therefore wakes up too early in the morning (this 
has to do mainly with having a slightly shorter circadian rhythm, and environmental 
factors may be involved as well, such as life-style changes). This is similar to delayed 
sleep phase disorder, in which the individual struggles to fall asleep in the evening and 
then has difficulties getting up at the socially desired time in the morning (this is related 
to a slightly longer circadian rhythm and environmental factors may be involved as 
well, for example, staying up late on purpose to have more leisure time) (ICSD 
Diagnostic Classification Steering Committee, 1990). Advanced or delayed sleep phase 
disorder and insomnia are sometimes difficult to differentiate. They can overlap, not 
just in terms of early awakenings or problems falling asleep at night; but they might 
also include negative cognitions associated with sleep or arousal as the individual may 
get frustrated because of the sleep problems (American Academy of Sleep Medicine, 
2015). However, they differ from insomnia, as an individual with advanced or delayed 
sleep phase disorder would not have any sleep complaints if he/she was able to stick to 
his/her own circadian rhythm (American Academy of Sleep Medicine, 2015).   
In restless legs syndrome and periodic limb movement syndrome, involuntary 
movements of the legs (or arms or legs respectively) during sleep causes a disturbance 
of sleep (APA, 2013). For sleep related breathing disorders, it is problems breathing 
during the night (pauses in breathing as well as snoring) that can cause a disturbance in 
sleep rather than insomnia (APA, 2013).  
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Narcolepsy is another sleep disorder that should be differentiated from insomnia. 
Symptoms include excessive daytime sleepiness (this includes falling asleep 
involuntarily), sleep paralysis (an inability to move after waking up), cataplexy (a 
sudden loss of muscle tone while being fully conscious which is often triggered by 
intense emotions) and/or sleep-related hallucinations (APA, 2013). The ICSD-3 also 
states that falling asleep unintentionally is not a common feature of insomnia disorder, 
but typical for sleep disorders such as narcolepsy or sleep apnoea (American Academy 
of Sleep Medicine, 2015). However, insomnia can also lead to brief ‘lapses', which are 
moments of non-responsivity or micro-sleep (Roth & Roehrs, 2003). 
Parasomnias include involuntary behaviours during sleep (for example, 
sleepwalking) that can disturb the sleep and cause awakenings (APA, 2013). Insomnia-
like symptoms can also be caused by alcohol or illicit drug or medication abuse (APA, 
2013). 
The ICSD-3 also distinguishes between insomnia and insufficient sleep 
syndrome which is caused by voluntarily delaying sleep because of social activities, 
busy daytime schedules or in order to enjoy more leisure time (also called ‘social jet 
lag’, American Academy of Sleep Medicine, 2015). 
In practice, if not thoroughly assessed, the sleep disorders outlined above may be 
mistaken for insomnia. The sleep disorders outlined above may result in nightly 
awakenings, low sleep quality, unrestful sleep, problems falling asleep or waking up too 
early in the morning, which may be misinterpreted by a layperson as insomnia 
symptoms. For example, parasomnias or restless legs syndrome may cause nightly 
awakenings, or sleep disordered breathing can result in low sleep quality and unrestful 
sleep. Delayed sleep phase disorder may cause problems falling asleep at night and 
advanced sleep phase disorder may cause the early morning awakenings – there are 
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numerous examples (Taylor et al., 2014). As the treatment for all of these disorders can 
to some extent differ from the treatment for insomnia, it is important to exclude these 
differential diagnoses (APA, 2013; Taylor et al., 2014). Therefore, the individual with 
the sleep problem needs to be questioned carefully. It should be easy to obtain 
information about the person’s shift work and it is usually also possible to identify 
advanced and delayed sleep phases simply by asking the patient the right questions. 
However, restless legs syndrome, periodic limb movement disorder, sleep related 
breathing disorders, narcolepsy and parasomnias can be more difficult to exclude. It can 
be helpful to ask the patient’s bed partner or to assess the person in a sleep laboratory to 
make sure that the right diagnosis is made (Taylor et al., 2014). 
It is worth mentioning a further disorder here that should be considered as being 
different from the insomnia discussed in this thesis. Fatal familial insomnia is a 
completely different disorder which is unrelated to the insomnia discussed here. It is 
rare disorder of genetic origin which is characterised by motor disturbances, 
dysautonomia (a disorder of autonomic nervous system function) and an inability to 
sleep which leads to rapid death (Lugaresi et al., 1986; Lugaresi, Tobler, Gambetti, & 
Montagna, 1998). The usual age for the onset of this disease is 50 (although cases of 
early onset have been discovered – Harder et al. 2004). This disorder should be 
differentiated from the insomnia as discussed in this PhD thesis and will therefore not 
be discussed further. 
 
1.3 What do we know about insomnia from a theoretical point of 
view? 
Various theories of insomnia have been developed in order to attempt to 
understand the mechanisms and the aetiology of insomnia (Marques, Allen Gomes, 
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Clemente, Santos, & Castelo-Branco, 2015). In the light of the vast number of theories 
of insomnia that have derived from the different areas of research, it is only possible to 
present a selection of the ones that are most relevant to the topic of this PhD thesis. The 
main focus of this thesis is on the cognitive theories of insomnia and, in particular, on 
the most recent model by Ong and colleagues (2012) – the metacognitive model of 
insomnia. Only some of the main cognitive models will be discussed in more detail 
while other theories will just be briefly mentioned and/or excluded from this review 
altogether. 
It is important to note that some of the theories mentioned here are discussed 
using different names in the various literature. For example, the integrative model of the 
interaction between sleep-interfering and sleep-interpreting processes by Lundh & 
Broman, 2000 is also called hybrid cognitive-behavioral model (Marques et al., 2015). 
This model will be referred to as hybrid cognitive-behavioral model from here on. The 
micro-analytic model of insomnia by Morin (1993) was also called integrative model of 
insomnia in the original publication but also sometimes referred to as cognitive-
behavioural model of insomnia (see Ong et al., 2012). This model will be referred to as 
micro-analytic model of insomnia from here on. 
1.3.1 Theories most relevant to this thesis – Cognitive models of insomnia 
1.3.1.1 The 3P model of insomnia 
Starting with the theories most relevant to the topics discussed in this thesis, one 
of the most important early models of insomnia, which was the basis for many other 
models of insomnia, is the ‘3P model of insomnia’ (Spielman & Glovinsky, 1991; 
Spielman, Caruso, & Glovinsky, 1987). In this theory the factors involved in the various 
possible stages of insomnia (acute, short-term and chronic) are discussed. The three Ps 
refer to: Predisposing factors (such as hyperarousal), precipitating factors 
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(psychological and medical factors and life events) that may trigger insomnia, and 
perpetuating factors which maintain insomnia (certain thoughts and beliefs and 
unhelpful adopted behaviors). The 3P model of insomnia is an attempt to explain how 
the different stages of insomnia may be developed. This model has stimulated research 
and has led to the development of many related theories, often including similar 
elements, but setting different foci. For example, more recently the role of the cortisol 
awakening response was discussed as being a possible measure of a biological process 
that is related to the predisposition, precipitation and perpetuation of insomnia (Elder, 
Wetherell, Barclay, & Ellis, 2014). Self-reported worry (a trait-like characteristic 
related to predisposition as discussed in the ‘3P model’) was associated with a greater 
display of cortisol awakening response in healthy individuals (Spielman et al., 1987; 
Spielman & Glovinsky, 1991; Zoccola, Dickerson, & Yim, 2011). Cortisol is released 
when stress is experienced, which also affects the cortisol awakening response (Izawa, 
Saito, Shirotsuki, Sugaya, & Nomura, 2012). Life events which cause stress or stress 
itself can be considered to be a precipitating factor, according to the 3P model (Elder et 
al., 2014). An example of how the cortisol awakening response can be related to a 
perpetuating factor of insomnia is maladaptive behaviours, such as drinking coffee 
(Spielman et al., 1987; Spielman & Glovinsky, 1991). Caffeine intake (measured in 
coffee consumption per week) is related to the cortisol awakening response (Harris, 
Ursin, Murison, & Eriksen, 2007). It can be criticised that this study only focused on 
nursing staff. It can therefore be questioned if the findings apply to the general 
population. 
1.3.1.2 The hybrid cognitive-behavioural model 
Another interesting theory is the hybrid cognitive-behavioural model (also called 
integrative model of the interaction between sleep-interfering and sleep-interpreting 
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processes, Lundh & Broman, 2000; Marques et al., 2015 – see Figure 1.1). It suggests 
that, in the case of insomnia, sleep-interfering and sleep-interpreting processes interact. 
Various factors can contribute to predispose individuals to sleep-interfering processes. 
These include behavioural and cognitive strategies (including, for example, rumination), 
conflicts in interpersonal relationships, increased levels of arousability and stimulus-




Figure 1.1 The integrative model of the interaction between sleep-interfering and sleep-
interpreting processes. Reprinted from “Insomnia as an interaction between sleep-
interfering and sleep-interpreting processes” by L. G. Lundh and J. E Broman, 2000, 
Journal of Psychosomatic Research, 49(5), p. 308. 
In contrast to the sleep-interfering processes, the sleep-interpreting processes 
include: perfectionistic expectations about sleep and daytime functioning, dysfunctional 
beliefs about sleep and false attributions about the consequences of insomnia. This 
theory stimulated the idea of including the mindfulness approach as a possible element 
in the treatment of insomnia (Lundh, 2011; Lundh & Broman, 2000).  
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1.3.1.3 The microanalytic model of insomnia 
The microanalytic model is another well-studied theory (Marques et al., 2015; 
Morin, 1993; also called integrative model of insomnia in the original publication and 
called cognitive-behavioural model by Ong et al., 2012). It considers how insomnia is 
maintained as a vicious cycle of sleep disruption, feeding into arousal, negative 
cognitions, maladaptive behaviours – all of which again cause disturbance of sleep 
(Morin, 1993; Ellis, Gehrman, Espie, Riemann, & Perlis, 2012). This theory considers 
hyperarousal to be a central element in the development and maintenance of insomnia, 
as arousal (cognitive, emotional and somatic arousal) which is a crucial factor in 
regulating wakefulness and sleep (Morin, 1993) – see Figure 1.2. 
 
Figure 1.2 Microanalytic model of insomnia (also called Cognitive-Behavioral Model 
of insomnia) (Morin, 1993). Reprinted from “Improving sleep with mindfulness and 
acceptance: A metacognitive model of insomnia” by J. C. Ong, C. S. Ulmer and R. 
Manber, 2012, Behaviour Research and Therapy, 50, p. 652. 
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Arousal may be affected by various influences such as negative daytime events. 
In turn, arousal and sleeplessness may lead to rumination and worries over sleep, which 
again results in sleep disturbance and daytime consequences such as fatigue. Insomnia 
symptoms and its negative consequences during the day then lead to maladaptive 
behaviours (for example, spending excessive time in bed, trying to fall asleep), as the 
individual tries to cope with the sleeping problem. The various factors interact rather 
then influence each other in just one direction only (Morin, 1993). 
1.3.1.4 The cognitive model of insomnia 
Another theory that builds on the ideas behind the ‘3P model’ is Harvey’s (2002) 
cognitive model of insomnia (see Figure 1.3 overleaf) which attempts to explain the 
factors involved in maintaining insomnia. This theory states that increased negative 
cognitive activation leads to somatic arousal, which is one of the factors that cause a 
distorted perception of sleep deficits in the night and distorted daytime functioning (two 




Figure 1.3 Harvey’s cognitive model of insomnia. Reprinted from “Improving sleep 
with mindfulness and acceptance: A metacognitive model of insomnia” by J. C. Ong, C. 
S. Ulmer and R. Manber, 2012, Behaviour Research and Therapy, 50, p. 653. 
Somatic arousal refers to physical arousal and includes symptoms such as 
increased heart rate, while cognitive activation relates to the psychological part that 
includes for example, not being able to ‘shut off’ thoughts, etc. (Nicassio, Mendlowitz, 
Fussell, & Petras, 1985). Furthermore, dysfunctional beliefs about sleep exacerbate 
negative cognitions (for example, excessive worry), which in turn leads to safety 
behaviours (for example, spending an excessive amount of time in bed). Safety 
behaviours again reinforce dysfunctional beliefs about sleep and exacerbate negative 
cognitions. A recent literature review has shown that there is plenty of support for the 
cognitive model of insomnia as proposed by Harvey (2002; Hiller, Johnston, Dohnt, 
Lovato, & Gradisar, 2015). The model ‘3P model’ by (Spielman et al., 1987) and 
Harvey’s cognitive model were also the basis for understanding insomnia through 
cognitive modelling as outlined by Espie (2007). 
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1.3.1.5 The metacognitive model of insomnia 
One of the most recent and most comprehensive cognitive theories is the 
metacognitive model of insomnia (Ong et al., 2012). It builds on the previous cognitive 
theories, as well as on the hybrid cognitive-behavioural model (also described as the 
integrative model of the interaction between sleep-interfering and sleep-interpreting 
processes) by Lundh and Broman (2000) (Marques et al., 2015). This theory also aimed 
to illuminate how mindfulness-based therapies help to enhance cognitive flexibility, 
equanimity (a stance in which the individual is no longer overly attached to the outcome 
of sleep), balanced appraisal and commitment to values (all metacognitive processes) to 
lower secondary distress, reduce sleep-related arousal and, in this way, to also improve 
insomnia (Ong et al., 2012). By re-conceptualising cognitive arousal, another level was 
added, dividing it into primary arousal and secondary arousal. Primary arousal is 
influenced by expectations about sleep, consequences of insomnia during the day and 
by an increase in mental activity while in bed (Ong et al., 2012). Secondary arousal, on 
the other hand, comprises cognitive bias, rigidity of thought, attachment to negative 
thoughts, and absorption in terms of interpretative value – this refers to a metacognitive 






Figure 1.4 Two-level model of sleep-related arousal, presented in the metacognitive 
model of insomnia by Ong and colleagues (2012). Reprinted from “Improving sleep 
with mindfulness and acceptance: A metacognitive model of insomnia” by J. C. Ong, C. 
S. Ulmer and R. Manber, 2012, Behaviour Research and Therapy, 50, p. 653. 
Note: Primary arousal = cognitive processes relate to the inability to sleep; Secondary arousal = (meta-level) 
addressing how the individual relates to thoughts about sleep. 
The idea is that metacognitive awareness is the first step in allowing a shift in the 
relationship with the negative cognitions, rather than attempting to change the thoughts 
themselves, hence trying to adopt a new metacognitive stance (Ong et al., 2012). The 
metacognitive stance incorporates the main principles of acceptance and mindfulness, in 
which balance is achieved. This means that the individual neither avoids nor is overly 
attracted to emotions and thoughts related to sleep (Ong et al., 2012). For example, the 
person does not avoid the thought of going to bed because he/she does not expect to not 
be able to fall asleep anyway, and neither is staying in bed for an excessive time after 
awakening trying harder to fall asleep in spite of not being able to fall asleep again. 
Furthermore, with this approach, flexibility is practiced, which means to let go of the 
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rigidity of thoughts about sleep and to realise that thoughts are not facts. For example, 
by regarding every night as a new opportunity to sleep well again (adopting a 
beginner’s mind) (Ong et al., 2012). Also, it is attempted to achieve equanimity, which 
describes a stance in which the individual is no longer overly attached to the outcome of 
sleep, thus facilitating de-arousal. Finally, increasing commitment to their own values 
again is another way in which metacognitive processes can help to improve insomnia 
(Ong et al., 2012). This means not losing focus on other important aspects or needs in 
life. For example, by not sleeping in after a bad night’s sleep but going to the gym as 
planned to keep oneself physically fit (Ong et al., 2012). In this way, an over-emphasis 
on the topic ‘sleep’ can be avoided and long-term goals (for example, staying physically 
fit) are not given up over short-term goals (for example catching up on more sleep). For 
a more detailed outline of all aspects in which metacognitive processes help to improve 
insomnia, see Ong and colleagues (2012).  
This theory was supported by the findings of a longitudinal study that certain 
cognitive processes (including selective attention, worry, dysfunctional beliefs about 
sleep, somatic arousal, monitoring and maladaptive safety behaviours) were associated 
with the persistence of insomnia, and distinguishes those individuals with insomnia 
from good sleepers (Norell-Clarke, Jansson-Fröjmark, Tillfors, Harvey, & Linton, 
2014). It can be criticised that attrition was high (53%) in this study and that responders 
were significantly older than non-responders. Furthermore, it was not possible to 
determine if the participants had experienced one long episode of insomnia or various 
shorter episodes during the time-span considered in this study (data was collected at 
three time points, spanning 18 months overall) (Norell-Clarke et al., 2014). 
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1.3.2 Occurrence of the analysed traits in cognitive theories 
The numerous cognitive models of insomnia include traits similar to those 
analysed within this PhD thesis. For example, please refer to the Figures 1.1, 1.2 and 
1.3 above for a comparison of a selection of the different cognitive models of insomnia: 
the hybrid cognitive-behavioural model (also called integrative model of the interaction 
between sleep-interfering and sleep-interpreting processes, Lundh & Broman, 2000; 
Marques et al., 2015), the microanalytic model (Marques et al., 2015; Morin, 1993; also 
called integrative model of insomnia in the original publication and called cognitive-
behavioural model by Ong et al., 2012) of insomnia and the cognitive model of 
insomnia (Harvey, 2002). 
This illustrates the claim that cognitive pre-sleep arousal, somatic pre-sleep 
arousal and dysfunctional beliefs about sleep all play a role in insomnia and that there 
are other factors which may also be important in those theories. Mindfulness is not 
included directly in these three theories but it is implicit here. Indeed, meta-cognitive 
processes can be interpreted as a form of mindfulness and acceptance in terms of how 
an individual think about thinking (Ong et al., 2012). This is also related to sleep-
interpreting processes in the model by Lundh & Broman (2000, see Figure 1.1 above).  
Similarly, the attitudes about sleep and the interpretative value of dysfunctional 
cognitions can be interpreted as overlapping with metacognitive processes or as being 
related to mindfulness (Ong et al., 2012; see Figure 1.4 above).  
Furthermore, the selective attention and monitoring discussed in Harvey’s (2002) 
cognitive model of insomnia also refers to facets of mindfulness (Baer et al., 2006; 




One element mentioned in these theories that was not included in this thesis, as 
no data was collected on this trait for G1219, is maladaptive behaviours. It will 
therefore not be discussed here in detail but will be mentioned in various sections of this 
discussion, whenever relevant. Maladaptive behaviours predict the severity of insomnia 
– the stronger the need to adopt safety behaviours, the more severe the insomnia 
experienced. They are also associated with dysfunctional beliefs about sleep – the more 
frequent the safety behaviours, the more dysfunctional beliefs about sleep (Hood et al., 
2011). 
It can be summarized that all these cognitive models include elements similar to 
the traits mindfulness, cognitive pre-sleep arousal, somatic pre-sleep arousal and 
dysfunctional beliefs about sleep. Although they seem to play a crucial role in the 
development and maintenance of insomnia, very little is known about their aetiology 
and origin it was decided to analyse these from a behavioural genetic perspective for 
this PhD thesis. 
1.3.3 Interaction of the analysed traits in cognitive theories 
According to previous literature about cognitive models of insomnia, it is likely 
that the variables analysed within this PhD thesis interact with and influence each other 
rather than being linked in a one-directional way (see Harvey 2002, Morin, 1993; Ong 
et al., 2012). The cognitive models vary in how they describe the way in which the traits 
that have been discussed interact. In the hybrid cognitive-behavioural model, cognitive, 
physiological and emotional arousal influence sleep directly but they are not directly 
influenced by beliefs about sleep (Lundh & Broman, 2000). In contrast to this model, 
the microanalytic model states that arousal (including emotional, cognitive and 
physiological arousal) interacts with dysfunctional cognitions and vice versa and both 
also mutually influence insomnia (Morin, 1993). In Harvey’s (2002) cognitive model of 
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insomnia, it is stated that the direction of influence of the various factors shows less 
interaction with each other. Beliefs are only influenced by safety behaviours and have a 
one-way association with negative cognitions which influence arousal and distress and 
are themselves also influenced by selective attention and distorted perception. For an 
illustration of this explanation, see Figures 1.1, 1.2 and 1.3 above. All these models 
include additional factors that influence insomnia, which are discussed in detail 
elsewhere (see, Harvey, 2002; Lundh & Broman, 2000; Morin, 1993). In summary, it 
can be said that, even though these cognitive theories vary, they all consider cognitive 
pre-sleep arousal, somatic pre-sleep arousal and dysfunctional beliefs about sleep to be 
in some way important factors in the development and maintenance of insomnia and 
they also indirectly include aspects that are (to some extent) indirectly related to 
mindfulness. The role of mindfulness in insomnia symptoms may be indirect (as 
discussed by Ong et al., 2012). However, the underlying mechanisms of the association 
between these traits and insomnia symptoms are unclear. Therefore, the relationship 
between these elements and insomnia symptoms are considered phenotypically in the 
analyses included in this PhD thesis. Furthermore, some light is shed on the extent to 
which genetic and environmental influences are involved in these associations to 
broaden our knowledge about the roots of insomnia. 
1.3.4 Overview of other main theories of insomnia 
In addition to the theories discussed above, other approaches have been taken in 
order to consider insomnia from a theoretical point of view, taking into account various 
points of view including medical/pharmacological, neurological, circadian, 




One of the first theories relating to insomnia was the internalising of conflicts 
model (Kales, Caldwell, Preston, Healey, & Kales, 1976). It attempted to define the 
type of personality that would be typical of patients with primary insomnia, stating that 
internalising emotions, conflicts and problems (for example, in the form of depression) 
is a characteristic of individuals with insomnia. This leads to an increase in emotions 
(for example, fear of sleeplessness) which again promotes physiological arousal, 
making the person less likely to be able to fall asleep (Borkovec, 1982; see also 
Marques et al., 2015). Finding personality traits associated with insomnia is still the 
subject of current research. For example, most recently a study of insomnia in shift 
workers showed that neuroticism predicts insomnia (the higher the score in neuroticism, 
the higher the insomnia symptoms score), while morningness was found to be 
negatively associated with insomnia symptoms (Larsgård & Saksvik-Lehouillier, 2016). 
This study can be criticised because the response rates in time 1 and time 2 were low 
(only 30% of the contacted individuals at time 1 and less than 30% of the contacted 
individual at time 2 responded) and there were only 86 participants remaining for the 
final analyses. Furthermore, different types of shift work were all analysed together 
(Larsgård & Saksvik-Lehouillier, 2016). The findings are in line with the theory of 
Harvey, Gehrman and Espie (2014) that individuals who are high in neuroticism are 
more likely to exhibit high stress-reactivity and more negative emotions, suggesting that 
when experiencing the first disruptions in sleep, this is learned to be associated with the 
sleep environment and with sleep itself (Harvey et al., 2014).  
In another study, it was outlined that carrying the s/s homozygous variant for the 
serotonin transporter polymorphism 5HTTLPR (two s-allele), which is involved in the 
serotonin regulation in the synapse, is associated with a genetic vulnerability to 
increased stress reactivity (this also taps into the concept of neuroticism) (Karg, 
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Burmeister, Shedden & Sen, 2011). This is thought to be related to disrupted sleep and 
is relevant to the onset of insomnia and to how ‘easily’ someone can be conditioned to 
develop insomnia (Deuschle et al., 2010). This theory builds a bridge from genetics to 
neurobiological and to the psychological perspective (Harvey et al., 2014). However, it 
should be pointed out that research has moved away from looking at single genetic 
variants (such as that a certain serotonin transporter polymorphism 5HTTLPR may be 
involved here) as being the big cause of complex traits (Plomin, DeFries, Knopik, & 
Neiderheiser, 2013). Even when considering the whole genome to identify genetic 
patterns involved in insomnia, findings are still very limited. A more detailed discussion 
can be found under 1.7.2 Genes involved. The finding, that 5HTTLPR is involved in 
the serotonin regulation in the synapse, is in line with the idea of the stimulus control 
model (Bootzin, 1973; see also Marques et al., 2015). This suggests that insomnia arises 
from an erroneous conditioning of stimuli that are supposed to induce sleep and stimuli 
that cause arousal (for example, lying in bed causes arousal, but sitting on the sofa 
watching TV induces sleep).  
The psychobiological inhibition model (Espie et al., 2006), suggests that there is 
an attention-intention-effort pathway involved in the development of insomnia. In a 
nutshell, the model states that falling asleep is a passive or unintentional process that 
can be distracted by actively directing one’s attention to it (scanning mode), instructing 
oneself to fall asleep (planning mode) and trying harder to sleep (performing mode) 
(Espie et al., 2006). This leads to maladaptive behaviours (such as alcohol use) which 
again reduce the chances of a good night’s sleep. The theory underlines the role that 
homeostatic and circadian processes play in sleep and states that the body/brain must be 
ready for sleep. It also argues that the inability to de-arouse is the main problem with 
insomnia (Espie et al., 2006).  
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Another model that should be mentioned is the hyperarousal model as proposed 
by Riemann and colleagues (2010). Reviewing studies considering EEG, autonomous, 
neuroimaging, neuroendocrine and neuro-immunological measures of participants with 
insomnia, it was found that there is an increase of arousal at night as well as during the 
day (Riemann et al., 2010). In conjunction with earlier theories of neurobiological 
mechanisms involved in the regulation of the wake-sleep rhythm (see, Lu et al., 2006; 
Morruzi & Magoun, 1995; Saper et al., 2005), it was argued that these findings support 
the idea of a genetic predisposition to hyperarousal. This genetic predisposition makes 
the individual more vulnerable to experiencing insomnia symptoms and stressors can 
trigger the vicious cycle of developing insomnia. The hyperarousal model is an 
interesting attempt to incorporate different perspectives. A more detailed discussion of 
this theory can be found elsewhere (see, Riemann et al., 2010). 
 
1.4 Risk factors, comorbidities and associated negative factors 
1.4.1 General risk factors  
The most common risk factors that were found to be associated with insomnia 
are gender, age, shift work and medical and psychiatric diseases (Roth et al., 2011; Roth 
& Roehrs, 2003). Having a disability or a severe disease such as cancer was also found 
to be associated with an increased likelihood of developing insomnia (Roth et al., 2011; 
Savard & Savard, 2013). Another study found that there is an association between age 
and the probability of experiencing insomnia but it also stated that the impairment 
caused by sleep problems actually declines with age. This leads to the assumption that 
sleep problems may be better tolerated with increasing age (Roth et al., 2011), which is 
also an interesting point to keep in mind when considering the prevalence rates of 
insomnia at different ages. Even though the study by Roth and colleagues (2011) 
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mentioned here was based on a large sample size, it can be criticised for just focusing 
on the north American population and just on individuals who were members of a large 
commercial health plan.  
There is some inconsistency as to what extent people with insomnia differ from 
normal sleepers in terms of physically (or objectively) measurable parameters of 
arousal, such as heart rate variability, cortisol levels or metabolic indices (Bonnet & 
Arand, 1998; Nofzinger et al., 2004; Nofzinger et al., 2006). For example, the long-held 
claim that heart rate variability is impaired in individuals with insomnia could not be 
confirmed in a recent review (Dodds, Miller, Kyle, Marshall, & Gordon, in press).  
Alcohol, caffeine and stimulant (drug) use/abuse are also a risk factor for 
developing insomnia (American Academy of Sleep Medicine, 2015, Ohayon, 2002). 
Furthermore, various medications can also cause insomnia symptoms (for example, 
endocrine drugs such as Tamoxifen or antiviral drugs such as Didanosine) (Taylor et al., 
2014). Therefore, it is important to check which medications are being taken by the 
patient with insomnia symptoms (for a detailed review, see, Taylor et al., 2014). 
However, it should be kept in mind that side effects can differ from individual to 
individual and it is possible that multiple factors are involved at the same time. 
Furthermore, the sleep environment itself can also play a role in the development of 
insomnia. Uncomfortable surroundings, for example too much noise or too much light 
can also cause sleep disturbances which can subsequently lead to insomnia symptoms 
(Ohayon, 2002). This is a point that may be under-estimated by the patient but may 
become evident in comments such as ‘I do not mind sleeping in bright daylight, I never 
close the curtains’ and then the next moment, the patient is once again complaining 
about his/her insomnia symptoms. 
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1.4.2 Gender differences  
Insomnia does occur in males and females of all ages but women are slightly 
more likely to experience insomnia than men, and insomnia is also more common in 
older rather than younger individuals (APA, 2013; Lichstein, Durrence, Taylor, Bush, & 
Riedel, 2003; Ohayon, 2002). However, these findings are inconsistent because there is 
not always a clear association between age and insomnia (see, for example, Weyerer & 
Dilling, 1991). For adolescents, the prevalence of an insomnia disorder is also higher in 
females but only after puberty (American Academy of Sleep Medicine, 2015; Roberts et 
al., 2008). Here again, estimates for prevalence rates vary. 
1.4.3 Insomnia and the brain  
There is mixed evidence as to whether individuals with insomnia have a brain 
structure different from that of normal sleepers (Riemann et al., 2007; Winkelmann et 
al., 2010). However, brain lesions caused by multiple sclerosis, brain trauma or stroke 
can all cause insomnia symptoms but these are usually accompanied by a variety of 
other neurological symptoms rather than just appearing on their own (American 
Academy of Sleep Medicine, 2015). Furthermore, some neurobiological studies on the 
sleep-wake regulation have shown that the ascending reticular activation system 
(ARAS) may play a crucial role in cortical arousal and the regulation of sleep and 
wakefulness (Moruzzi & Magoun, 1995). And it has been suggested that there might be 
something like a ‘key-switch’ in the hypothalamus which is related to switching off 
arousal during sleep (Lu, Sherman, Devor, & Saper, 2006; Saper, Scammell, & Lu, 
2005). It has been speculated that this switch plays a role in insomnia (Riemann et. al, 
2010). However, it can be criticised that some of the reviewed PSG studies showed only 
a very small difference between those individuals with insomnia and good sleepers in 
terms of the objective measures of sleep, compared to subjectively reported sleep 
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(Riemann et. al, 2010). For more information about insomnia and related neurological 
structures, see also 1.3.4 Overview of the main theories of insomnia. 
1.4.4 Comorbidities and associated negative factors  
Insomnia is associated with a wide range of medical and psychiatric diseases, as 
well as chronic pain, disabilities, and poor health in general (for more details, see also, 
Roth et al. 2011; Roth & Roehrs, 2003; Taylor et al., 2014). Some of these 
consequences have already been discussed under 1.2.4 Symptoms versus diagnosis. 
The most common comorbid mental health problem associated with insomnia is 
depression (Roth & Roers, 2003). The prevalence of psychiatric disorders in individuals 
with chronic insomnia lies between 40% and 50%, with affective disorders and anxiety 
being most frequently diagnosed (Ohayon & Roth, 2003). Insomnia and burnout were 
also found to be linked, having an aversive effect on one another (Armon, 2009). 
Burnout predicted a change in insomnia over time and vice versa, even when the 
participant was experiencing, for example, low work pressure (Armon, 2009). However, 
it should be mentioned here that the effect of burnout on insomnia, as measured at the 
second time point, was only minimal (the β weight of the effect of burnout on insomnia 
at time 2 was < 0.10 in the regression model). 
As discussed under 1.2.4 Symptoms versus diagnosis, a direction of causation 
is difficult to establish. However, some findings indicate that insomnia more frequently 
precedes than follows depressive and anxiety disorders and longitudinal studies have 
shown that individuals with insomnia were more likely to experience depression (see, 
for example, Ohayon & Roth, 2003; Roth & Roehrs, 2003).  
Insomnia has also been found to be linked with an increased likelihood of 
suicide and accidental, fatal drug overdose (for a review see Winsper & Tang, 2014). 
For example, depressed patients differ in their sleep, depending on whether or not they 
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are suicidal, and insomnia was found to be linked to suicidality in depressed participants 
(Agargun et al., 2007; Chellappa & Araujo, 2007; Li, Lam, Yu, Zhang, & Wing, 2010; 
McCall et al., 2013). It should be pointed out that there were some inconsistencies in 
these findings. In one of the previously mentioned studies (Li et al., 2010), the link 
between suicidality and insomnia was no longer significant when controlling for 
depression or nightmares. It was also shown that the link between insomnia and 
suicidality was mediated by nightmares and dysfunctional beliefs about sleep (McCall 
et al., 2013). 
A review of the literature shows that transient (also called short-term) insomnia 
is related to increased sleepiness and impaired psychomotor functioning (including 
slower reaction-times and problems with attention and vigilance), while chronic 
insomnia is not always associated with these problems (Roth & Roehrs, 2003). The 
review also shows that quality of life and memory functioning were found to be 
impaired, while the findings that insomnia is a risk factor for drug use were not 
consistent (Drummond et al., 2013; Roth & Roehrs, 2003). Fatigue is the most common 
complaint among patients with chronic insomnia (Roth & Roehrs, 2003). It can be 
criticised that this review was carried out some time ago. However, it does flag up some 
interesting points. For more physical risks and consequences associated with insomnia, 
see also the point mentioned under 1.2.3.2 Sleep length. 
1.4.5 Costs of insomnia 
Sleep problems are a significant problem in our society and also present a 
financial burden as they generate both direct costs (for example, treatment costs) and 
indirect costs (for example, car accidents caused by sleepiness) and put a strain on our 
health care system (Daley, Morin, LeBlanc, Grégoire, & Savard, 2009). For example, 
the costs associated with reduced work efficiency in the United States due to insomnia 
 
61 
are estimated to be around 63 billion dollars (Kessler et al., 2011). Insomnia was also 
found to be linked to workplace injuries, costly workplace accidents and also to errors 
that add to the costs of a company (Kessler et al., 2011; Shahly et al., 2012; Uehli et al., 
2014). It was estimated that workplace accidents and errors associated with insomnia 
added up to a combined cost of about 31.1 billion dollars a year (Shahly et al., 2012). A 
recent field experiment showed that this link can to some extent be explained by a 
worker’s decreased safety behaviours if he/she is suffering from insomnia (Kao, 
Spitzmueller, Cigularov, & Wu, 2016). It can be criticised that this study used a cross-
sectional design. Therefore, causality cannot be inferred and the sample was limited 
solely to the construction industry (Kao, Spitzmueller, Cigularov, & Wu, 2016). Using a 
wait list control (random assignment), the findings show that CBT-I not only improves 
insomnia and well-being directly but also indirectly enhances work-related outcomes 
(Barnes, Miller, & Bostock, 2017). This suggests that it may be beneficial for 
organizations to offer cost effective CBT-I to those employees who are experiencing 
insomnia (Barnes et al., 2017). It could be criticised that this study could have been 
improved by including a placebo treatment group in order to rule out a placebo effect, 
which has been done in the past. (see, for example, Espie et al., 2012). As a placebo 
treatment, for example, Imagery Relief Therapy can be used, i.e. training to visualise 
objects and at the same time thinking about their evening routine. This would be 
provided on the same application platform, with a similar design and functionality as for 
CBT, but with no active therapeutic elements (Espie et al., 2012). However, even when 
a placebo treatment group had been included, CBT-I has been shown to be effective 




1.5 How can insomnia be measured? 
Since there were different definitions of insomnia in the past (across the various 
diagnostic manuals and across research), an attempt was made to standardise definitions 
and approaches for assessing insomnia (Bloom et al., 2009; Buysse, Ancoli-lsrael, 
Edinger, Lichstein, & Morin, 2006; Edinger et al., 2004). This was attempted, for 
example, by outlining research diagnostic criteria for insomnia (Edinger et al., 2004). 
However, a certain degree of heterogeneity remains, as is demonstrated in the variety of 
measures that have been used to date and the differences in diagnostic criteria discussed 
(see below). 
1.5.1 Subjective measures  
1.5.1.1 Self-report questionnaires for insomnia   
Various self-measure questionnaires to assess insomnia or insomnia symptoms 
or sleep disturbance are currently used in research and clinical practice. Common 
measures of insomnia symptoms include the Athens Insomnia Scale, the Insomnia 
Severity Index, the Insomnia Symptoms Questionnaire and the Sleep Condition 
Indicator. Furthermore, the Pittsburgh Sleep Quality Index and the Ford Insomnia 
Response to Stress Test are frequently used in conjunction with measures of insomnia. 
Only the Insomnia Severity Index and the Insomnia Symptoms Questionnaire are 
relevant to this thesis and will be discussed here. 
1.5.1.1.1 Insomnia Severity Index (ISI) 
The ISI is mainly based on the diagnostic criteria of the DSM-IV and the ICSD 
(Bastien, Vallières, & Morin, 2001). It focuses on the insomnia symptoms experienced 
and the distress and negative consequences caused by insomnia. It includes seven items 
targeting problems with falling asleep and maintaining sleep, satisfaction with quality of 
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sleep, issues with daytime functioning and distress and impairment caused by insomnia 
(Bastien et al., 2001; Morin, Belleville, Bélanger, & Ivers, 2011). It is available as a 
self-report measure, or it can be used by a clinician. There is also a version which can 
be completed by a significant other (meaning bedpartner) (Bastien et al., 2001). A 
recent meta-analysis comparing the PSQI, AIS and ISI found that all three had 
comparable psychometric properties (Chiu et al., 2016). It should be pointed out here 
that one limitation of this meta-analysis was that when the data was combined, the 
different diagnostic criteria used across the studies may have caused an inaccuracy in 
the estimates judging the psychometric properties of the self-report-questionnaires 
(Chiu et al., 2016). 
1.5.1.1.2 Insomnia Symptom Questionnaire (ISQ) 
The ISQ is similar to the ISI as it is based on the diagnostic criteria for insomnia 
of the DSM-IV as well, but is usually coded as a dichotomous variable in terms of 
whether or not the diagnostic criteria for insomnia are met (Okun et al., 2009). The ISQ 
is the measure (in a 6-item version) used in the analyses in this thesis and is therefore 
discussed in more detail in the third chapter (see 3.2.3 Insomnia symptoms). 
1.5.1.2 Sleep diaries   
Sleep diaries are a further option for adding extra information when assessing 
insomnia subjectively. However, they are usually not used on their own to measure 
insomnia symptoms. Various versions of sleep diaries exist and an attempt was made to 
find a common consensus in terms of which elements should be included (see Carney et 
al., 2012, for the consensus sleep diary). The idea is that the participant fills out the 
sleep diary every morning after waking up (preferably not longer than 30 minutes after 
awakening) and then gives a retrospective report on the previous night’s sleep guided by 
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answering standardised questions. For example, “What time did you go to bed?”; “What 
time did you fall asleep?”, etc. (Carney et al., 2012; Taylor et al., 2014). However, sleep 
diaries are usually used for two weeks only. A longer period of time would be required 
to provide enough information to diagnose insomnia (APA, 2013). 
1.5.1.3 Structured interviews   
Conducting a structured interview with the participants is another option for 
assessing insomnia. It is more common within a clinical setting than in a research 
context and it is a time-consuming method that requires training (Chiu et al., 2016; 
Taylor et al., 2014). A validation of the different structured clinical interviews is still 
needed (Taylor et al., 2014). One available option is the Insomnia Interview Schedule 
(ISS; for further details, see Morin, 1993). This can be helpful for making a diagnosis 
according to the current diagnostic guidelines (American Academy of Sleep Medicine, 
2015; APA, 2013; WHO, 1992).  
1.5.2 Objective measures  
Various options for measuring sleep or insomnia symptoms exist but this review 
will just focus on the two most common and best evaluated objective methods: 
polysomnography and actigraphy. However, it should be mentioned here that insomnia 
is mainly a subjective complaint (see, for example, American Academy of Sleep 
Medicine, 2015; APA, 2013; Krystal, Edinger, Wohlgemuth, & Marsh, 2002). 
1.5.2.1 Polysomnography 
Polysomnography (PSG) is the gold standard for measuring sleep problems 
objectively but it is costly and time consuming (Gehrman et al., 2011). With PSG 
various measures (EEG, electro-oculograph, electromyograph and visual monitoring, 
also other biological signals such as heart rate may be included) are recorded 
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simultaneously over the course of a whole night (Hertenstein et al., 2015; Kolk, 
Hanewald, Schagen, & van Wijk, 2003). Usually, several nights are recorded and the 
data from the first night might be disregarded as the patient may have trouble sleeping 
because of the ‘first night effect’ (meaning having to get used to the new environment 
and the idea of having their sleep assessed, etc.) (Normand, St-Hilaire, & Bastien, 
2016). Adaptions in technology now also allow PSG to be used in the home of the 
participants (home PSG, Blackwell et al., 2016). However, recent findings indicate that 
even when using ‘home PSG’, sleep is worse on those nights with the PSG measure 
compared to those nights where it is not used (assessed by actigraphy and subjective 
measure) (Blackwell et al., 2016). In order to determine the sleep architecture of the 
participant (or patient), the data is usually analysed according to standardised rules, to 
examine which sleep stage the participant was in at what time and for how long. This 
also includes sleep-onset latency (SOL) and wake time after sleep onset (WASO) 
(Gehrman et al., 2011, Kolk et al., 2003). 
Sometimes a discrepancy is found between the objective measures and the 
reported subjective complaint of the individual. For example, polysomnographic 
measures might indicate problems with sleep continuity and patients seem to remain in 
stage 1 sleep for longer, spending less time in sleep stages 3 and 4 (deeper sleep) but 
they do not always reflect the severity of the patient’s subjective complaint (American 
Academy of Sleep Medicine, 2015; APA, 2013, Krystal et al., 2002; Normand et al., 
2016). 
In some PSG studies, it was not possible to detect any objective indications at all 
for disturbed sleep even though the participants had experienced insomnia subjectively 
(Gehrman et al., 2011). It is possible that this is related to the complexity of the EEG 
data and that the methods of analysis need to be further improved in order to better 
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understand sleep architecture (Gehrman et al., 2011). Another possible explanation is 
that the individual may sleep better when taken out of their usual environment in order 
to have their sleep assessed in a sleep-laboratory (Gehrman et al., 2011). 
There is a general tendency in individuals with insomnia to over-estimate their 
wake-time and under-estimate their sleep duration as measured by polysomnography. 
This may in part also be explained by the increased activity in the beta frequency range 
observed in insomnia patients during sleep (determined by EEG) which has been shown 
in computer-based spectral analysis methods that allow a more detailed examination of 
the sleep architecture (Gehrman et al., 2011; Perlis, Merica, Smith, & Giles, 2001; 
Perlis, Smith, Andrews, Orff, & Giles, 2001). This EEG pattern is usually associated 
with mental activity during wake-time, supporting the idea that insomnia might be a 
mixed wake-sleep state which is misinterpreted by the individual as being awake (Perlis 
et al., 2001). According to the results, insomnia seems to be characterised by 
hyperarousal in the central nervous system (Perlis et al., 2001). It should be pointed out 
here that this study assumes that arousal in the central nervous system can be considered 
separately from somatic arousal, which is controversial (Perlis et al., 2001). 
Furthermore, a study comparing participants with insomnia with a group of 
participants with good sleep in their subjective and objective (PSG) measures of sleep, 
showed that on the basis of the subjective measure, more participants with insomnia 
(compared to good sleepers) over-estimated their objective wake-times. Arousal was 
increased in participants with insomnia (mainly during REM sleep phases) and further 
analysis showed that the time spent in REM-sleep contributed significantly to subjective 
wake time, meaning that objectively measured REM sleep might be partly perceived 
and recalled as being awake in patients with insomnia (Feige et al., 2008). It can be 
criticised that the subjective measure was not used for all participants with insomnia and 
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the good sleeper control group (Feige et al., 2008). The findings suggest that REM 
sleep-related processes may play a role in the subjectively experienced sleep 
disturbance and the overestimation of wake times in insomnia patients (Feige et al., 
2008). 
But there is also some evidence that individuals with insomnia do in fact sleep 
objectively worse. A meta-analysis reviewing polysomnographic data of individuals 
with primary insomnia compared to good sleepers showed that sleep continuity was 
disrupted (6 more awakenings per night). This was associated with a reduction of rapid-
eye-movement sleep as well as slow wave sleep (11min less ‘deep sleep’) (Baglioni et 
al., 2014). Furthermore, individuals reporting insomnia had less total sleep time (23 
minutes), more wake time after sleep onset (22 minutes) and a lower sleep efficiency 
(Baglioni et al., 2014). One of the limitations of this meta-analysis was that some of the 
included studies have taken only one night into consideration while others have taken an 
average over several nights. This means that confounding first-night-effects (i.e. 
sleeping worse on the first night of PSG measure) were not controlled for in all of the 
studies (Baglioni et al., 2014). 
Most recently, the issue was raised again that objective, quantitative measures 
such as those obtained from PSG should be included in our definition and diagnosis of 
insomnia (Edinger, 2016; Pillai, Roth, & Drake, 2016). A study by Edinger (2016) 
examined wake time after sleep onset (WASO) and sleep-onset latency (SOL) in 
individuals with a diagnosis of insomnia (according to the DSM-5 criteria) and included 
a follow-up after one year. It was found that most of the participants showed a 
‘remission’ from insomnia (according to the DSM-5 criteria) but 66% of these 
participants still reported more than half an hour of WASO or SOL during the night and 
a daytime impairment similar to the group of participants who had no remission from 
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insomnia. This supports the argument to add a quantitative cut-off (for WASO or SOL) 
to the diagnosis of insomnia (Pillai et al., 2016). It can be criticised that no objective 
measure of sleep was used in this study and therefore the estimates for WASO or SOL 
may not be representative. Even though the DSM-5 and ICSD-3 do provide some rough 
guidelines for WASO and SOL which could be considered as disruption of sleep (20-30 
minutes), they do not form part of the diagnostic criteria for insomnia (Edinger, 2016; 
APA, 2013; American Academy of Sleep Medicine, 2015). It has also been pointed out 
that other sleep disorders (for example, obstructive sleep apnoea) do already include 
specific PSG measures within their diagnostic criteria, but PSG measures are not 
included for insomnia symptoms even though they might be useful (American Academy 
of Sleep Medicine, 2015; Edinger, 2016). However, a good argument against the 
inclusion of PSG measures for the diagnostic criteria of insomnia is that insomnia 
seems to be a mainly subjective complaint (see arguments outlined above). 
1.5.2.2 Actigraphy 
Another cheaper way of measuring sleep objectively that provides an additional 
measure used in context with the assessment of insomnia is actigraphy (Natale, Plazzi, 
& Martoni, 2009). An actigraph is a small device that is worn around the wrist to 
monitor wake and sleep times (Larouche, Lorrain, Côté, & Bélisle, 2015). A sleep log 
diary is often used in conjunction with the actigraphic measure as this makes it easier to 
interpret the data. A big advantage of actigraphy is that sleep can be monitored in the 
participant’s normal environment over a period of several days (typically one week or 
longer) without the person having to get used to sleeping in a sleep lab. It also seems to 
disturb the sleep less compared to home PSG, which has recently been used more and 
more frequently (Blackwell et al., 2016). Furthermore, sleep and wake times are not just 
monitored during the night but also during the day (including napping times). 
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Actigraphy is still used in recent research to measure sleep parameters and to provide 
additional information in the assessment of insomnia (see, for example, Larouche et al., 
2015). 
1.5.3 Insomnia assessed within a clinical context: Patient history 
The handbook of insomnia suggests that, in clinical practice, a patient’s sleep 
history should be taken whenever a patient reports insomnia symptoms (Taylor et al., 
2014). This should include any medical factors that may affect sleep (for example, 
osteoarthritis, as this causes pain), any psychological disorders which may possibly be 
associated with insomnia (for example, depression) and also general anxiety levels and 
mood. If any mental illness is reported, then it should be assessed to what extent this 
correlates with insomnia. In the case of depression for example, it is important to 
establish whether or not insomnia persists in the non-depressive phases of life. The 
patient should also be questioned about any events prior to the onset of insomnia (if 
there are any) or about any other possible factors that may have triggered insomnia (for 
example, a change in medication). A sleep history should be taken, including sleep 
times, bed times, time taken to fall asleep, number of awakenings during the night (and 
possible reasons for the interruption in sleep, such as a snoring bedpartner), difficulties 
initiating sleep again after waking up, napping routines, onset of insomnia, number of 
nights per week affected, early awakenings, sleep hygiene, the severity of insomnia 
symptoms over time (constant in form or rather fluctuating) and daytime functioning. 
This might help to identify the factors that cause and/or maintain the sleep problems. 
Any information about the chronotype and the daily routine of the patient may also be 
helpful. If patients have a different sleep schedule on the days that they do not work and 
if they sleep better on those days than during the time when they are working, then this 
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is an indication that their sleep problems may be due to a circadian rhythm problem 
rather than as a result of insomnia (Taylor et al., 2014).  
 
1.6 How can insomnia be treated? 
1.6.1 Psychotherapeutic treatment of insomnia 
A wide range of psychotherapeutic treatment methods for insomnia exist, 
including: sleep restriction therapy, sleep hygiene, stimulus control therapy, relaxation 
techniques, paradoxical intention, sleep compression, cognitive restructuring, cognitive 
therapy, cognitive behavioural therapy, intensive sleep retaining, behavioural 
experiments, brief behaviour treatment and mindfulness-based therapy, as well as 
interventions to reduce misperceptions of sleep, dysfunctional beliefs about sleep and 
maladaptive safety behaviours (Perlis, 2011). This review will focus mainly on the 
therapies involving a cognitive component (hence cognitive behavioural therapy) and 
mindfulness-based therapy, as these are the areas most relevant for the analyses 
conducted in this thesis. A detailed description and discussion of all methods mentioned 
above can be found elsewhere (see, for example, Espie 1991; Perlis, 2011).  
Cognitive therapy targets dysfunctional beliefs directly by applying behavioural 
experiments to help the participants to challenge their beliefs and, in this way, to 
implement cognitive restructuring (for example, by staying up all night to challenge the 
worry about daytime functioning following a poor night’s sleep). Behaviour therapy is 
mainly directed at altering behaviour, applying sleep restriction and helping the 
participants to control stimuli (for example, by removing the TV from the bedroom). 
Cognitive behavioural therapy (CBT) combines the two approaches and attempts to 
alter behaviour and to restructure cognitions (Eidelman et al., 2016). 
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A recent review of the behavioural and psychological treatments commonly used 
to treat insomnia (including sleep hygiene education, stimulus control, sleep restriction, 
relaxation training, brief behavioural treatment, cognitive therapy and cognitive 
behavioural therapy) showed that CBT-I had the best outcomes (Brasure et al., 2016). 
This again confirms the results of an earlier meta-analysis which showed that CBT is 
effective for treating insomnia (Okajima, Komada, & Inoue, 2011). Stimulus control 
and multicomponent behavioural therapy may also improve sleep to some extent. The 
other single-component interventions showed only limited evidence for improvement in 
sleep (Brasure et al., 2016). It can be criticised that this review did not control for 
publication bias and, because of the large number of comparisons that were included, 
the ability to pool data was limited. A meta-analysis also showed that CBT-I was 
effective for treating insomnia with other comorbid physiological or psychological 
disorders (for example, chronic pain or depression), even when the other disorder 
‘overshadowed’ the insomnia (Grandner & Perlis, 2015). It can be criticised that this 
meta-analysis included all forms of CBT-I without differentiating between them, even 
though some of the included studies considered the different elements separately (for 
example, whether or not sleep restriction was included in CBT-I) (Grandner & Perlis, 
2015). 
CBT-I has further been recommended by the practice guidelines of the American 
College of Physicians as the first choice of treatment for chronic insomnia in adults, 
even before considering medication as forms of treatment (Qaseem, Kansagara, Forciea, 
Cooke, & Denberg, 2016). It can be criticised that the sample size of most of the 
randomised controlled trials included in this review were small. It should be mentioned 
that in general a large placebo effect was observed for the studies considering 
pharmacological treatment of insomnia (Qaseem et al., 2016).  
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By focusing exclusively on CBT delivered via the internet, a recent meta-
analysis confirmed that it is indeed effective for treating insomnia. On average, sleep 
efficiency improved by 7%, sleep time increased, insomnia symptoms improved, and so 
did the depression symptoms (Seyffert et al., 2016). The internet-delivered CBT did not 
differ significantly from the person-delivered version in outcome and the effects lasted 
over time (between 4 weeks and 48weeks following treatment) (Seyffert et al., 2016). It 
should be mentioned that even though an overall improvement in insomnia symptoms 
was found, not all measures of sleep were found to improve significantly. For example, 
the number of awakenings after sleep onset was not improved. Furthermore, it can be 
criticised that some of the studies that were included had a relatively high attrition rates 
(up to 25% in the insomnia group). However, the drop-out in the control group (in-
person delivery of CBT) was similarly high (20%). 
Some evidence has shown that sleep restriction therapy (delivered as a single-
component treatment rather than in the full CBT-I package) may actually have negative 
effects on the patient, rather than improving their insomnia symptoms (Kyle et al., 
2014). Sleep restriction therapy was associated with increased daytime sleepiness, 
reduced overall sleep time (objectively measured) and impaired vigilance (objectively 
measured). One limitation of this study is that the sample size was relatively small (16 
participants), but it does flag up an important issue that should be investigated further 
(Kyle et al., 2014). 
Mindfulness-based approaches are also used to treat insomnia (Hofmann, 
Sawyer, Witt, & Oh, 2010; Hubbling, Reilly-Spong, Kreitzer, & Gross, 2014). 
Mindfulness-Based Therapy for Insomnia (MBTI) combines elements of the 
Mindfulness-Based Stress Reduction Program (MBSR) and Mindfulness-Based 
Cognitive Therapy (MBCT) with components of behavioural therapy (sleep hygiene, 
 
73 
sleep restriction and stimulus control) (Ong & Manber, 2011). MBSR and MBCT are 
described in detail elsewhere (see, Kabat-Zinn, 1990; Kabat-Zinn, 2013). MBTI is 
usually delivered as a group therapy (6 to 8 participants) and it is a person-centered 
approach that encourages the participants to reflect on the feelings and thoughts that 
arise during the meditation exercises and behavioural components. The idea is to 
facilitate mindfulness. This means that each night should be considered as a new night 
(beginner’s mind) and that the patients should understand that sleep cannot be forced 
(non-striving) but that they should let go of the idea of an ideal sleep and not regard 
waking up during the night as negative but rather they should accept what cannot be 
changed (for example, getting out of bed if they aren’t tired). They should try to simply 
trust in their body and its ability to regulate sleep and exercise patience (Ong & Manber, 
2011; Ong & Sholtes, 2010). 
There is already some evidence indicating that mindfulness-based approaches are 
effective for treating insomnia (see, for example, Carlson & Garland, 2005; Ong, 
Shapiro, & Manber, 2008; Ong, Shapiro, & Manber, 2009). A small study (only 12 
participants), using pre- and post-intervention measures for sleep, has recently 
confirmed that mindfulness-based therapy is a useful approach for treating insomnia, 
showing a significant improvement in the subjective and also in objective measures of 
sleep (obtained by actigraphy), in addition to enhanced coping strategies (Larouche et 
al., 2015). A pre-test post-test design was adopted and no control or comparison group 
was used. Because of the small sample size and the design of the study, it can be 
questioned how meaningful the findings are. Randomised controlled trials are needed to 
further evaluate the effectiveness of mindfulness-based approaches for the treatment of 
insomnia in comparison to other forms of treatment (Ong et al., 2008). Such a study is 
currently being conducted by Morin and colleagues (see, Morin et al., 2016). 
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1.6.2 Pharmacological treatment of insomnia 
Between 1993 and 2007, the frequency of medication being prescribed for 
treating insomnia increased drastically, with nonbenzodiazepine sedative hypnotics 
being prescribed 30-times more often (Moloney et al., 2011). It can be criticised that 
this study did not include the lower income groups of people who use emergency 
services for their primary health care. According to a review of sleep medication 
prescribed to treat insomnia in the US (1999 until 2010), the most common medications 
were ‘Z-medications’ (eszopiclone, zaleplon and zolpidem), Trazodone, 
Benzodiazepines, Quetiapine and Doxepin – listed in order from the most frequently 
prescribed to the least frequently prescribed (Bertisch, Herzig, Winkelman, & Buettner, 
2014). Both reviews mentioned here were based on the US population. It can be 
criticised that, it may not be possible to generalise the findings because the approaches 
and the amount of sleep medicine prescribed in the US may differ from that prescribed 
in other countries. 
The recommendations for medicine to be prescribed to treat insomnia vary. 
Whilst the handbook of insomnia, which is frequently used for guidance within a 
clinical context, lists benzodiazepine receptor agonists, non-benzodiazepine hypnotics, 
zaleplon, zolpidem, melatonin receptor agonists, antidepressants and other new 
medications (Suvorexant – Orexin; Tasimelton) as pharmaceutical treatment options, 
the ICSD-3 only recommends prescribing benzodiazepine receptor agonists for the 
treatment of insomnia, without mentioning the other options (American Academy of 
Sleep Medicine, 2015; Taylor et al., 2014).  
One sedating tricyclic drug that has been approved more recently for treating 
insomnia is doxepin (3 mg and 6 mg) (Yeung, Chung, Yung, & Ng, 2015). In a recent 
review including randomised placebo-controlled trials (including a total of 1983 
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participants), it was found that a low dose of doxepin could be safely used and 
effectively increased sleep duration and helped to maintain sleep but it did not aid sleep 
initiation (Yeung et al., 2015). It can be criticised that all studies included in this review 
were industry sponsored. 
Based on a review of the research, the recent guidelines by the American College 
of Physicians for the treatment of chronic insomnia disorder suggest that CBT-I should 
be offered to patients first. In addition, one of the following medications may be 
prescribed, but only if CBT-I has not been successful: Eszopiclone, Zolpidem, 
Suvorexant and Doxepin (Ramelton rather than Suvorexant was recommended for older 
adults) (Qaseem et al., 2016). Note that product names may vary from country to 
country. 
More research is needed to compare the different pharmacological and 
psychological therapies used to treat insomnia as well as a combination of the two. 
Currently, a randomised controlled trial is being conducted that considers sequential 
psychological and pharmacological therapies for insomnia (primary, as well as 
comorbid) and results are expected to be published soon (Morin et al., 2016).  
For the choice of sleep medication, it should further be considered when the 
insomnia symptoms are most prevalent during the night (problems falling asleep, 
maintaining sleep or early awakenings) (Schweitzer & Feren, 2017). Furthermore, it is 
also important to bear in mind that the pharmacological treatment of insomnia does 
come with certain risks. Some medications have been found to be not safe to use, and 
side effects may be caused (Schweitzer & Feren, 2017). 
1.6.3 Self-medication of insomnia 
When someone is struggling with sleeping problems, one unhealthy coping 
strategy can be to self-medicate using alcohol (or illicit drugs) in order to induce sleep 
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at night and/or caffeine (or other drugs) to fight sleepiness during the day (American 
Academy of Sleep Medicine, 2015; APA, 2013). This can potentially lead to substance 
use disorder (APA, 2013).  
Over the counter (OTC) medicines present another form of self-medication for 
insomnia (Culpepper & Wingertzahn, 2015). A recent review (including studies 
considering H1 antagonists or antihistamines, melatonin, valerian and valerian/hops) 
showed that there is not yet enough clinical evidence to support the view that OTC 
medicines are effective in improving the symptoms of insomnia. Furthermore, it was 
not even possible to confirm that OTC medicines are safe to use (Culpepper & 
Wingertzahn, 2015). It can be criticised that studies of OTC medicines used for 
occasional sleep disturbance in otherwise healthy individuals have also been included 
here (rather than only studies of individuals experiencing insomnia symptoms or who 
were diagnosed with insomnia).  
1.6.4 New and alternative forms of treatment 
Different types of treatments for insomnia keep appearing in the literature. These 
include acupuncture, Tai Chi and other less common or less evaluated types of 
treatment (see, for example, Lee & Lim, 2016; Raman, Zhang, Minichiello, 
D’Ambrosio, & Wang, 2013; Sarris & Byrne, 2011). Evidence supporting these 
alternative forms of treatment is very limited. However, one example of a less 
frequently used form of therapy to treat insomnia that is worth mentioning is light 
therapy.  
1.6.4.1 Light therapy 
An alternative form of treatment for insomnia that is supported by various 
studies is light therapy (Berson et al., 2002; Guardiola-Lemaitre & Quera-Salva, 2011; 
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van Maanen, Meijer, van der Heijden, & Oort, 2016). There is no consensus about the 
exact guidelines that should be applied in terms of timing and light intensity but the 
basic idea is that light is a zeitgeber for the circadian rhythm and it can help to regulate 
it (Berson et al., 2002; Guardiola-Lemaitre & Quera-Salva, 2011). For example, light 
exposure in the early morning (4 am, when the body temperature is at its lowest) helps 
to shift the biological clock to an earlier timing (this may help the participant to fall 
asleep more easily earlier in the evening). In a recent meta-analysis, light therapy was 
shown to be effective for treating both insomnia and other sleep disorders and higher 
light intensity seemed to be particularly helpful for treating insomnia (van Maanen et 
al., 2016). It can be criticised that not all of the included studies focused on insomnia or 
sleep disorders as defined in the common diagnostic manuals (DSM, ICD or ICSD) and 
that there were large discrepancies in relation to the diagnostic criteria applied. 
Furthermore, publication bias was found for some of the outcome measures even though 
an attempt has been made to include unpublished studies. 
 
1.7 The heritability of insomnia 
1.7.1 Studies of genetic influence 
The findings of a small number of published family history studies or familial 
aggregation studies show that a family history of insomnia predisposes for developing 
insomnia (Dauvilliers & Morin, 2013; Gehrman et al., 2011). These results are in line 
with the findings of the twin studies, suggesting that insomnia is heritable to a modest 
degree as described above (see also Gehrman et al., 2011).  
The ICSD-3 does not acknowledge that there are familial patterns associated 
with insomnia but only mentions that the prevalence of insomnia is higher between MZ 
twins than between DZ twins and between first degree-relatives (compared to the 
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general population; Zhang et al., 2010). However, plenty of research evidence does 
suggest that insomnia is heritable (see Gehrman, Byrne, Gillespie, & Martin, 2011 for a 
review of the genetics of insomnia). The exact estimates of heritability for insomnia 
vary across previous studies (for example, Drake, Friedman, & Wright Jr, 2011, A = .43 
for males and A = .55 for females; Gehrman et al., 2011, A = .30; Wing et al., 2012, A 
= .48) as heritability is a population statistic and estimates may vary in the different 
samples considered (Plomin et al., 2013). For adults, the heritability of insomnia-related 
measures consistently falls into a range between .25 and .45 (Gehrman et al., 2011; 
some exceptions exist giving higher estimates (see, for example, Drake et al., 2011). For 
the G1219 sample, which was used for the various analyses in this thesis, the 
heritability of insomnia was estimated to be .29 (95% confidence interval = .13 - .43) 
for wave 4 and .31 (95% confidence interval = .08 - .49) for wave 5 (Gregory et al., 
2016). Compared to other traits (such as depression), relatively few studies exist that 
estimate the genetic and environmental influence on insomnia as this is a new area of 
research (Gehrman et al., 2011). We need to consider these previous findings in order to 
check if the current findings are in line with them or if they deviate (for example, if the 
sample was not representative). This is particularly important because the genetic and 
environmental influences for other key variables (mindfulness, pre-sleep arousal and 
dysfunctional beliefs about sleep) have been estimated for the first time in an adult 
sample in the current analyses and therefore no point of reference exists for them. 
Decomposing the genetic and environmental influence on a trait is key in understanding 
the aetiology of the trait and deepens our understanding of the concept by illuminating 
its roots. (Carlin, Gurrin, Sterne, Morley, & Dwyer, T., 2005). Estimating the 
heritability of insomnia can be considered as a first important step, providing direction 
and the foundation for new research. For example, if insomnia was found to be highly 
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heritable (which was not the case), it would have made sense to invest in locating the 
associated genes. As it was not found to be highly heritable, this might stimulate future 
research to focus more on detecting the potential environmental factors that influence 
insomnia. 
1.7.2 Genes involved 
The rare subtype of fatal familial insomnia was found to be a single-gene 
disorder, whereas, in the case of the other types of insomnia, the picture is more 
complex (Dauvilliers & Morin, 2013). Issues such as the discrepancy between 
subjective and objective measures, short sleep versus long sleep duration, comorbid 
versus primary, transient versus chronic insomnia, etc. make it more difficult to identify 
the genes involved in insomnia (Dauvilliers & Morin, 2013). A range of candidate gene 
studies, linkage studies and genome-wide association studies (GWAS) have attempted 
to identify genes (or genetic patterns) associated with insomnia with some success but 
still need replication. These results are discussed elsewhere (for a review of finding see 
Dauvilliers & Morin, 2013; Gehrman et al., 2011).  
A most recent GWAS study, which is worth mentioning, considered self-
reported insomnia symptoms, sleep duration and excessive daytime sleepiness in a 
sample of 112,586 adults (UK Biobank) (Lane et al., 2017). Specific genes that are 
significantly associated with insomnia symptoms were discovered (MEIS1, 
TMEM132E, CYCL1, WDR27 – for males, TGFBI – for females). Also some loci 
associated with sleep duration (PAX-8), daytime sleepiness (near AR/OPHN1), as well 
as for a composite trait, including sleep duration, insomnia symptoms, excessive 
daytime sleepiness, and chronotype were located (near INADL and HCRTR2) (Lane et 
al., 2017). The same study also found a genetic correlation for longer sleep duration and 
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schizophrenia (rA = .29), and increased daytime sleepiness and BMI (rA = .20). These 
are exciting new findings that need to be replicated. 
Identifying the genes associated with insomnia will open up new opportunities 
and interesting areas of research for the future. The first attempts have been made to use 
gene editing in humans to treat diseases (for example, lung cancer or HIV). However, 
there is still a long way to go before disorders such as insomnia can be treated using this 
method (Cyranoski, 2016; Tebas et al., 2014). But identifying genes associated with 
insomnia may, at some point in the future, also help us to detect who might be at risk of 
developing this disorder and will allow us to help those individuals by using targeted 
prevention and potentially help us develop new treatment methods (Palagini, Biber, & 
Riemann, 2014; Dauvilliers & Morin, 2013; Gehrman et al., 2011). Again, it should be 
pointed out that research has moved away from looking at single genetic variants as 
being the big cause of complex traits (Plomin et al., 2013) and even when considering 
the whole genome to identify genetic patterns involved in insomnia, findings are still 
limited. There is still a large discrepancy between the influence the genes we identify 
have on the overall variance of a trait and the estimated heritability of the trait (for a 
detail explanation of the missing heritability problem, see, for example, Manolio et al., 
2009). 
1.7.3 Epigenetic studies 
The evidence for epigenetic mechanisms related to insomnia has been discussed 
by some researchers (see, for example, Palagini et al., 2014). Epigenetics is a term that 
refers to the idea that gene expression (meaning that genes produce protein if they are 
instructed to do so by the DNA via an RNA messenger) does not happen in isolation but 
can to some extent be influenced by the environment or external factors. Information 
can be passed on from one cell to another, ‘switching’ gene expression on or off 
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(Plomin et al., 2013). This can happen through cellular or molecular changes, such as 
histone modification or DNA methylation, which regulate gene expression and can 
‘silence’ genes without changing the DNA sequence itself, even though these changes 
can remain for a considerable period of time (Plomin et al., 2013). Explaining this at a 
very basic level, histone modification refers to the enzymatic modification of histone 
proteins which change their interaction with the DNA. This is how gene expression is 
influenced here (in terms of up or down regulation) (Strachan & Read, 2011). In DNA 
methylation groups of methyl connect to the DNA and, in this way, can stop this part of 
the DNA from being active (for example, by repressing the transcription of genes when 
this takes place in a gene promoter region) (Strachan & Read, 2011). The exact 
biochemical process of how histone modification or DNA methylation works is 
discussed elsewhere (see, for example, Plomin et al., 2013 or, for a more detailed 
explanation, see Strachan & Read, 2011). 
The idea that epigenetic mechanisms play a role in insomnia has been discussed 
recently (Palagini et al., 2014). For example, we know that DNA methylation and 
histone modification are epigenetic processes that have been found to be associated with 
stress-related changes in the hippocampus (see, for example, Hunter, McCarthy, Milne, 
Pfaff, & McEwen, 2009). It has been argued that there is a certain degree of genetic 
influence on reacting with disturbed sleep when stressful life events occur and also a 
reduced volume of the hippocampus has been found to be associated with insomnia 
(Palagini et al., 2014). However, it should be mentioned that the findings are not 
consistent. Various processes that are involved in sleep were found to be affected by 
epigenetic mechanisms as well, which lead to the idea that epigenetic mechanisms may 
be involved in developing and maintaining insomnia (for a detailed discussion, see, 
Palagini et al., 2014). This discussion underlines that environmental factors (in spite of 
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a possible genetic predisposition) may play a role in the development and recovery of 
insomnia (Perlis et al., 2014). However, it can be criticised that no evidence of 
epigenetic mechanisms being directly involved in insomnia has yet been found and that 
the arguments outlined by Palagini and colleagues (2014) do include some speculation. 
Furthermore, some of the epigenetic research is based on animal models and future 
research will show to what extent these findings can be extrapolated to humans (Perlis 
et al., 2014). However, the hypothesis that epigenetic mechanisms are involved in 
developing and maintaining insomnia is interesting and should be further investigated in 
future research. 
 
1.8 What can you learn about insomnia from this thesis? – Rationale 
and research questions 
The rationale behind this PhD thesis is to gain a better understanding of the 
concept and aetiology of insomnia symptoms by illuminating the key elements involved 
in the development and maintenance of insomnia symptoms and by testing current 
theory. In considering the various cognitive (and arousal) theories of insomnia, it has 
been shown that that mindfulness, pre-sleep arousal and dysfunctional beliefs about 
sleep all play a crucial role in insomnia symptoms. These theories are supported by a 
wide variety of research findings. Behavioural genetic studies further indicate that that 
insomnia is heritable to a certain extent. However, at the present time, the cognitive 
theories of insomnia (and findings) and genetic research are largely considered 
separately. The missing piece of the puzzle is how to bring those two areas together. 
This is the underlying idea behind this PhD thesis which is entitles ‘Genetic and 
Environmental Influences on Insomnia Symptoms and Associated Cognition and 
Arousal in Young Adults’.  
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In order to gain a better understanding of the concept of insomnia, the underlying 
mechanisms described in the cognitive (and arousal) theories of insomnia will be 
considered from a behavioural genetics perspective by taking various steps. Firstly, each 
of the main elements (mindfulness, pre-sleep arousal and dysfunctional beliefs about 
sleep) that play a crucial role in the cognitive models of insomnia and particularly in the 
meta-cognitive model of insomnia are examined closely. This is done by assessing the 
genetic and environmental influence on each of them separately in order to understand 
the root of these traits. This has never been done before and is therefore important 
because it deepens our understanding of the aetiology of those key traits and broadens 
our knowledge of why these traits develop. In addition, the genetic and environmental 
influences on insomnia symptoms will also be estimated. The association of each of 
these elements with insomnia symptoms will be considered phenotypically and the 
genetic and environmental influence on these associations will also be investigated, 
which will help us to illuminate the mechanisms involved. We do know that these traits 
are important in the development and maintenance of insomnia symptoms but we do not 
know yet how these associations work. These associations have never been investigated 
from a behavioural genetics perspective. To add a further level of detail, an additional 
aim of this thesis is to consider the subscales of those variables (mindfulness, pre-sleep 
arousal and dysfunctional beliefs about sleep) and their association with insomnia. This 
will help us to dissect the relationship of these elements with insomnia symptoms at a 
deeper level. Once again, this has never been done before. Furthermore, possible 
environmental factors involved in dysfunctional beliefs about sleep are also explored. In 
order to gain an even broader insight into the concept of insomnia, non-behavioural 
genetics analyses were added, focusing on similar variables, to illuminate the concept of 
insomnia from various angles, testing the theory that there are two distinct types of 
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insomnia – one with short sleep length and one with normal sleep length (insomnia SSD 
versus insomnia NSD; Vgontzas et al., 2013). In summary, five empirical studies were 
conducted, using a twin and sibling sample of young adults to consider:  
1) Mindfulness (its subscales) and its association with symptoms of insomnia, 
anxiety and depression;  
2) Associations between pre-sleep arousal (its subscales) and insomnia symptoms; 
3) Dysfunctional beliefs about sleep (its subscales) and insomnia symptoms; 
4) Non-shared environmental factors associated with dysfunctional beliefs about 
sleep; 
5) Self-reports of insomnia with short versus normal sleep duration: comparing the 
subtypes in terms of heritability, associated phenotypes and persistence over 
time 
Please note that, in the first study which considers mindfulness and its 
association with insomnia symptoms, the depression and anxiety variables were added 
These variables were not considered in the other studies. They were only added because 
a study of genetic and environmental influences on mindfulness and its association with 
depression and anxiety in adolescence had recently been published (see, Waszczuk et 
al., 2015) and it was attempted to re-evaluate the results in an adult sample. Another 
reason for just adding them to this study only was that a lot of mindfulness-based 
treatment for insomnia is based on the mindfulness-based treatment for depression and 
anxiety. However, conceptually, the measures used for anxiety and depression 
symptoms overlap too much with the measure for pre-sleep arousal and/or dysfunctional 
beliefs about sleep to be included in the same studies (these are the key variables that 
have been investigated in the other chapters). Therefore, symptoms of anxiety and 
depression have not been added for any of the other studies conducted.  
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The final chapter of this PhD thesis aims to put the current findings (of studies 
one to five) into context, alongside the current cognitive (and arousal) theories about 
insomnia which have been very influential but have so far largely neglected the 
aetiological influence of genetics on insomnia. The role that pre-sleep arousal and 
dysfunctional beliefs about sleep play and how mindfulness fits in with all of this will 
be discussed in detail in the final chapter of this thesis. In this way, it is hoped that light 
can be shed on the mechanisms underlying the aetiology of insomnia symptoms, which 
could help us to gain an insight into the developmental processes involved and to 
deepen our understanding of the concept of insomnia symptoms. This will help us to 
gain a better understanding of the current cognitive models.  
If a high genetic overlap between these traits and insomnia symptoms is found, 
this may indicate that they are part of the same genetic cluster (as indicated in previous 
research, for example, for sleep disturbances and depression disorders; Middeldorp, 
Cath, Van Dyck, & Boomsma, 2005). This could provide us with some clues about 
possible candidate genes that can be considered in future studies. Furthermore, if we 
know that these traits are highly (genetic and/or environmental) correlated then the 
development of one (or more) these traits might give us a hint that there is a good 
chance of developing the insomnia symptoms. In the future, this could potentially help 




CHAPTER 2: Methods 
 
2.1 Overview 
This methods chapter aims to provide an overview of the methodology which is 
relevant to the empirical chapters. The chapter begins by explaining the basics of path 
diagrams, as these are used throughout the PhD thesis. Following this, the main 
principles behind the twin method will be illustrated and the main assumptions, 
univariate analysis, structural equation modelling, model fitting, multivariate analysis 
and the ADE model will be outlined. In addition, detailed information about the G1219 
sample is provided, as this sample was the basis for all the analyses conducted for this 
PhD thesis. Finally, details concerning the main variable (insomnia symptoms) will be 
provided. 
 
2.2 Path diagrams 
The method of using path coefficients was first described in detail by Wright 
(1934). Path diagrams are still widely used today as a common method of illustrating 
the models presented in twin studies (see, for example, Gregory et al., 2016; Spirtes, 
Richardson, Meek, Scheines, & Glymour, 1998). They can help us to understand the 
algebra behind the model by outlining the analysed relationships in a visual way and by 
illustrating the resemblance between twins and/or the relationships between the various 
factors involved (including the variances and covariances in a model). There are certain 
conventions as to how the elements in a path diagram should be interpreted – see 




a) Latent variable 
 
Circle or ellipsis = refers to a latent variable. This is a 
parameter which is estimated in a model. For example, the 
variance components to be estimated.  (A = genetic influence; 
C = shared environment; E = non-shared environment)  
b) Observed variable 
 
Rectangle = refers to an observed variable. This is a measured 
parameter (i.e. something fed into the model to work with). For 
example, insomnia symptoms as measured in the current 
sample. 
c) Causal Path 
 
One-sided, straight arrow = represents a causal pathway (or 
partial regression coefficient), meaning that one element leads 




Double-headed arrow = indicates a correlation or a 
(standardised) covariance between two elements in the model. 
This element is, for example, used to illustrate the genetic 
correlation between two traits. 
Figure 2.1 Conventions for the elements used in path diagrams 
In addition, there are a number of path tracing rules to follow when interpreting a path 
diagram (Rijsdijk, 2015): 
1) The covariance between two traits (or two twins) is represented by the sum of 
the paths which connect the two elements in the path diagram.  
2) For a chain of paths, a numerical value can be calculated by multiplying the 
coefficients of each path traced. 
3) It is not possible to trace through the same variable twice when following a 
chain of paths. 
4) In relation to the one-headed arrows: the tracing can go backward and then 
forward, but not vice versa (meaning forward and then backward). 
5) For every chain of paths that is traced, there can only be one bi-directional path 
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(double-headed arrow). Bi-directional paths’ from an independent variable to 
itself are traced unless there is another double-headed arrow (for example, 
indicating a correlation). 
For an illustration of how path tracing works, see the example explained under 2.3.2.1 
The ACE model. 
 
2.3 The twin method 
2.3.1 Assumptions and associated limitations  
2.3.1.1 Equal environments assumption 
The twin method is based on a series of assumptions. The first assumption is that 
the environment for MZ twins is just the same as it is for DZ twins if they are reared 
together. If MZ twins were treated more equally than the DZ twin pairs (for example, by 
dressing them alike), then this would possibly increase the MZ correlations and increase 
the difference to the DZ correlations. This would result in an inflated estimate of genetic 
influence on the trait being considered (Plomin et al., 2013). MZ twins were found to 
share the same bedroom more frequently than DZ twins of the same sex (Loehlin & 
Nichols, 1976). This may potentially affect their sleep during childhood and it is not 
clear as to what extent this effect may carry over into adulthood. However, for most 
phenotypes that have been investigated, it appears that the equal environment 
assumption is valid (see, for example, Bouchard Jr & Propping, 1993; Derks, Dolan, & 
Boomsma, 2006). A more recent review of literature, evaluating whether or not the 
equal environments assumption is applicable, argued that the evidence is mixed but that 
the bias caused in case of a violation was found to be only modest most of the time 
(Felson, 2014). It was concluded that twin studies are no more flawed than other studies 
and may actually be less flawed (Felson, 2014). Furthermore, some evidence indicates 
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that twins do not differ from non-twins in terms of insomnia experienced (Kendler et 
al., 1995). In addition to this, a recent study comparing MZ twin pairs, DZ twin pairs 
and non-twin pairs found no mean level differences for sibling relationship quality and 
no substantial differences in the way the three types of siblings behaved towards each 
other (Mark, Pike, Latham, & Oliver, 2017). It should also be mentioned here, that all 
analyses conducted for this thesis controlled for non-independence of observations. 
2.3.1.2 Sibling interaction 
A further point that should be taken into consideration is that siblings or twins 
actually form part of each other’s environment and therefore interaction is inevitable. 
Therefore, a trait in one twin may influence the trait in the other twin. For example, if 
twins/siblings share the same bedroom and one has sleeping problems, this is likely to 
negatively affect the sleep of the other twin/sibling (Plomin et al., 2013). 
A further limitation may be related to the approach of including siblings (non-
twins) in the twin analyses to add participants to the DZ group (in order to increase 
power). DZ twins are the same age whereas siblings are not. This may lead to greater 
differences in their experience and their development compared to DZ twins, which 
could lead to a bias in the results. However, siblings were modelled as a separate group 
(additional to MZ twins and DZ twins) for all analyses and the assumptions (whether or 
not the groups can be equated in means and variances) were checked thoroughly. 
Therefore, this limitation should be irrelevant for the current findings. It should be 
pointed out that the inclusion of siblings can also considered to be a strength as it 
increases the sample size and should therefore increase statistical power (for more 
details see Chapter 2: Methods, 2.3.3 Structural equation modelling) 
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2.3.1.3 Assortative mating 
The second assumption is that mating is random, not selective (or assortative). If 
this is the case, then DZ twins should, on average, share about 50% of their segregating 
genes, which is one of the fundamental principles on which the twin design is based 
(see also, Falconer’s formula outlined under 2.3.2.1 The ACE model). Segregating 
genes are the genes that make us different from each other as individuals, as opposed to 
the genes that make us similar as a human species (Plomin et al., 2013). If this is not the 
case and we were to choose partners who were similar to us, then this would result in a 
greater variance in traits within the general population, because extremes would not be 
averaged out. This would also mean that DZ twins are more likely to turn out to be 
similar, increasing the correlation between them (as it would be more likely that they 
would inherit the same genes if the parents were genetically similar), while MZ twins 
should not be affected as they share 100% of their segregating genes (Rijsdijk, 2015). 
Therefore, the difference between MZ correlations and DZ correlations would be 
reduced and the genetic influence would be underestimated. If the opposite was the case 
and the saying ‘opposites attract’ was true, this would result in a lower variance in traits 
within the general population, as traits would ‘balance out’ (Evans & Martin, 2000). For 
example, if tall individuals always mated with shorter ones, then the result would be 
that the offspring would be of average height (Plomin et al., 2013; Rijsdijk, 2015). 
Research indicates that we are prone to choosing a partner who is similar to ourselves. 
For example, assortative mating for psychiatric disorders has been found. This means 
that individuals with a psychiatric disorder are more likely to choose a partner who is 
also suffering from a psychiatric disorder (Maes et al., 1998). 
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2.3.1.4 Gene-environment correlation and interaction 
Further assumptions are that there are no gene-environment interactions or gene-
environment correlations (Evans & Martin, 2000). However, it is possible that genes 
and environment do not act independently but that they can also interact with one 
another, producing effects that are greater than each in itself (Plomin et al., 2013). 
Gene-environment interaction means that an individual can have a certain genetic 
predisposition which makes him/her more likely to be affected by certain environments 
(Plomin et al., 2013). For example, it was found that individuals who carry the s/s 
homozygous variant for the serotonin transporter polymorphism 5HTTLPR (two s-
allele), were more likely to experience depression after stressful life events as compared 
to others (long alleles in 5-HTTLPR) (Caspi et al., 2003).  
Gene-environment correlation can occur in three different forms: passive, 
evocative or active. Taking musical ability (which is heritable) as an example, if a child 
is musically gifted, he or she may have parents who are also musical and would 
therefore provide an environment in which the child’s musical ability could thrive 
(passive gene-environment correlation). The musical ability of the child may also be 
recognised at school where he/she may evoke a positive reaction from others and be 
further encouraged to develop this ability (evocative gene-environment correlation). 
The child may also actively choose environments that allow for the development of the 
musical ability, for example by joining a band (active gene-environment correlation) 
(Plomin et al., 2013; Evans & Martin, 2000). These examples illustrate how genes can 
play a role in our environment. 
2.3.1.5 Generalisability 
Finally, it is assumed that the findings obtained from twin samples can be 
generalised to the general population, assuming that twins are not different from non-
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twins (Plomin et al., 2013; Rijsdijk, 2015). However, it is known that twins differ from 
non-twins in a range of factors such as birth weight or complications at birth (Evens & 
Martin, 2000). Furthermore, MZ twins where found to be more likely to share the same 
room than DZ twins of the same gender, it is likely that twins in general share a 
bedroom more often compared to non-twins (Loehlin & Nichols, 1976). Furthermore, 
an early study showed that twins and singletons differ in terms of problem behaviours 
and emotional problems (Gau, Silberg, Erickson, & Hewitt, 1992).  
2.3.2 Univariate analysis 
2.3.2.1 The ACE model 
If all the assumptions outlined above are correct, then we can say that any 
difference between MZ twins must be due to non-shared environment (as they share 
100% of their segregating genes and 100% of their environment). Non-shared 
environment does include error as well. DZ twins share 100% of their environment but 
only 50% of their segregating genes. Therefore, any difference between DZ twins could 
be due to genes and/or non-shared environment (Plomin et al., 2013). In all the current 
analyses siblings were added. However, in order to keep the following explanation 
simple, the role of siblings will not be discussed below, but at some later point (see 
2.3.3 Structural equation modelling).  In twin analysis, intra-class correlations 
between MZ twin pairs and DZ twin pairs for a trait are compared in order to estimate 
the relative contribution of additive genetic (A), shared environmental (C) (or non-
additive genetic influence: D, dominance - when the effects of the alleles are not equal; 
see 2.3.2.2 The ADE model for further explanation) and non-shared environmental 
influence (E) on the trait under investigation. Intra-class correlations are different from 
the regular Pearson’s correlations as they are based on the whole group (all MZ twin 
pairs or DZ twin pairs or pooled), rather than on the single pairs independently (Rijsdijk 
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& Sham, 2002). In summary, if we compare the difference in similarity in a trait 
between the MZ group and the DZ group, the relative contribution of genetic and 
environmental influences on that trait can be estimated. How this works exactly is 
illustrated below, using path diagrams. 
According to Wright’s rules of path tracing (1934), the variance (which is the 
covariance of a trait with itself) is the sum of all legitimate paths’ in the chain as 
outlined below (Rijsdijk, 2015). By following the dotted arrows in the path diagram, the 
expected variance can be calculated using the formula below. To describe the variance 
of any measured trait (irrespective of whether it is an MZ twin or DZ twin) the chain of 
paths would be traced as follows: starting at the measured variable, we go up the ‘a’ 
path, multiply by one and go down again. Then we trace up the ‘c’ path, multiply by 
one and go down again, Finally, the chain of paths is completed by going up the ‘e’ 
path, multiplying by one and then going back to the measured variable again (see 
Figure 2.2). 
 
Following the chain of paths using the path tracing 
rules, we arrive at the following result for the 
variance of a trait (Vt): 
a * 1 * a = a² 
and 
c * 1 * c = c² 
and 
e * 1 * e = e² 
Therefore, the total variance of a trait is Vt = a² + c² 
+ e² (Rijsdijk, 2015). 
Figure 2.2 The variance of a trait in any twin/sibling (applies to both twins/siblings of a 
twin/sibling pair) 
Note: a = path coefficient for genetic influence; c = path coefficient for shared environmental influence; e = path 
coefficient for non-shared environmental influence; A = estimate of additive genetic influence; C = estimate for 




The covariance between twin one and twin two for the same trait for MZ twins is 
the sum of all legitimate paths’ in the chain as outlined below (Rijsdijk, 2015). 
Following the dotted lines in Figure 2.3: We trace from twin 1 (measured trait) up the 
‘a’ path of the first twin and move across the double-headed arrow, which has the value 
1 assigned to it (as MZ twins share 100% of the segregating genes). Then we trace 
down the ‘a’ path of the second twin (to the measured trait in the second twin). We also 
need to add a second chain of paths, going up the ‘c’ path of the first twin, moving 
across the double-headed arrow which has the value 1 assigned to it (as MZ twins share 
100% of their environment), then going down the ‘c’ path of the second twin (to the 
measured trait of the second twin).  
 
 
The covariance between MZ twin 1 
and MZ twin 2 (CovMZ) is 
= (a * 1 * a) + (c * 1 * c) = 
= a² + c² 
or 
CovMZ = A + C (also rMZ = A + C) 
 
Figure 2.3 The covariance for any trait for MZ twin pairs (reared together) 
Note: a = path coefficient for genetic influence; c = path coefficient for shared environmental influence; e = path 
coefficient for non-shared environmental influence; A = estimate of additive genetic influence; C = estimate for 




The covariance between twin one and twin two for the same trait for DZ twins is 
the sum of all legitimate paths’ in the chain as outlined below (see Figure 2.4) 
(Rijsdijk, 2015). Following the dotted lines in Figure 2.4: We trace from twin 1 
(measured trait) up the ‘a’ path of the first twin, move across the double-headed arrow 
which has the value .5 assigned to it (as DZ twins share on average 50% of the 
segregating genes), then go down the ‘a’ path of the second twin (to the measured trait 
in the second twin). We also need to add a second chain of paths, going up the ‘c’ path 
of the first twin, moving across the double-headed arrow which has the value 1 assigned 
to it (as DZ twins share 100% of their environment), then going down the ‘c’ path of the 
second twin (to measured trait of the second twin).  
 
 
The covariance between DZ twin 1 and 
DZ twin 2 (CovDZ) is 
 = (a * .5 * a) + (c * 1 * c) = 
 = .5 * a² + c² 
or 
CovDZ = .5A + C  
(also rDZ = .5A + C) 
 
Figure 2.4 The covariance for any trait for DZ twin pairs (reared together) 
Note: a = path coefficient (unstadardised) for genetic influence; c = path coefficient for shared environmental 
influence; e = path coefficient for non-shared environmental influence; A = estimate of additive genetic influence;  




In order to obtain the covariance between MZ twins, as well as when considering 
DZ twins, we do not need to trace the ‘e’ path. Only genes and shared environment 
contribute to the similarity between twins, while non-shared environment includes all 
those factors that make them different from each other. Therefore, this path does not 
need to be traced.  
The path coefficients can be standardised by dividing their value by the square-
root of the (overall, unstandardised) variance. Once they are then multiplied by 
themselves (a², c² or e²) they are also referred to as A, C and E (as they describe the path 
for the estimate). Note also that a correlation is a standardised covariance (Rijsdijk, 
2015). 
In summary, the variance of a trait is Vt = a² + c² + e², the covariance within MZ 
twin pairs for a trait is rMZ = a² + c² and the covariance within DZ twin pairs for a trait 
is rDZ = .5 * a² + c². If we combine all this information into one formula, we know that: 
a² = 2(rMZ - rDZ) 
c² = rMZ - a² 
e² = 1 - rMZ 
This means that if we have data that provides information about Vt, rMZ and 
rDZ for a trait, then we have enough information to estimate a², c² and e² for that trait – 
this is also known as Falconer’s formula or equation (Rijsdijk & Sham, 2002). As we 
have three parameters to be estimated (a², c² and e²) and three predictive statistics (Vt, 
rMZ and rDZ), the model is described as a ‘just identified’ one. Theoretically, the total 
variance of a trait is Vt = a² + c² + d² + e², which also includes the non-additive genetic 
influence (d²). However, in order to make the above explanation simpler, d² has been 
omitted. Furthermore, it is only possible to estimate three parameters using the formula 
(as we only have three predictive statistics, otherwise the model would not be identified 
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– a model is ‘identified’ if we estimate as many parameters as we have predictive 
statistics). Therefore, we can either estimate a², c² and e² (called ACE model) or a², d² 
and e² called ADE model) in a univariate model like the one outlined above (Rijsdijk & 
Sham, 2002; Purcell, 2013). For more information about the ADE model, see below. 
 
2.3.2.2 The ADE model 
In one of the chapters, an additional model (the ADE model) was run but was not 
presented as it did not add any useful information (D was not significant in the model - 
95% confidence interval overlapping 0). This model is therefore discussed only briefly 
here. This model was run in Chapter 4: Associations between pre-sleep arousal and 
insomnia symptoms in early adulthood: a twin and sibling study, because the 
difference between the MZ correlations and the DZ correlations was relatively large. 
We can explain the difference between the genetic influences in the following way: 
while we assume for ‘A’ that genetic influences add up, ‘D’ refers to dominance or non-
additive genetic influence. Non-additive genetic influence occurs when alleles (variants 
of genes) at the same locus interact (in contrast to epistasis which refers to alleles 
interacting at different loci) (Rijsdijk, 2015). Dominance does not play a role in the 
similarity of MZ twins, as they are genetically identical. For DZ twins, the chances of 
inheriting the same allele for a DZ twin pair are one in four for each gene (which has 
two allele), as only one allele is inherited from each parent and two DZ twins are 
considered (Plomin et al., 2013). Therefore, DZ twins correlate .25 for D – hence the 
algebra behind the ACE model can easily be adapted to test the ADE model (by 
changing the value of 1 for C in the ACE model to .25 for D to represent the ADE 
model). However, in the performed analysis, D was not significant. Therefore, this 
model did not add any useful information and was not reported.  
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2.3.3 Structural equation modelling 
The Falconer’s formula outlined above gives us a rough idea of the magnitude of 
genetic, shared and non-shared environmental influences explaining the variance in a 
trait when analysing twin data. Whereas simple algebra can be calculated by hand, 
structural equation modelling is more advanced in that it allows us to obtain more exact 
estimates and also 95% confidence intervals which provide information about the 
precision of the estimates. 
Structural equation modelling also provides more flexibility as it allows us to 
form the model according to certain requirements, which makes it more exact. For 
example, in the analyses presented in this PhD thesis, siblings were included as a 
separate group to be modelled in addition to the MZ and the DZ twins, rather than just 
adding them to the DZ twin group. This allowed for the assumptions to be checked and 
tested whether or not the two groups could be equated without a significant decrease in 
model fit. The details about the sibling group are provided in the tables of the 
descriptive statistics and in the tables for the twin/sibling correlations for each of the 
studies conducted. However, as it was possible to equate the sibling group to the other 
groups for all analyses, this group will not, from this point on, be discussed separately 
and will only be referred to as the DZ twin group in all result sections, explanations and 
discussions. 
An additional advantage of structural equation modelling is that it allows for 
different models to be compared. For example, it is possible to drop parameters (or add 
constraints) and then to check whether or not the fit becomes significantly worse. If this 
is the case, then we know that the model is better with that parameter included in it – 
hence, the parameter must have played a role to some extent (Rijsdijk, 2015). When 
different models are compared, the one that best describes the data is chosen. This gives 
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a more detailed insight than just considering the rough estimates obtained using the 
Falconer’s formula. 
2.3.4 Model fitting 
The twin analyses conducted within this PhD thesis were all run in OpenMX, a 
twin model fitting package in ‘R’ (Boker et al., 2011). This software starts by fitting a 
saturated model to the twin/sibling data. A saturated model describes the data perfectly 
by including a maximum number of free parameters to describe the means, variances 
and covariances/correlations for an observed trait (or various observed traits) (Rijsdijk, 
2015). It provides a baseline for fit comparison. Furthermore, the twin model 
assumptions are tested in the saturated model by checking whether or not means and 
variances can be equated within the twin/sibling pairs and across the different zygosity 
groups (Rijsdijk, 2015). In addition, it is possible to test whether means and variances 
can be equated between the twin allocated as ‘1’ and the twin allocated as ‘2’ according 
to their birth-order. For the G1219 sample the twins were entered in a random order, but 
this assumption was still tested. In the next step, a genetic model is fitted (dropping 
parameters, or adding constraints) and compared to the saturated model. Model fitting is 
basically a process of optimisation which means that the parameters are manipulated 
(changing the parameters in an intelligent way, trying out different values) to find out 
which estimates produce the best fit for the observed values (sample-dependent) and the 
expected values (model-dependent) (Purcell, 2013). In the genetic model, parameters 
can be dropped until the most parsimonious model (which still fits the data well) is 
achieved. Parsimony refers to the idea of a ‘simpler’ model, which means that fewer 
parameters are estimated wherever possible (Sober, 1981; Vandekerckhove, Matzke, & 
Wagenmakers, 2014). In general, according to the law of parsimony or ‘Ockham’s 
razor’ (“entities should not be multiplied beyond necessity” Neale, 2015, p. 9), more 
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parsimonious models should be preferred over less parsimonious ones, unless this 
results in a decreased model fit (Neale, Heath, Hewitt, Eaves, & Fulker, 1989). This is 
based on the idea that the simpler the theory, the more likely it is that it can be applied 
and the less difficult it is to test – hence the more parsimonious the model, the more 
likely it is to be accurate (Neale et al., 1989). If the fit does not get significantly worse, 
this indicates that the nested model still fits the data well (with the parameters dropped). 
It should be noted that E can never be dropped as it includes measurement error 
(Purcell, 2013).  
The goodness of fit is indicated by the difference in twice the negative log 
likelihood (-2LL), which is tested in OpenMX by applying a chi-squared test. A p-value 
> .05 indicates that the fit for the nested model got worse and therefore it would be less 
ideal for describing the data (Rijsdijk & Sham, 2002). The idea is to choose the most 
parsimonious model which still describes the data well (meaning that it does not get 
significantly worse in fit in comparison to other models which include more parameters 
or fewer constraints) (Purcell, 2013). 
A further indicator for the model fit is the Akaike Information Criterion (AIC). It 
is calculated by the chi-squares minus two times the degrees of freedom (Neale et al., 
1989; Tabachnick & Fidell, 2007).  
AIC = χ2 - 2(df)  
(Tabachnick & Fidell, 2007, p.719) 
A negative AIC is an indication of a good model fit, and the lower the AIC, the better 
the goodness of fit (Neale et al., 1989). 
2.3.5 Multivariate analysis 
Multivariate genetic analysis allows consideration of various traits at the same 
time, making it possible to illuminate the role that genetic and environmental factors 
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play on their associations. Instead of just estimating the correlations between twins or 
sibling pairs for one trait (as in univariate analysis), within-twin/sibling-cross-trait and 
cross-twin/sibling-cross-trait covariances are added to the model to illuminate the 
genetic, shared environmental and non-shared environmental factors involved in the 
association between the considered variables. This is done in addition to estimating the 
influence of A, C and E on each trait separately, as in univariate analyses (Rijsdijk & 
Sham, 2002). Common aetiological influences can be inferred from the within-
twin/sibling-cross-trait covariances, while the cross-twin/sibling-cross-trait covariances 
indicate whether or not these influences are familial (meaning because of an overlap in 
A and/or C). By considering the ratio between the MZ cross-twin-cross-trait covariance 
and the DZ/sibling-cross-twin-cross-trait covariance, it can be differentiated if these 
common familial factors are due to genetic or shared environmental influences (Rijsdijk 
& Sham, 2002). 
For the multivariate analysis referred to in various chapters (see Chapters 3, 4 
and 5), three models were compared: the correlated factors solution, the independent 
pathway and the common pathway model. These models are outlined in the following 
examples using four variables for illustration. They make similar assumptions but they 
vary in terms of the model constraints which are added (Rijsdijk & Sham, 2002). As the 
three models are nested, it is possible to compare them (see also, Chapters 3, 4 and 5). 
Models are nested within each other if they make similar assumptions, but just 
constraints are added or parameters are dropped (for a more detailed explanation see 
2.3.5.3 The common pathway model). If a model fit does not get significantly worse, 
then the more parsimonious model can be chosen. A further indicator that can help with 
the decision as to which model to choose is the AIC (see, explanation above). Note that 
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other models do exist but are not mentioned here as they are not relevant to the analyses 
conducted within this PhD thesis. 
The decision which variables to include in a multivariate analysis in the first 
place is usually based on theoretical knowledge and on the phenotypic correlations. It 
should be mentioned here that there is a general consensus that very small or non-
significant associations should not be decomposed at all but there is no consensus as to 
where the exact cut-off point should be for associations that are worth decomposing. 
Consequently, no cut-off point has been provided for the analyses conducted in this 
PhD thesis. However, only significant phenotypic correlations were considered for 
multivariate analysis. Note also that, conceptually, it does not make sense to include an 
overall score in the same multivariate as the subscales because this is just the sum of the 
subscales. 
2.3.5.1 The correlated factors model 
For the correlated factors solution, it is assumed that each trait has genetic, 
shared-environmental and non-shared environmental influences. These influences are 
allowed to correlate with the same influences on the other traits in the model (see 
Figure 2.5 on the next pages, Loehlin, 1996). Note that the correlated factor solution 
and the Cholesky decomposition are mathematically equivalent (Rijsdijk, 2015). This is 
not relevant to the analyses conducted within this PhD and is therefore not discussed 
here in detail. However, the Cholesky model makes additional assumptions about the 
causal directions of effects and should therefore only be used if the analysis is based on 
a specific hypothesis or theory that justifies these causal directions (Loehlin, 1996). As 
causality cannot be established reliably from cross-sectional data, this model is better 
used with longitudinal data (Loehlin, 1996).  
The path diagram below illustrates that the correlated factors solution allows us 
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to draw conclusions about the extent to which the genetic factors influencing variables 
W, X, Y and Z correlate with each other. If a high genetic correlation is found for all 
variables, this means that there is overlap between genes influencing one trait and the 
others (see Figure 2.5.a, Loehlin, 1996; Rijsdijk & Sham, 2002). This kind of analysis 
can, for example, also reveal that there is a genetic overlap between two traits but not 
between other traits – allowing us to differentiate between the various associations. 
The correlated factors solution also shows the extent to which there is an overlap 
in shared environment. This examines whether or not the shared environmental factors 
on one trait correlate with those that influence another trait (see Figure 2.5.b; Loehlin, 
1996; Rijsdijk & Sham, 2002). Genetic and shared environmental factors are influences 
that contribute to the similarity between twins. There is a wide range of possible shared 
environmental factors, for example, parental education or neighbourhood – although 
these are only ‘shared environmental influences’ if they increase similarity within 
individuals within a family (Plomin et al., 2013). 
The model also reveals the extent to which the non-shared environmental factors 
of one trait correlate with the other traits (see Figure 2.5.c, Loehlin, 1996; Rijsdijk & 
Sham, 2002). This refers to the overlap in non-genetic factors which makes twins 
dissimilar. For example, if there was a high correlation of non-shared environmental 
factors between the variables X, Y and Z, but not with W, this would mean that the 
environmental factors that cause a difference between twins in variables X overlap with 
the ones that cause a difference between twins in variables Y and Z while for variable 
W other factors were involved causing dissimilarities. Examples of non-shared 
environmental influences could include peer influence, accidents or independent life 
events in general (such as the death of the spouse), although specific non-shared 
environmental influences depend on the effect they have (Plomin et al., 2013). 
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   a. 
 
   b. 
 
   c. 
 
Figure 2.5 Correlated factors solution 
Note: A = additive genetic influence; C = shared environmental influence; E = non-shared environmental influence; 
part a. shows the genetic correlations; part b. shows the shared-environmental correlations; part c. shows the non-





2.3.5.2 The independent pathway model 
The independent pathway model assumes that common genetic factors, common 
shared environmental factors and common non-shared environmental factors influence 
traits directly. Specific genetic, shared environmental and non-shared environmental 
factors are also allowed to contribute to the variance of each phenotype individually 
(see Figure 2.6) (Markon & Krueger, 2004). The independent pathway model is nested 
in the correlated factor solution (if more than three variables are analysed) and it is the 
more parsimonious model (Markon & Krueger, 2004). 
 
Figure 2.6 Independent pathway model 
Note: A = additive genetic influence; C = shared environmental influence; E = non-shared environmental influence 
 
2.3.5.3 The common pathway model 
The common pathway model assumes a genetic, shared environmental and a 
non-shared environmental influence on the variables via a higher order latent 
(estimated) factor (Rijsdijk & Sham, 2002). Specific genetic, shared environmental and 
non-shared environmental factors that contribute to the variance of each phenotype 
independently are also specified (see Figure 2.7 overleaf) (Markon & Krueger, 2004). 
The common pathway model is nested in the two previously discussed models, makes 
similar assumptions but estimates fewer parameters. Therefore, it is even more 
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parsimonious than the independent pathways model. An easy way to demonstrate that 
the common pathway model is more parsimonious than the independent pathway 
model, which again is more parsimonious than the correlated factor solution, is to count 
the paths for each model (illustrated as arrows). The common pathway model with four 
variables includes 19 paths while the independent pathway model has 24, and the 
correlated factor solution has 30 paths. If we add the number of variables to the total 
number of paths counted (as the mean for each of the four variables is also estimated), 
then we get the total number of estimated parameters for the model. 
 
Figure 2.7 Common pathway model 
Note: A = additive genetic influence; C = shared environmental influence; E = non-shared environmental influence 
 
2.3.5.4 Models including three measured variables 
If three variables are included, then the same number of parameters are estimated 
for both the correlated factors solution and the independent pathway model (21 
parameters in total: the mean for each variable plus all the paths’, see Appendix A for 
illustration). In this case, the independent pathway model is not nested in the correlated 
factor solution (neither is it more parsimonious). Two models can only be compared in 
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fit if one model is nested in the other. This means that the set of parameters of the first 
model is a subset of parameters of the second (nested) model (Rijsdijk and Sham, 2002; 
see also, chapter four). 
 
2.4 The G1219 sample 
2.4.1 History of data collection for G1219: Waves 1, 2 and 3  
The participants for the Genesis 12-19 sample (G1219) were recruited from two 
different sources – via the families of the GENESiS study (Sham et al., 2000) and via 
the UK Office for National Statistics. Of the 40,000 adults from the GENESiS study, 
approximately 9,000 indicated that they had children. Those adults were invited to 
participate if their children were between 12 and 19 years old. This resulted in responses 
from 1,241 families with 1,747 adolescent children (aged 12 - 19 with a mean age 15), 
including 445 sibling pairs (McAdams et al., 2012). The twins were mainly recruited 
through the UK Office of National Statistics by randomly selecting twin pairs born 
between 1985 and 1988 and then contacting their parents (2,947 families in total). Of 
the total number of parents contacted, 1,381 families and just as many twin pairs agreed 
to participate (McAdams et al., 2012). Over five consecutive waves, data was collected 
from the twin and sibling pairs, as well as from their parents (but not for all the waves). 
The original aim was to investigate how genes and environment interplay in depression 
in adolescence but measures of various other traits were added across the waves 
(McAdams et al., 2012). 
The data collection for wave one started in 1999 and 1,890 families with 3,640 
adolescents (aged 12 to 19, with a mean age of 14 and with 48% males) took part. In 
2001/02, the second wave of data collection was conducted but only twin and sibling 
pairs (not their parents) were asked to complete the battery of questionnaires. There was 
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some attrition which meant that 73% of the original sample took part, resulting in a total 
of 2,651 participants (1,372 families). The age range was 12 to 21 (mean age 15 years) 
and 44% of the participants were male (McAdams et al., 2012). In 2003/04, the third 
wave of data was collected. This included twins, siblings and their parents (parents 
reported their own emotions and behaviour, as well as that of their children). Again 
there was some attrition and, in comparison to wave two, 67% participated in the study. 
In comparison to wave one, 48% participated in the third wave. This meant that 1,778 
twins and siblings from 913 families actually took part. They were aged between 14 and 
23 (with a mean age of 17) and 40% of them were males. For wave 2 and 3, zygosity 
was assessed by using a questionnaire which asked the mothers of the twins about 
physical similarities (Cohen et al., 1975). Where there was doubt, a genetic test was 
undertaken to obtain zygosity (26 cases) (McAdams et al., 2012). 
2.4.2 Relevance to the current analyses: Waves 4 and 5 
The data from waves 4 and 5 of the G1219 longitudinal twin and sibling study 
was the focus of the analyses in this PhD thesis, as sleep-related measures were only 
added for those two waves. Wave 4 data was collected in 2007 and 88% of the 
participants of the previous wave agreed to take part. In comparison to wave one, 42% 
participated in the fourth wave. This meant that a total of 1,556 individuals from 896 
families participated. The sample included 39% of males with an age range of 18 - 27 
and a mean age of 20. (Denis et al., 2015; McAdams et al., 2012).  
The most recent data collection wave took place in 2012/13. Wave 5 was the 
only wave in which the key variables central to this PhD topic were measured 
(mindfulness, pre-sleep arousal and dysfunctional beliefs about sleep). This is the 
reason why wave 5 data was used for all of studies in this PhD thesis. For one study it 
was also possible to use wave 4 (see Chapter 7: Self-reports of insomnia with short 
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versus normal sleep duration: comparing the subtypes in terms of heritability and 
associated phenotypes) because all the variables relevant to the analysis were collected 
in wave 4 as well. Tests showed that there was no selective attrition in the key variables 
between those waves (for more information, see Chapter 7, 7.4.4 Persistence over 
time). In comparison to the previous wave, 55% participated in wave five (23% in 
comparison to wave one). Wave 5 included data from 862 individuals, consisting of 223 
monozygotic (MZ) twins, 404 dizygotic (DZ) twins and 218 siblings (Denis et al., 
2015). Participants were aged between 22 and 32 (with a mean age of 25) and 34% of 
them were male (Denis et al., 2015).  
2.4.3 Ethical approval 
For all data collection waves, ethical approval was either gained from 
Goldsmiths College, University of London (for waves 4 and 5) or from the Research 
Ethics Committees of the Institute of Psychiatry (South London and Maudsley NHS 
Trust, for waves 1 to 4). Informed consent was obtained from all participants (either 
directly if >= 16 years of age, or via the parents if < 16 years of age). 
2.4.4 Data preparation 
SPSS (IBM, 2013; version 22) was used for data cleaning and transformation of 
various variables and deleting outliers +/ - 3 SD away from the mean, as is standard (if 
required; Gregory et al. 2016). The variables which were skewed or showed kurtosis 
were transformed where necessary. Furthermore, sex and age were regressed out in 
preparation for the genetic model fitting with OpenMX (Boker et al., 2011), as is 
standard for twin/sibling analyses (Bolhuis et al., 2014; Gregory et al., 2011). Age and 
sex should be regressed out because if we do not correct for these influences this would 
result in an over-estimation of the intraclass twin correlations (McGue & Bouchard, 
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1984). Age is the same in both MZ and DZ twin pairs and could make them more alike 
if age was an important factor influencing the trait under investigation (i.e. artificially 
inflating both MZ and DZ intraclass correlations). Sex needs to be regressed out 
because it is perfectly correlated in MZ but not in DZ twin pairs. Therefore, this could 
artificially inflate the MZ twin intraclass correlation in comparison to the DZ intraclass 
correlation (McGue & Bouchard, 1984). It should also be mentioned that cases where 
the zygosity information is missing (N = 14) were excluded from all analyses.  
 
2.5 Sensitivity analyses 
Sensitivity analyses were performed for all analyses run in SPSS (IBM, 2013), 
STATA (StataCorp, 2015) and OpenMX (Boker et al., 2011). This means that all 
analyses were re-run on raw data (without transforming the variables, deleting outliers 
or regressing out age and sex), verifying whether or not different results were obtained. 
Wherever the sensitivity analyses showed similar results, only the results from the 
prepared data were presented. 
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CHAPTER 3: Mindfulness and associations with symptoms of 




Mindfulness, or meta-cognition, is the central element of the meta-cognitive 
theory of insomnia (Ong et al., 2013) (see 1.3.1 Theories most relevant to this thesis – 
Cognitive models of insomnia for a detailed discussion). The rationale of this study is to 
gain a better understanding of the concept and the aetiology insomnia, by considering the 
roots of mindfulness and its association with insomnia symptoms from a behavioural 
genetics perspective. By understanding the mechanisms underlying the aetiology of 
insomnia symptoms and gaining an insight in the elements involved at a deeper level (by 
considering the subscales of insomnia) it may further be possible to improve insomnia 
treatment in the future. Furthermore, in spite the great research interest in mindfulness 
over the last two decades (Ie, Ngnoumen, & Langer, 2014; Kabat-Zinn, 2003), there is 
still much to learn. We need to further understand the reasons why some people are more 
mindful than others. Here, a behavioural genetic approach is adopted to shed light on 
these individual differences. 
3.1.1 Conceptualisation of mindfulness 
When conducting research involving mindfulness, it is crucial to explain how 
mindfulness is conceptualised for the present study. Mindfulness is generally defined as 
being present in the moment and being aware of inner as well as outer experiences while 
adopting a non-judging perspective (Kabat-Zinn, 1994). Mindfulness can be 
conceptualised in various ways: as a state, trait, or a skill that is learned (Sauer et al., 
2013). To allow for a detailed insight into the concept of state mindfulness, five elements 
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are focused on in the current analyses: ‘nonreactivity to inner experience’, ‘observing’, 
‘acting with awareness’, ‘describing’ and ‘nonjudging of inner experience’. 
‘Nonreactivity to inner experience’ refers to the extent to which one is able to notice 
emotions and thoughts but then to be able to let them go without having to react to them. 
For example, one may notice that he/ she is sad without having to cry. ‘Observing’ 
reflects the extent to which someone is able to observe, notice or attend to the world 
around them as well as their inner experience, including their sensations, perceptions, 
thoughts and feelings. The ‘acting with awareness’ component examines the extent to 
which one is present in the moment, the here and now, and is paying attention to what 
they are doing or experiencing. The facet ‘describing’ refers to the ability to label or 
describe any experience of the inner world (for example feelings, thoughts, beliefs and 
expectations). Finally, ‘nonjudging of inner experience’ reflects the extent to which 
someone is able to accept feelings and thoughts, avoiding making a judgement about 
their inner experience (Baer, Smith, Hopkins, Krietemeyer and Toney, 2006). This is in 
line with Baer and colleagues view (2006) of mindfulness as having various facets which 
are useful to be explored. 
3.1.2 Mindfulness sub-scales and other traits 
Before exploring the association of mindfulness (and its subscales) with insomnia 
symptoms, depression and anxiety, it is useful to consider what we already know about 
the association mindfulness and related traits in this area. Greater mindfulness has been 
associated with better sleep quality (Howell, Digdon, Buro & Sheptycki, 2008), greater 
well-being (Brown & Ryan, 2003) and with lower levels of depressive and anxiety 
symptoms (Cash & Whittingham, 2010; Waszczuk et al., 2015).  Furthermore, 
mindfulness-based approaches are used to treat insomnia, depression and anxiety 
(Hofmann et al., 2010; Hubbling et al., 2014; Ong et al., 2012; Vøllestad, Sivertsen, & 
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Nielsen, 2011). Metacognitive processes such as mindfulness were further discussed to 
be crucial in the development and maintenance of insomnia and have taken a central role 
in cognitive theories of insomnia (for a detailed discussion see 1.3.1 Theories most 
relevant to this thesis – Cognitive models of insomnia). Despite these associations, it 
is important to consider mindfulness subscales when examining co-occurrence with other 
traits because certain mindfulness subscales may be particularly strongly associated with 
certain psychiatric difficulties. For example, self-reported ability to adopt a nonjudging 
attitude has been shown to predict lower levels of depression and anxiety symptoms 
(Cash & Whittingham, 2010). Furthermore, a greater ability to act with awareness was 
found to predict lower levels of depression symptoms but did not predict anxiety 
symptoms (Cash & Whittingham, 2010). It should be mentioned that this study used 
cross-sectional data. Therefore, causality cannot be inferred. Furthermore, a non-clinical 
sample was used. In a different study, four of the five subscales of mindfulness 
(‘nonreactivity to inner experience’, ‘describing’, ‘acting with awareness’ and 
‘nonjudging of inner experience’, but not ‘observing’) were found to be associated with 
sleep quality (Caldwell, Harrison, Adams, Quin & Greeson, 2010) – with greater 
mindfulness being related to better sleep quality. It can be criticised that this study 
focused exclusively on college students. No study has yet examined the role that the 
subscales of mindfulness play in insomnia symptoms (at the time that this chapter was 
written). 
3.1.3 Heritability of mindfulness 
Little is known about the heritability of mindfulness. To date, only one twin 
study has explored the genetic and environmental influences on ‘trait’ mindfulness in 
adolescents. This study focused exclusively on the attentional aspect of mindfulness, 
finding that ‘trait’ mindfulness in adolescence was moderately heritable (additive 
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genetic influence, A = .32) and was influenced by non-shared environmental factors (E 
= .66), with no significant influence of shared environmental factors (C = .02; 
Waszczuk et al., 2015). However, it can be criticised that only a shortened version of 
the measure Mindfulness Attention and Awareness Scale (5 items only) was used, 
giving a rather limited insight into the concept of mindfulness (Waszczuk et al., 2015; 
Bergomi et al., 2013). 
Twin studies can go beyond telling us about the heritability of a trait and can 
also help to elucidate the reasons why it overlaps with other traits (see Plomin et al., 
2013). Only one study has addressed the reason for overlap between mindfulness and 
other variables (namely depressive symptoms and anxiety sensitivity) and this work was 
conducted in the aforementioned adolescent sample (Waszczuk et al., 2015). It was 
found that mindfulness, symptoms of depression, and anxiety sensitivity shared 
moderate genetic and to a lesser extent non-shared environmental correlations. 
Furthermore, genetic influences accounted for more than half of the phenotypic 
association between the three traits. The results are yet to be evaluated in an adult 
sample. Therefore, the variables depression and anxiety symptoms were added in the 
current study. Furthermore, the genetic and environmental influences on the association 
between mindfulness and insomnia symptoms are yet to be explored.  
 
3.1.4 Aims of the current study 
Given the links between mindfulness, sleep and good mental health, it is 
important to understand more about what makes people differ in terms of this trait. 
Understanding more about the aetiology of the overlap between mindfulness and 
symptoms of insomnia (and depression and anxiety) will also help us to further 
understand these interesting links with the ultimate aim of using this information to 
 
115 
facilitate prevention efforts and treatment. Very little is known about the heritability of 
mindfulness. The current study is novel in that it estimates genetic and environmental 
influences on mindfulness and its subscales for the first time (in early adulthood). 
Furthermore, the genetic and environmental influences on the association between 
overall mindfulness and symptoms of insomnia, depression and anxiety and their 
association will be estimated for the first time. Therefore, aims where formulated rather 
than hypotheses, which would point into a certain direction: 
1) The magnitude of associations between mindfulness (including focusing on 
the subscales) and symptoms of insomnia, depression and anxiety.  
2) Genetic and environmental influences on mindfulness (including focusing on 





Data from wave 5 of the Genesis 12-19 (G1219) longitudinal twin/sibling study 
(Denis et al., 2015) was the focus of this study as this is the only wave in which 
mindfulness has been measured. Wave 5 included data from 223 monozygotic (MZ) 
twins, 404 dizygotic (DZ) twins and 218 siblings (see Denis et al., 2015). Participants 
were aged between 22 and 32 (mean age 25 years) and, out of a total of 862 individuals, 
34.3% were male. For a more detailed description of the sample, see Chapter 2: 





Mindfulness was assessed by the Five Facet Mindfulness Questionnaire (FFMQ, 
Baer et al., 2006). The FFMQ comprises five subscales (‘nonreactivity to inner 
experience’, ‘observing’, ‘acting with awareness’, ‘describing’ and ‘nonjudging of inner 
experience’). The original version of the measure contains 39 items, but for the current 
study, it was shortened to 21 items (see Appendix B: Items included from the FFMQ). 
The four items with the highest factor loading for each subscale were selected (Baer et 
al., 2006). The ‘nonreactivity to inner experience’ subscale had three items with the 
same factor loading so five items where included for this scale (Baer et al., 2006). Each 
item of the FFMQ was coded 1-5, ranging from “never or very rarely true”, to “always 
or almost always true”, as recommended in the original publication of the FFMQ (Baer 
et al., 2006). Items were summed for the subscales and for overall mindfulness (the 
latter therefore had a theoretical range from 21 to 105). Cronbach’s alphas for the 
current sample were ‘nonreactivity to inner experience’ = .87; ‘observing’ = .80; ‘acting 
with awareness’ = .84; ‘describing’ = .86; ‘nonjudging of inner experience’ = .88; and 
overall mindfulness = .81.  
Usually, higher scores on the FFMQ indicate greater mindfulness. For ease of 
interpretation and to allow the decomposition of positive associations in the multivariate 
genetic models, all mindfulness scores were reverse coded so that higher scores indicate 
less mindfulness. The question “How much experience do you have with meditation?” 
was added to the battery. This allowed us to control for meditation experience in our 
analyses, which is known to influence the mindfulness score (see, for example, Baer et 
al., 2006; Walach, Buchheld, Buttenmüller, Kleinknecht & Schmidt, 2006). This way it 




3.2.3 Insomnia symptoms  
Insomnia symptoms were measured using the Insomnia Symptoms 
Questionnaire (ISQ, Okun et al., 2009), using a 6-item version. The first data collection 
for insomnia symptoms (wave 4) was in process already before the ISQ was published, 
while collaborating with one of the co-authors (Dan Buysse). In the final published 
version of the ISQ a few items were added which are here summarised under item 6 
(Okun et al., 2009). The ISQ was designed to be coded as a dichotomous variable but 
was coded as a continuous variable for the purpose of the current study (after 
corresponding with one of the authors of the original measure, Dan Buysse). Each item 
was coded 0 - 4 based on frequency response (‘never/don't know’ = 0; ‘rarely’ = 1; 
‘sometimes’ = 2; ‘frequently’ = 3; ‘always’ = 4). The total scale score was calculated by 
taking the sum of all the responses, ranging from 0 to 24, with higher scores indicating 
more severe insomnia symptoms. The items of the ISQ (Okun et al., 2009) overlap 
largely with the items of the ISI (Morin et al., 2011), which is coded as a continuous 
variable (see Appendix C for a list of items included in the ISQ and the ISI). The ISQ 
was coded as a continuous measure in a previous study using the G1219 sample 
(Gregory et al. 2016), as well as in other studies (see, for example, Sánchez-Ortuño & 
Edinger, 2010). Furthermore, Cronbach’s alpha for the ISQ in the current sample was 
.87 and the ISQ score was highly correlated with the global score of the Pittsburgh 
Sleep Quality Index (PSQI; r = .73, p < .01; Buysse et al., 1989), confirming the 
validity of the continuous scoring of the measure. 
3.2.4 Depression symptoms 
Depression symptoms were measured by the mood and feelings questionnaire 
(MFQ; Angold et al., 1995) which assesses depression symptoms experienced over the 
past 2 weeks via self-measurement. The measure includes 13 items which are coded as 
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0 = ‘not true’, 1 = ‘sometimes’ and 2 = ‘true’. Items were summed to produce a total 
score. Items include “I felt miserable or unhappy” or “I cried a lot”. The scores have a 
theoretical range from 0 to 26. Cronbach’s alpha for the current sample was .90 (see 
Gregory et al., submitted).  
3.2.5 Anxiety symptoms 
Symptoms of anxiety were measured by an age-adapted version of the Revised 
Children Anxiety and Depression Scale (RCADS, Chorpita, Yim, Moffitt, Umemoto & 
Francis, 2000; Willis, 2007), comprising 36 items for assessing symptoms of anxiety as 
described by the DSM-IV (APA, 2000). For example, items such as “I would feel afraid 
of being on my own at home” or “I feel worried when I think someone is angry with 
me” were included (Chorpita et al., 2000; Willis, 2007). The total score was calculated 
by coding each item (never = 0, sometimes = 1, often = 2, always = 3) and then taking 
the sum (Gregory et al., 2011). The scores have a theoretical range from 0 to 108. 
Cronbach’s alpha for the current sample was .94. This age-adapted version of the 
RCADS has been used in previous research (see for example Gregory et al., 2011). 
3.2.6 Data preparation 
The data was prepared (see 2.4.4 Data preparation for more details). The 
variable depression symptoms was slightly skewed (skew = 1.42, SE = .08, kurtosis = 
1.67, SE = .17) and therefore it was log10-transformed, which has been done in 
previous publications including this variable (see, Gregory et al., 2016). This procedure 
successfully reduced the skewness (skew = -.15, SE = .08; kurtosis = -.79, SE = .17).  
3.2.7 Analysis 
Descriptive statistics were run on untransformed variables in SPSS (version 22; 
IBM, 2013). Phenotypic correlations (focusing on one twin only to control for non-
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independence of observations) examined associations between the variables and partial 
correlations were used to explore the independent role of each subscale in the 
association between mindfulness and symptoms of insomnia, depression and anxiety. 
The partial correlations allowed us to consider the associations between each 
mindfulness subscale and insomnia, depression and anxiety symptoms without being 
confounded by the relationship with the other subscales. For example, when assessing 
the association between ‘acting with awareness’ and symptoms of insomnia, depression 
and anxiety, the analysis controlled for the effects of all the other mindfulness 
subscales. In this manner it was possible to assess whether certain mindfulness 
subscales were more important than others in driving associations. The resulting partial 
correlations were compared in magnitude using JavaScript (Lee & Preacher, 2013; 
Steiger, 1980). For all phenotypic analyses, the focus was on the transformed data of 
one twin/sibling from each pair to control for non-independence of observations, using 
SPSS (version 22; IBM, 2013). 
Twin analyses were used to investigate the aetiology of mindfulness and its 
relationship with anxiety, depression and insomnia. See Chapter 2: Methods, 2.3. The 
twin method for a detailed explanation of the analyses. All twin/sibling analyses were 
performed, using R with a package for genetic model fitting called OpenMX which uses 
maximum likelihood estimation to compare model fits (Boker et al. 2011; McAdams, 
Gregory, & Eley, 2013). For more background about the structural equating modelling 
and model fitting applied in OpenMX, see Chapter 2: Methods, 2.3.3 Structural 
equation modelling and 2.3.4 Model fitting. 
A univariate analysis was run for each variable, applying maximum-likelihood 
model fitting analysis to estimate the relative contribution of genetic, shared and non-
shared environmental influence (Neale & Cardon, 2013). For a detailed explanation of 
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univariate analysis, see Chapter 2: Methods, 2.3.2 Univariate Analysis.   
Multivariate analyses, including overall mindfulness, insomnia symptoms 
depression symptoms and anxiety symptoms, were run to examine the contribution of 
A, C and E on the associations between traits. For a detailed explanation of multivariate 
analysis, see Chapter 2: Methods, 2.3.5 Multivariate analysis. Three models were 
compared: the correlated factors solution, the independent pathway and the common 
pathway model. For an explanation of the three models fitted, see Chapter 2: Methods, 
2.3.5.1 The correlated factor model, 2.3.5.2 The independent pathway model and 
2.3.5.3 The common pathway model. 
Sensitivity analyses were performed as outlined under 2.5 Sensitivity analyses. 
Additional sensitivity analysis was performed by excluding all cases with meditation 
experience (N = 246) and re-running all twin analyses. The results were similar. 
Therefore, the results from the complete sample will be presented here to maximise 
statistical power.  
 
3.3 Results 
3.3.1 Descriptive statistics  
Descriptive statistics for each variable are summarised in Table 3.1 (please see 
table on the following pages). There were significant sex differences for overall 
mindfulness (t(847) = 3.01, p < .01, d = .21), males were more mindful than females. 
For insomnia symptoms, significant sex differences were found as well (t(625) = -3.28, 
p < .01, d = .25), males reported fewer insomnia symptoms than females. For 
depression symptoms, significant sex differences were found (t(681) = -2.63, p < .01, d 
= .19), males reported fewer depression symptoms than females. Also, for symptoms of 
anxiety, significant sex  
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differences were found as well (t(662) = -7.23, p < .01, d = .52), males reported fewer 
symptoms of anxiety than females.  
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Table 3.1 Means (SD) of raw scores for overall mindfulness, mindfulness subscales and 
symptoms of insomnia, depression and anxiety 
 Means (SD) 
     Total     Males      Females 
Overall Mindf.  35.70 (10.37) 34.23 (10.90)*  36.46 (10.01)* 
‘Nonreactivity’  9.40 (4.54)  8.00 (4.39)  10.12 (4.45) 
‘Observing’  9.53 (3.59)  9.42 (3.54)  9.59 (3.61) 
‘Acting with Awareness’  5.27 (3.21)  5.37 (3.27) 5.21 (3.18) 
‘Describing’ 6.69 (3.66)  6.70 (3.79)  6.69 (3.60) 
‘Nonjudging’  4.83 (3.73)  4.79 (3.68)  4.85 (3.76) 
Insomnia symptoms 6.48 (5.22)  5.65 (4.89)*  6.92 (5.33)* 
Depression symptoms 5.31 (5.30)  4.68 (4.73)* 5.64 (5.55)* 
Anxiety symptoms 22.13 (14.81)  17.31 (13.19)*  24.65 (14.99)* 
      MZ      DZ   Siblings 
Overall Mindf.  35.88 (10.47) 36.19 (10.74) 34.67 (9.68) 
‘Nonreactivity’  9.77 (4.72) 9.44 (4.57) 8.96 (4.35) 
‘Observing’  9.47 (3.75) 9.49 (3.67) 9.60 (3.29) 
‘Acting with Awareness’  5.07 (3.15) 5.30 (3.39) 5.42 (2.95) 
‘Describing’ 6.85 (3.88) 6.93 (3.60) 6.16 (3.60) 
‘Nonjudging’  4.74 (3.77) 5.04 (3.91) 4.54 (3.30) 
Insomnia symptoms 6.09 (4.97) 6.68 (5.38) 6.61 (5.19) 
Depression symptoms 5.34 (5.44) 5.73 (5.73) 4.54 (4.21) 
Anxiety symptoms 23.93 (15.03) 22.32 (15.32) 20.11 (13.32) 
Note: *sex differences were found. Mindfulness scores are reverse coded. Overall Mindf. = overall score of 
mindfulness (FFMQ); ‘Nonreactivity’ = subscale of mindfulness (FFMQ), higher scores indication stronger reaction 
to inner experience; ‘Observing’ = subscale of mindfulness (FFMQ), higher scores indicating lower ability to 
observe, notice, attend to sensations, perceptions, thoughts and feelings; ‘Acting with A.’ = subscale of mindfulness 
(FFMQ), higher scores indicating acting less aware; ‘Describing’ = subscale of mindfulness (FFMQ), higher scores 
indicating lower ability to describe or label feelings, thoughts, beliefs, expectations, etc.; ‘Nonjudging’ = subscale of 
mindfulness (FFMQ), higher score indicating more judging of inner experience; Insomnia symptoms = insomnia 
symptoms (ISQ), higher scores indicating more insomnia symptoms; Depression symptoms = symptoms of 
depression (MFQ), higher scores indicating more symptoms of depression; Anxiety symptoms = symptoms of 
anxiety (RCADS), higher scores indicating more anxiety symptoms. 
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3.3.2 Phenotypic correlations and MZ, DZ and sibling correlations  
The phenotypic correlations are displayed in Table 3.2 (please see table 
overleaf). Less mindfulness was associated with more insomnia symptoms, higher 
depression and more anxiety symptoms (r = .22 to .48, p < .01). When considering 
mindfulness subscales, ‘nonjudging’ was the subscale most highly correlated with 
insomnia symptoms (r = .34, p < .01), depression symptoms (r = .54, p < .01) and 
anxiety symptoms (r =.55, p < .01). 
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Table 3.2 Phenotypic correlations for overall mindfulness, subscales of mindfulness, symptoms of insomnia, depression and anxiety 
 Overall 
mindf. 










Overall mindfulness  1         
‘Nonreactivity’  .62** 1        
‘Observing’  .32** .16** 1       
‘Acting with a.’  .54** .08 -10* 1      
‘Describing’ .63** .17** .11* .28** 1     
‘Nonjudging’ .54** .12* -.17** .40** .24** 1    
Insomnia symptoms .22** .01 -.13** .31** .17** .34** 1   
Depression symptoms .48** .25** -.08 .42** .26** .54** .49** 1  
Anxiety symptoms .46** .29** -.16** .37** .26** .55** .46** .62** 1 
Note: * p < .05; ** p < .01. Correlations were calculated on transformed data, using twin 1 only to control for non-independence of observations. Overall mindfulness = overall score of 
mindfulness (FFMQ), reverse coded, higher score indicating lower mindfulness; ‘Nonreactivity’ = subscale of mindfulness, reverse coded, higher scores indication stronger reaction to inner 
experience; ‘Observing’ = subscale of mindfulness, reverse coded, higher scores indicating lower ability to observe, notice, attend to sensations, perceptions, thoughts and feelings; ‘Acting with 
a.’ = subscale of mindfulness, reverse coded, higher scores indicating acting less aware; ‘Describing’ = subscale of mindfulness, reverse coded, higher scores indicating lower ability to describe 
or label feelings, thoughts, beliefs, expectations, etc.; ‘Nonjudging’ = subscale of mindfulness, reverse coded, higher score indicating more judging of inner experience; Insomnia symptoms = 
insomnia symptoms (ISQ), higher scores indicating more insomnia symptoms; Depression symptoms = symptoms of depression (MFQ), higher scores indicating more symptoms of depression; 





Further examining these associations, partial correlations were explored. 
However, none of the subscales was found to drive the association between overall 
mindfulness and symptoms of insomnia, depression and anxiety (see Table 3.3).  After 
partialling out the other subscales, the ‘nonjudging of inner experience’ subscale still 
showed the highest correlation with insomnia symptoms, r = .23, p < .01 (note however 
that the correlation between ‘acting with awareness’ and insomnia symptoms, r = .18, p 
< .01 was not significantly lower). The ‘nonjudging of inner experience’ subscale (as 
compared to the other mindfulness subscales) also correlated most strongly with 
depression symptoms (r = .43, p < .01) and anxiety symptoms (r = .44, p < .01). The 
subscales ‘describing’ and ‘observing’ were not significantly correlated with insomnia 
and depression; and ‘describing’ was not significantly correlated with anxiety 
symptoms, after controlling for the other subscales. 
Table 3.3 Phenotypic correlations for each subscale of mindfulness with symptoms of 
insomnia, depression and anxiety after partialling out all other subscales  
 ‘Nonreact.’  ‘Observ.’  ‘Acting w. a.’ ‘Describing’ ‘Nonjudging’  
Insomnia 
symptoms 
-.04 -.07 .18** .06 .23** 
Depression 
symptoms 
.21** -.03 .23** .07 .43** 
Anxiety 
symptoms 
.29** -.15** .19** .07 .44** 
Note: * p < .05; ** p < .01. ‘Nonreactivity’ = subscale of mindfulness, reverse coded, higher scores indication 
stronger reaction to inner experience; ‘Observing’ = subscale of mindfulness, reverse coded, higher scores indicating 
lower ability to observe, notice, attend to sensations, perceptions, thoughts and feelings; ‘Acting with a.’ = subscale 
of mindfulness, reverse coded, higher scores indicating acting less aware; ‘Describing’ = subscale of mindfulness, 
reverse coded, higher scores indicating lower ability to describe or label feelings, thoughts, beliefs, expectations, etc.; 
‘Nonjudging’ = subscale of mindfulness, reverse coded, higher score indicating more judging of inner experience; 
Insomnia symptoms = insomnia symptoms (ISQ), higher scores indicating more insomnia symptoms; Depression 
symptoms = symptoms of depression (MFQ), higher scores indicating more symptoms of depression; Anxiety 
symptoms. = symptoms of anxiety (RCADS), higher scores indicating more symptoms of anxiety. 
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The MZ, DZ and sibling within-trait correlations are presented in Table 3.4 and 
Table 3.5 and cross-trait correlations for all of the variables are presented in Table 3.5 
(please see table overleaf). The MZ correlations for overall mindfulness (and all 
subscales, except for ‘nonreactivity’), symptoms of insomnia, depression and anxiety 
were larger (although not significantly, as indicated by overlapping confidence 
intervals) than the DZ correlations, indicating possible genetic influence. As the MZ 
correlations are substantially less than 1 for all of the traits, the importance of non-
shared environmental influence (E; including error) is highlighted. 
Table 3.4 Twin/sibling correlations for the subscales of mindfulness 
 Correlations 
 MZ DZ Sibling 
‘Nonreactivity’  .11 (-.10 - .31) .14 (-.03 - .29) .14 (-.10 - .36) 
‘Observing’  .25 (.04 - .44)  .01 (-.15 - .17) -.03 (-.28 - .22) 
‘Acting with 
awareness’  
.19 (-.02 - .38) .16 (.01 - .31) .18 (-.05 - .39) 
‘Describing’ .40 (.21 - .56) .07 (-.09 - .23) -.08 (-.30 - .15) 
‘Nonjudging’  .22 (.01 - .41) .08 (-.08 - .24) -.01 (-.27 - .26) 
Note: The 95% confidence intervals are presented in brackets. MZ = monozygotic twins; DZ = dizygotic twins;  
Sibling = sibling pairs; the MZ, DZ and Sibling correlations are based on the transformed data, outliers deleted with 
age and sex and obtained from OpenMX. ‘Nonreactivity’ = subscale of mindfulness (FFMQ), reverse coded, higher 
scores indication stronger reaction to inner experience; ‘Observing’ = subscale of mindfulness (FFMQ), reverse 
coded, higher scores indicating lower ability to observe, notice, attend to sensations, perceptions, thoughts and 
feelings; ‘Acting with awareness.’ = subscale of mindfulness (FFMQ), reverse coded, higher scores indicating acting 
less aware; ‘Describing’ = subscale of mindfulness (FFMQ), reverse coded, higher scores indicating lower ability to 
describe or label feelings, thoughts, beliefs, expectations, etc.; ‘Nonjudging’ = subscale of mindfulness (FFMQ), 




Table 3.5 Twin/sibling correlations (within-trait and between-traits) for overall 
mindfulness, insomnia symptoms, depression and anxiety 
 Correlations 
       MZ       DZ      Sibling 
Within-trait    
Overall mindfulness .27 (.07 - .44) .20 (.05 - .34) .14 (-.14 - .38) 
Insomnia symptoms .37 (.19 - .53) .21 (.05 - .36) .12 (-.13 - .34) 
Depression symptoms .36 (.17 - .52) .20 (.05 - .33) -.03 (-.27 - .21) 
Anxiety symptoms .41 (.24 - .54) .21 (.07 - .34) .35 (-.01 - .56) 
Cross-traits-cross-twins    
Overall mindfulness –
Insomnia symptoms 
.09 (-.05 - .22) .07 (-.04 - .18) .18 (-.01 - .34) 
Overall mindfulness – 
Depression symptoms 
.23 (.08 - .35) .08 (-.04 - .19) .09 (-.11 - .28) 
Overall mindfulness – 
Anxiety symptoms 
.16 (.01 - .28) .09 (-.02 - .20) .24 (-.01 - .42) 
Insomnia symptoms –
Depression symptoms 
.32 (.18 - .45) .10 (-.02 - .21) .05 (-.14 - .24) 
Insomnia symptoms – 
Anxiety symptoms 
.32 (.18 - .44) .09 (-.02 - .20) .17 (-.05 - .35) 
Depression symptoms  –
Anxiety symptoms 
.31 (.16 - .43) .11 (-.01 - .22) .18 (-.08 - .37) 
Note: The 95% confidence intervals are presented in brackets. MZ = monozygotic twins; DZ = dizygotic twins; 
Sibling = sibling pairs; Overall mindf. = overall score of mindfulness (FFMQ), reverse coded, higher score indicating 
lower mindfulness; Insomnia symptoms = insomnia symptoms (ISQ), higher scores indicating more insomnia 
symptoms; Depression symptoms = symptoms of depression (MFQ), higher scores indicating more symptoms of 
depression; Anxiety symptoms = symptoms of anxiety (RCADS), higher scores indicating more anxiety symptoms 
 
3.3.3 Univariate genetic model fitting  
Univariate analyses were run on all variables for completeness; even for 
‘nonreactivity to inner experience’ for which the DZ correlations were very slightly 
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higher than the MZ correlations and so genetic influence would not be assumed. The fit 
statistics and the results of the full ACE models are presented in Table 3.6 (please refer 
to table overleaf).  
 
129 
Table 3.6 Fit statistics of all univariate genetic model fitting analyses  
Variable/ 
Model 
ep -2LL df AIC ∆ -2LL ∆ df p 
Overall mindfulness       
Saturated 15 6165.79 818 4519.77 - - - 
ACE 4 6166.07 829 4508.07 10.29 11 .50 
E 2 6181.56 831 4519.56 15.48 2 < .01 
‘Nonreactivity’ 
Saturated 15 4835.75 821 3193.75 - - - 
ACE 4 4845.43 832 3181.43 9.68 11 .56 
E 2 4850.46 834 3182.46 14.71 2 .08 
‘Observing’ 
Saturated 15 4505.53 823 2859.54 - - - 
ACE 4 4516.76 834 2848.76 11.22 11 .32 
E 2 4520.42 836 2848.42 3.66 2 .16 
‘Acting with awareness’ 
Saturated 15 4244.63 819 2609.63 - - - 
ACE 4 4260.19 830 2600.19 15.56 11 .16 
E 2 4269.73 832 2605.73 9.54 2 .01 
‘Describing’ 
Saturated 15 4524.38 824 2876.38 - - - 
ACE 4 4533.24 835 2863.24 8.86 11 .63 
E 2 4544.54 837 2870.54 11.30 2 < .01 
‘Nonjudging of inner experience’ 
Saturated 15 4503.57 820 2869.86 - - - 
ACE 4 4522.29 831 2860.29 18.72 11 .07 
E 2 4526.87 833 2860.87 4.58 2 .10 
Insomnia symptoms        
Saturated 15 5033.03 819 3395.03 - - - 
ACE 4 5041.81 830 3381.81 8.78 11 .64 
E 2 5059.69 832 3395.69 17.88 2 < .01 
Depression symptoms        
Saturated 15 724.47 829 -933.53 - - - 
ACE 4 736.00 840 -944.00 11.53 11 .40 
E 2 752.27 842 -931.73 16.27 2 < .01 
Anxiety symptoms        
Saturated 15 6632.89 820 4992.89 - - - 
ACE 4 6653.79 831 4991.79 20.89 11 .03 
E 2 6682.30 833 5016.30 28.51 2 < .01 
Note: All analyses focus on transformed variables, regressed out age and sex. ep = estimated parameters;  
-2LL = -2*(log likelihood); df = degrees of freedom; ∆χ2 and ∆df = change in chi-square statistic and corresponding 
degrees of freedom (computed as the difference in likelihood and df between each model and the saturated model; 
AIC = Akaike’s Information Criterion statistic (calculated as χ2 - 2df). The fit of the ACE model is relative to 
saturated model, the fit of the E model relative to ACE model.  
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The estimates of genetic (A), shared environmental (C) and non-shared 
environmental influence (E), with 95% confidence intervals, are presented in Table 3.7. 
Full ACE models are presented for the univariate analyses throughout. Overall 
mindfulness was mainly influenced by E (.72; 95% CI = .06 - .88). When A and C were 
both dropped from the model, it led to a significant decline in fit (χ2 = 6181.56, df = 
831, p < .01, AIC = 4519.56), suggesting that familial influences also play a role in the 
aetiology of mindfulness. For the subscales, non-shared environment appeared to be 
most important and familiality was indicated for the subscales ‘acting with awareness’ 
and ‘describing’ but not for ‘observing’ and ‘nonjudging of inner experience’. 
Similarly, non-shared environmental influence was key for symptoms of insomnia, 
depression and anxiety, which were all found to also show familiality. 
Table 3.7 Estimates for A, C and E for the univariate genetic model fitting analyses 
Variable Parameter Estimates 
    A (CI)      C (CI)       E (CI) 
Overall mindfulness .17 (0 - .45) .11 (0 - .32) .72 (.06 - .88) 
‘Nonreactivity’ 0 (0 - .28) .13 (0 - .24) .87 (.72 - .98) 
‘Observing’ .16 (0 - .31) 0 (0 - .16) .84 (.69 - 1) 
‘Acting with awareness’ .09 (0 - .40) .12 (0 - .28) .79 (.60 - .93) 
‘Describing’ .28 (.06 - .42) 0 (0 - .13) .72 (.58 - .88) 
‘Nonjudging’ .18 (0 - .33) 0 (0 - .21) .82 (.67 - .99) 
Insomnia symptoms .36 (0 - .50) 0 (0 - .30) .64 (.50 - .84) 
Depression symptoms .33 (.01 - .48) 0 (0 - .20) .67 (.52 - .83) 
Anxiety symptoms .36 (0 - .53) .04 (0 - .33) .60 (.47 - .77) 
Note: All analyses focus on transformed variables, regressed out age and sex. A = additive genetic, C = shared 




3.3.4 Multivariate model fitting  
Fit statistics for multivariate analyses are presented in Table 3.8. The fit of the 
correlated factors solution (χ2 = 17616.00, df = 3312, p = .07, AIC = 10992.00) and the 
independent pathway model (χ2 = 17623.34, df = 3318, p = .06, AIC = 10987.34) were 
similar, while the common pathway model had a significantly worse fit (χ2 = 17650.15, 
df = 3324, p < .01, AIC = 11002.15). The independent pathway model had a slightly 
better fit (lower AIC) and was more parsimonious. Therefore, results from the 
independent pathway model are presented, see Figure 3.1. Given the similar fit of the 
correlated factors solution, this has been presented additionally in Appendix D.  
Table 3.8 Fit statistics for the multivariate genetic model fitting analyses  
 ep -2LL df AIC ∆ -2LL ∆ df p 
Model: Overall mindfulness, symptoms of insomnia, depression and anxiety 
Saturated  132 17496.51 3214 11068.51 - - - 
ACE Correlated 
Factors Solution 
34 17616.00 3312 10992.00 119.49 98 .07 
ACE Independent 
Pathway 
28 17623.34 3318 10987.34 126.84 104 .06 
ACE Common 
Pathway  
23 17650.15 3324 11002.15 153.64 110 < .01 
Note: All analyses focus on transformed variables, regressing out age and sex. ep = estimated 
parameters; -2LL = -2*(log likelihood); df = degrees of freedom; ∆χ2 = change in chi-square 
statistic; ∆df = change in degrees of freedom; AIC = Akaike’s Information Criterion statistic; 
Saturated = full model, A = additive genetic, C = shared environmental; E = non-shared 
environmental. The fit statistics of the ACE correlated factors model, the ACE independent 
pathway model and the ACE common pathway model are relative to the saturated model. Model - 
Phenotypes: overall mindfulness (reverse coded, FFMQ), insomnia symptoms (ISQ), symptoms 
of depression (MFQ), anxiety (RCADS)  
From Figure 3.1 (please see figure on the next pages), we can see that overall 
mindfulness had no significant common genetic or shared environmental influence, only 
common non-shared environmental influence with symptoms of insomnia, depression 
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and anxiety. It was also influenced by specific non-shared environment. Insomnia 
symptoms had a significant common genetic influence with depression symptoms and a 
non-significant common influence with anxiety symptoms and significant common non-
shared environmental influence with symptoms of depression and anxiety. It was also 
influenced by specific non-shared environment and there was some non-significant 
shared-environmental influence indicated. Depression symptoms had only non-
significant common genetic and shared environmental influence, but significant 
common non-shared environmental influence with anxiety symptoms. Furthermore, 
significant specific non-shared environmental influence and some non-significant 






Figure 3.1 Path diagram of the independent pathway model, including overall 
mindfulness, symptoms of insomnia, depression and anxiety 
Note: Significant paths and estimates are presented in bold, see brackets for 95% confidence intervals. A = additive 
genetic; C = shared environmental; E = non-shared environmental; Overall Mindful. = overall score of mindfulness 
(FFMQ), reverse coded, higher score indicating lower mindfulness; Insomnia Symptom = insomnia symptoms (ISQ), 
higher scores indicating more insomnia symptoms; Depression Symptoms = symptoms of depression (MFQ), higher 
scores indicating more symptoms of depression; Anxiety Symptoms = symptoms of anxiety (RCADS), higher scores 
indicating more symptoms of anxiety 
 
3.4 Discussion 
The rationale of this study was to gain a better understanding of the concept and 
the aetiology insomnia, by considering the roots of mindfulness (its subscales) and its 
associations with insomnia symptoms from a behavioural genetics perspective. To 
achieve this, the association between mindfulness (its subscales) and symptoms of 
insomnia, depression and anxiety were considered phenotypically. In addition, the 
genetic and environmental influences on mindfulness (its subscales) and symptoms of 
insomnia, depression and anxiety were estimated. Furthermore, the genetic and 




3.4.1 Associations between variables 
Lower mindfulness was associated with greater symptoms of insomnia, 
depression and anxiety. This is in line with research by Waszczuk and colleagues 
(2015) – although the magnitude of the associations reported here were slightly higher 
than those in the aforementioned study (which focused on slightly different 
phenotypes).  
Of the mindfulness subscales, ‘nonjudging of inner experience’ had the strongest 
association with symptoms of insomnia, depression and anxiety (although the 
associations with ‘acting with awareness’ were of a similar magnitude for the 
association with insomnia symptoms). These findings are in line with previous research 
that focused on the subscales of mindfulness and sleep quality (Caldwell et al., 2010), 
depression and anxiety symptoms, which found that four of the five subscales of 
mindfulness (‘nonreactivity to inner experience’, ‘describing’, ‘acting with awareness’ 
and ‘nonjudging of inner experience’, but not ‘observing’) were found to be associated 
with sleep quality – with greater mindfulness related to better sleep quality (Cash & 
Whittingham, 2010). Baer and colleagues (2006) also found that of the five subscales 
‘nonjudging of inner experience’ had the highest (negative) correlation and ‘act with 
awareness’ had the second highest correlation with psychological symptoms. The 
current phenotypic analysis also showed that ‘observing’ was not associated with 
insomnia symptoms, which is in line with a study that focused on mindfulness and sleep 
quality (Caldwell et al., 2010). ‘Observing’ was further found to have a small non-
significant negative association with depression and a small significant association with 
anxiety. Interestingly, when evaluating the FFMQ, Baer and colleagues (2006) have 
previously pointed out that, when considering the association between the mindfulness 
subscales and other constructs, ‘observing’ was the only subscale that showed 
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correlations in an unexpected direction. A possible explanation for this was that the 
items of the ‘observing’ subscale may not adequately capture this aspect of mindfulness 
(Baer et al., 2006). Furthermore, Cash and Whittingham (2010) found that the observing 
subscale did not predict depression, anxiety and stress symptoms, while ‘non-judging of 
inner experience’ did. 
While none of the subscales appeared to drive the association between overall 
mindfulness and symptoms of insomnia, depression and anxiety, it may be worth further 
investigating the trends generated here. Indeed, finding that certain subscales are more 
strongly associated with symptoms of insomnia, depression and anxiety than others 
could potentially be useful for generating ideas for improving mindfulness-based 
treatment. For example, treatment could specifically focus on the importance of certain 
skills (such as the ability to avoid judgement about inner experiences such as thoughts 
and feelings).   
3.4.2 Familial influences 
In this study, it was found that overall mindfulness as well as the subscales 
‘acting with awareness’ and ‘describing’ (in addition to symptoms of insomnia, 
depression and anxiety) were familial. This means that some influence had come from 
factors common to family members (i.e., genetic and/or common environmental 
influences) - it was not possible to detangle these two influences, due to the small 
sample size. It was important to investigate the genetic and environmental influences on 
mindfulness and its subscales as this gives us insight in the aetiology of these traits, 
which are central in the development of insomnia, according to the meta-cognitive 
model of insomnia (Ong et al., 2013). The findings reported here are largely consistent 
with the only previous twin study which found genetic influence on the attentional 
aspect of mindfulness (Waszczuk et al., 2015). Therefore, the result that ‘acting with 
 
136 
awareness’ was indicated to be familial also fits in well with the previous findings on 
attentional mindfulness. The discrepancy in the magnitude of parameter estimates 
between studies (for example, there was greater genetic influence and no shared 
environmental influence in the previous study) may arise from having used a different 
measure and conceptualisation of mindfulness. Here, the focus was on mindfulness 
including attentional as well as emotional/interpretational aspects. Furthermore, the 
subscales of mindfulness were included as well, whereas the other report focused 
exclusively on the attentional aspects of mindfulness and only used a shortened version 
of the measure Mindfulness Attention and Awareness Scale (5 items only), giving a 
rather limited insight into the concept of mindfulness (Waszczuk et al., 2015; Bergomi 
et al., 2013). Furthermore, heritability is a population statistic, which means that 
estimates may vary in different samples and, while the current study focused on adults, 
the previous study analysed data from adolescents. Sleep, sleep disturbances and the 
prevalence of insomnia vary across the different ages (Roth et al., 2011; Roth & Roehrs, 
2003). Young adulthood is an interesting age to consider in the context with sleep 
because it is a time after the adaption of the circadian rhythm has happened (i.e. during 
adolescence) and the interaction between sleep homeostasis and the circadian system is 
in balance again, which means returning to a ‘normal’ sleep pattern (Crowley, 2016). 
Young adulthood is also the time of life when sleep duration is usually considered to be 
normal, whereas we speak of extended amount of sleep required during childhood and 
reduced amount of sleep required during late adulthood (Crowley, 2016). 
No common genetic influences for overall mindfulness and insomnia, 
depression and anxiety symptoms was found. It was important to investigate the genetic 
and environmental influences on these traits as this gives us deeper insight in the 
structure of the association suggested by the meta-cognitive model of insomnia and 
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helps us understand the mechanism underlying the association of this key element with 
insomnia symptoms.  
The current findings differ from the findings by Waszczuk et al. (2015) which 
highlighted a moderate genetic overlap for mindfulness with anxiety sensitivity and 
depression. However, it would have been difficult to find common genetic influences 
for overall mindfulness and insomnia, depression and anxiety symptoms in the current 
sample as the genetic influence on overall mindfulness was not significant here. In 
addition to the explanations provided above, it is important to note that measures also 
differed for depression and that the previous study focused on anxiety sensitivity (while 
the current study focused on anxiety).  
Although it was not the focus of this study, a common genetic influence for 
symptoms of insomnia, depression and anxiety (not significant) was found which is 
consistent with our previous work using G1219 data on this and similar topics (see for 
example, Gregory et al., 2006; Gregory, et al., 2011; Gregory et al., 2016). According to 
the “generalist genes hypothesis”, we would expect that mindfulness, symptoms of 
insomnia, depression and anxiety share common genetic influences as co-variation 
between traits is often explained by additive genetic influences – with environmental 
influences explaining differences (Eley, 1997). The findings indicate that mindfulness 
may not be part of the same genetic cluster which is influencing symptoms of insomnia, 
depression and anxiety.  
3.4.3 Non-shared environmental influences - Future directions 
Despite some evidence of familiality for mindfulness and associations with 
insomnia, depression and anxiety, the largest influence was that of the non-shared 
environment. Future research should attempt to specify non-shared environmental 
factors that play a role for mindfulness. While meditation experience is an obvious 
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candidate, with more meditation experience associated with greater mindfulness (see for 
example Walach et al., 2006; Baer et al., 2006) – this was controlled for in the current 
study by running a sensitivity analysis, so cannot explain the results reported here. 
Other candidates include certain life events, cultural influence and peer relationships 
(Waszczuk et al., 2015).  
3.4.4 Limitations 
The current study has some limitations which include the use of self-report 
measures, non-clinical data and the sample size. For a more detailed discussion of these 
limitations, see Chapter 8: Discussion, 8.4 General limitations.  
It should be pointed out that self-report measure is considered to be the optimal 
approach to assessing mindfulness and insomnia symptoms and this was necessary 
given the scope of the study. Nevertheless, future work should aim to incorporate 
additional information (for example, symptoms rated by other reporters, objective 
measures of sleep, etc.). Furthermore, it should be pointed out here that a shortened 
version of the mindfulness measure was used here (see Chapter 3, 3.2.2 Mindfulness). 
This has not been evaluated previously, but it did show a good Cronbach’s alpha of .81. 
There are further limitations relating to the method applied (twin design). These 
limitations are discussed in detail in the methods chapter (see Chapter 2: Methods, 
2.3.2 Assumptions and associated limitations). Based on the limitations, it is 
recommended that estimates should be considered as approximations rather than 
absolute values (Plomin et al., 2013).  
However, the current findings were largely in line with previous findings (for 
example the same subscales of mindfulness were found to be associated with insomnia 
as in a non-twin sample, see Caldwell et al., 2010) and when comparing twins and their 
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related non-twins, similar levels of symptoms of insomnia and depression were found 
(Kendler, Martin, Heath & Eaves, 1995).  
3.4.5 Conclusion 
It can be summarised that the link between mindfulness and symptoms of 
insomnia, depression and anxiety was confirmed. This supports the idea that 
mindfulness is an important element in the development and maintenance of insomnia 
as suggested in the meta-cognitive model (Ong et al.,2013). ‘Nonjudging of inner 
experience’ and ‘act with awareness’ were the mindfulness subscales most strongly 
(negatively) associated with symptoms of insomnia which shows us that these may be 
factors particularly useful to target in insomnia treatment. It further gives us a deeper 
insight in the meta-cognitive model of insomnia, as it dissects which facet of 
mindfulness is particularly relevant in the association with insomnia symptoms. 
Mindfulness and its subscales was not as heritable as we expected it to be, but did show 
familial influence. This give us insight in the roots of mindfulness and its subscales, and 
why individuals vary in this trait. Furthermore, it broadens our knowledge of the 
cognitive theories of insomnia as it sheds light on the aetiology of one of their central 
elements. Genetic influence was not important for explaining the association of 
mindfulness and symptoms of insomnia, depression and anxiety. This helps us to 
understand the underlying mechanisms of the development and maintenance of 
insomnia by illuminating how the association between mindfulness and insomnia 
symptoms works. The findings further suggest that overall mindfulness and insomnia 
symptoms may not be part of the same genetic cluster; instead this association was 
mainly found to be influenced by common non-shared environmental factors.  
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CHAPTER 4: Associations Between Pre-Sleep Arousal and   




The rationale behind this study is to gain insight in the aetiology of pre-sleep 
arousal and its subscales by considering the genetic and environmental influences on 
these traits, which helps us to understand why variation in these traits occur. Further-
more, it is attempted to shed light on the mechanisms involved in the development and 
maintenance of insomnia. This is done by considering the genetic and environmental 
influences on the association of pre-sleep arousal (and its subscales) with insomnia 
symptoms to understand how these associations work. This is inspired by the cognitive 
theories, which have never been investigated from a behavioural genetics perspective. 
 
4.1.1 Pre-sleep arousal and insomnia symptoms 
According to earlier literature, pre-sleep arousal plays a crucial role in insomnia. 
For example, Espie (2002) argued in the ‘psychobiological inhibition model of 
insomnia’, that the inability to de-arouse is the main problem associated with insomnia. 
Furthermore, Harvey (2002), in the cognitive model of insomnia, has stated that 
increased negative cognitive activation leads to somatic arousal, which is one of the 
factors that cause a distorted perception of sleep deficits during the night and distorted 
daytime functioning (two characteristics of insomnia). For a more detailed discussion of 
the role of pre-sleep arousal in cognitive theories see 1.3.2 Occurrence of the analysed 
traits in cognitive theories.  
That pre-sleep arousal plays a crucial role in insomnia is also supported by 
research findings. Cognitive and somatic arousal are often differentiated when 
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discussing treatment for insomnia (see, for example, Cincotta, Gehrman, Gooneratne & 
Baime, 2011; Schwartz & Carney, 2012). In one study, insomnia was treated by 
reducing cognitive arousal and, in turn, somatic arousal, which resulted in improved 
insomnia symptoms (Cincotta et al., 2011). It should be mentioned here that the sample 
size for this study was small (N = 17) and that no control group was included. 
Interestingly, whilst subjective sleep improved, no objective evidence of an 
improvement in sleep was found. Somatic arousal refers to physical arousal, including 
symptoms such as increased heart rate, while cognitive arousal relates to the 
psychological part including, for example, not being able to ‘shut off’ thoughts 
(Nicassio et al., 1985). It can therefore be concluded that the extent to which a person is 
easy or difficult to arouse seems to be an important factor in the development and 
maintenance of insomnia (Espie, 2007). Furthermore, cognitive and somatic aspects of 
pre-sleep arousal seem to differ in the role they play in insomnia (see for example 
Gregory, Willis, Wiggs, Harvey, & STEPS Team, 2008; Norell-Clarke et al., 2014). In 
addition, it was shown that it is important to target pre-sleep arousal when treating 
insomnia (see for example Ong et al., 2012; Ong et al., 2014). Previous research has 
also found that cognitive and somatic pre-sleep arousal are independent predictors of 
sleep disturbances (Gregory et al., 2008; Nicassio et al.,1985) and the results also 
indicate that cognitive pre-sleep arousal is associated to a greater extent with sleep 
disturbances than with somatic pre-sleep arousal. However, this previous study focused 
on children (not young adults) and the sleep disturbances were not formally diagnosed. 
Furthermore, there were some discrepancies between the sleep disturbances reported by 




4.1.2 Heritability of pre-sleep arousal 
The genetic and environmental influences on overall pre-sleep arousal as well as 
its subscales (cognitive and somatic pre-sleep arousal) in adults are yet to be explored. 
Furthermore, sleep researchers have recently become interested in why certain risks are 
associated with insomnia. For example, research has shown that insomnia symptoms 
and sleep reactivity (as measured by the Ford Insomnia Response to Stress; Drake et al., 
2004) share some genetic influences (Drake et al., 2011). Sleep reactivity describes the 
extent to which sleep disruption is caused by various challenges (for example, an 
important meeting the next day) and is distinct from pre-sleep arousal. Here, we are 
dealing with the arousal itself, measuring two sub-scales – somatic and cognitive 
arousal, which gives us a more detailed conceptualisation of arousal (Nicassio et 
al.,1985). To gain a better understanding of the aetiology of insomnia and to better 
understand why pre-sleep arousal (respectively the cognitive and somatic aspects of pre-
sleep arousal) is associated with insomnia symptoms, it would be useful to explore the 
genetic and environmental influences on pre-sleep arousal and insomnia symptoms.  
4.1.3 Aims of the current study 
No previous study has yet considered the genetic and environmental influences 
on pre-sleep arousal (and its subscales) and its association with insomnia symptoms. As 
research in this area is very limited, aims were formulated rather than hypotheses: 
1) Consider the magnitude of the associations between overall pre-sleep arousal, its 
cognitive and somatic arousal subscales and insomnia symptoms. In line with 
previous work, we expect insomnia symptoms to be associated more strongly 
with cognitive rather than somatic pre-sleep arousal.  
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2) Estimate the relative contribution of genetic and environmental influences on the 
variance of: a) overall pre-sleep arousal b) cognitive pre-sleep arousal c) somatic 
pre-sleep arousal and d) insomnia symptoms. 
3) Estimate genetic and environmental influences on the associations between 
overall pre-sleep arousal and insomnia symptoms and cognitive pre-sleep 




Data from Wave 5 of the Genesis 12-19 (G1219) longitudinal twin/sibling study 
was the focus of this study as this is the only wave by which pre-sleep arousal has been 
measured. Wave 5 included data from 223 monozygotic (MZ) twins, 404 dizygotic 
(DZ) twins and 218 siblings (Denis et al., 2015). The participants were aged between 22 
and 32 years (mean age 25 years) and 34.3% of them were male (Denis et al., 2015). 
For a more detailed description of the sample, see Chapter 2: Methods, 2.4 The 
G1219 sample. 
4.2.2 Pre-sleep arousal  
Pre-sleep arousal was measured using the pre-sleep arousal scale (PSAS, 
Nicassio et al.,1985). Each item was coded from 1 (‘not at all’) to 5 (‘extremely’), based 
on the participants’ responses. For the somatic arousal subscale, items 1 to 8 were 
added, and the scores have a theoretical range from 8 to 40 (actual range 8 to 33 in the 
current sample). The cognitive pre-sleep arousal subscale was calculated by summing 
the responses for items 9 to 16, and the scores have a theoretical range from 8 to 40 
(actual range 8 to 40 in the current sample). The total score is the sum of all responses, 
theoretical range from 16 to 80 (actual range 16 to 69 in this sample), with higher scores 
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indicating more overall pre-sleep arousal. The Cronbach’s alpha in the current sample 
was .78 for somatic arousal, .91 for cognitive pre-sleep arousal and .91 for the overall 
score. See Appendix E for a list of items included in the PSAS.  
4.2.3 Insomnia symptoms  
Insomnia symptoms were measured by the Insomnia Symptoms Questionnaire 
(ISQ, Okun et al., 2009), using a 6-item version. The total scale score is the sum of 
these responses, ranging from 0 to 24, with higher scores meaning more severe 
insomnia symptoms. For a more detailed explanation of the insomnia symptoms 
measure, see Chapter 3, 3.2.3 Insomnia symptoms. 
 
4.3 Analysis 
4.3.1 Data preparation 
The data was prepared (see 2.4.4 Data preparation for more details). The 
variable somatic pre-sleep arousal was skewed (skewness = 1.82, std. error = .08; 
kurtosis = 4.16, std. error = .17) and therefore it was log10-transformed, which 
successfully reduced the skewness (skewness = 1.03, std. error = .08; kurtosis = .63, std. 
error = .17).  
4.3.2 Preliminary analyses 
SPSS (IBM, 2013; version 22) was used for a preliminary analysis which 
included descriptive and inferential statistics. Pearson’s correlations for overall pre-
sleep arousal, the cognitive and somatic pre-sleep arousal subscales and insomnia 
symptoms were also considered (phenotypic correlations), focusing on twin 1 only to 
control for non-independence of observations. This was helpful to get a first idea of the 
role each variable plays in association with insomnia symptoms.  
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4.3.3 Regression analyses  
A regression analysis was run (controlling for non-independence of 
observations) in Stata (StataCorp, 2015; version SE 14.0) to examine whether or not 
cognitive and somatic arousal are independent predictors of insomnia symptoms, as was 
found in previous research (see Gregory et al., 2008; Nicassio et al.,1985). It was further 
considered whether or not cognitive pre-sleep arousal was associated to a greater extent 
with sleep disturbances rather than with somatic pre-sleep arousal. The covariates age 
and sex were added to the regression models. 
4.3.4 Twin/sibling analyses  
Twin and sibling correlations (within traits) as well as cross-twin-cross-trait 
correlations, were considered. This allowed a rough estimation of the relative 
contributions of genetic and environmental influences on pre-sleep arousal (and its 
cognitive and somatic arousal subscales) and insomnia symptoms. 
A univariate analysis was run for each variable (using OpenMX version 1, R 
version 3.0.3; Boker et al., 2011), applying maximum-likelihood model fitting analysis 
to estimate the relative contribution of genetic, shared and non-shared environmental 
influence (Neale & Cardon, 2013). For a detailed explanation of univariate analysis, see 
Chapter 2: Methods, 2.3.2 Univariate Analysis.   
A bivariate analysis was run to consider the association between overall pre-
sleep arousal and insomnia symptoms. A trivariate analysis was used to consider genetic 
and environmental factors in the association between cognitive pre-sleep arousal, 
somatic pre-sleep arousal and insomnia symptoms. To examine the extent to which 
genetic and environmental factors explain the association between cognitive pre-sleep 
arousal, somatic pre-sleep arousal and insomnia symptoms, the correlated factors 
solution was selected as an appropriate model (for a detailed explanation of the model 
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see Chapter 2: Methods, 2.3.5.1 The correlated factor model). The independent 
pathway model and common pathway model were also run and compared in fit (for a 
detailed explanation of the models see Chapter 2: Methods, 2.3.5.2 The independent 
pathway model and 2.3.5.3 The common pathway model). The best fitting model(s) 
will be presented. For a detailed explanation of multivariate analysis, see Chapter 2: 
Methods, 2.3.5 Multivariate analysis.   
 
4.4 Results 
4.4.1 Descriptive statistics 
Descriptive statistics for each variable are summarised in Table 4.1 (see table 
overleaf). For overall pre-sleep arousal, significant sex differences were found (t(651) = 
-2.42, p = .02, d = .17), males reported less overall pre-sleep arousal than females. For 
somatic pre-sleep arousal, significant sex differences were found (t(655) = -3.33, p < 
.01, d = .23), males reported less somatic pre-sleep arousal than females. For insomnia 
symptoms, significant sex differences were found as well (t(625) = -3.28, p < .01, d = 
.25), males reported fewer insomnia symptoms than females. 
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Table 4.1 Means (SD) of raw scores for overall pre-sleep arousal, cognitive arousal, 
somatic pre-sleep arousal and symptoms of insomnia 
  Means (SD)  
     Total     Males    Females 
Overall pre-sleep arousal 28.39 (9.64) 27.32 (8.96)*  28.94 (9.94)* 
Cognitive pre-sleep arousal  17.09 (6.76) 16.60 (6.32)  17.34 (6.98) 
Somatic pre-sleep arousal  11.30 (3.84) 10.72 (3.54)* 11.60 (3.96)* 
Insomnia symptoms 6.48 (5.22)  5.65 (4.89)* 6.92 (5.33)* 
       MZ       DZ   Siblings 
Overall pre-sleep arousal 28.29 (9.08) 28.78 (10.42) 27.98 (8.91) 
Cognitive pre-sleep arousal  16.96 (6.42) 17.31 (7.28) 16.97 (6.25) 
Somatic pre-sleep arousal  11.33 (3.70) 11.47 (4.05) 11.01 (3.67) 
Insomnia symptoms 6.09 (4.97) 6.68 (5.38) 6.61 (5.19) 
Note: * sex differences were found. Means and SD were obtained from SPSS and are based on the raw data 
(untransformed, including outliers, etc.); MZ = monozygotic twin; DZ = dizygotic twins; siblings = non-twin sibling 
pairs; Overall pre-sleep arousal = overall pre-sleep arousal (PSAS), higher score indicating higher overall pre-sleep 
arousal; Cognitive pre-sleep arousal = cognitive pre-sleep arousal (PSAS subscale), higher score indicating higher 
cognitive pre-sleep arousal; Somatic pre-sleep arousal = somatic pre-sleep arousal (PSAS subscale), higher score 
indicating higher somatic pre-sleep arousal; Insomnia symptoms = insomnia symptoms (ISQ), higher scores 
indicating more insomnia symptoms 
 
4.4.2 Phenotypic correlations 
The phenotypic correlations for all variables are displayed in Table 4.2 (please 
see table overleaf).  Higher overall pre-sleep arousal was associated with more insomnia 
symptoms (r = .61, p < .01). Higher cognitive pre-sleep arousal and higher somatic pre-
sleep arousal was also associated with more insomnia symptoms (r = .62, p < .01 r = 
.44, p < .01). Cognitive and somatic pre-sleep arousal were also found to be highly 
correlated (r = .60, p < .01). The correlation between cognitive pre-sleep arousal and 
insomnia symptoms was significantly larger than the correlation between somatic pre-
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sleep arousal and insomnia symptoms (p < .01; see Steiger, 1980 for the calculation that 
was performed to compare the magnitude of the correlations). These associations were 
further examined in a regression analysis (see information overleaf). 
Table 4.2 Phenotypic correlations for overall pre-sleep arousal, cognitive pre-sleep 
arousal, somatic pre-sleep arousal and symptoms of insomnia 
 Overall pre-








sleep arousal  
1    
Cognitive pre-
sleep arousal  
.95** 1   
Somatic pre-
sleep arousal  
.81** .60** 1  
Insomnia 
symptoms 
.61** .62** .44** 1 
Note: * p < .05; ** p < .01. Correlations were calculated on age and sex regressed variables, and after outliers (+/ - 3 
SD away from the mean) and data was transformed if necessary, using twin 1 only to control for non-independence of 
observations. Overall pre-sleep arousal = overall pre-sleep arousal (PSAS), higher score indicating higher overall pre-
sleep arousal; Cognitive pre-sleep arousal = cognitive pre-sleep arousal (PSAS subscale), higher score indicating 
higher cognitive pre-sleep arousal; Somatic pre-sleep arousal = somatic pre-sleep arousal (PSAS subscale), higher 
score indicating higher somatic pre-sleep arousal; Insomnia Symptoms = insomnia symptoms (ISQ), higher scores 
indicating more insomnia symptoms. 
 
4.4.3 MZ, DZ and sibling correlations 
The MZ, DZ and sibling within-trait and cross-trait-cross-twin correlations for 
all variables are presented in Table 4.3 (please refer to table overleaf). The MZ 
correlations for all variables were greater (although not significantly as indicated by 
overlapping confidence intervals) than the DZ correlations, indicating possible genetic 
influence. The MZ correlations are substantially less than 1 for all of the traits, which 
highlights the importance of non-shared environmental influence (E; including error).  
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Table 4.3 Twin/sibling correlations for overall pre-sleep arousal, cognitive arousal, 
somatic pre-sleep arousal and insomnia symptoms 
 Correlations 
        MZ        DZ       Sibling 
Within-trait    
Overall pre-sleep arousal .42 (.24 - .57) .26 (.10 - .40) .13 (-.10 - .34) 
Cognitive pre-sleep arousal .30 (.10 - .47) .25 (.09 - .39) .11 (-.11 - .33) 
Somatic pre-sleep arousal .44 (.28 - .58) .20 (.03 - .35) .11 (-.12 - .32) 
Insomnia symptoms .37 (.19 - .53) .21 (.05 - .36) .12 (-.13 - .34) 
Cross-traits-cross-twins    
Cogn. pre-sleep arousal - 
Som. pre-sleep arousal 
.41 (.27 - .52) .09 (-.03 - .21) .13 (-.12 - .32) 
Cogn. pre-sleep arousal - 
Insomnia symptoms 
.33 (.18 - .46) .18 (.05 - .29) .19 (-.04 - .38) 
Som. pre-sleep arousal - 
Insomnia symptoms 
.38 (.26 - .48) .08 (-.05 - .20) .09 (-.12 - .28) 
Note: The 95% confidence intervals are presented in brackets. MZ = monozygotic twins; DZ = dizygotic twins; 
Sibling = sibling pairs; Overall pre-sleep arousal = overall pre-sleep arousal (PSAS), higher score indicating higher 
overall pre-sleep arousal; Cogn. pre-sleep arousal = cognitive pre-sleep arousal (PSAS subscale), higher score 
indicating higher cognitive pre-sleep arousal; Som. pre-sleep arousal = somatic pre-sleep arousal (PSAS subscale), 
higher score indicating higher somatic pre-sleep arousal; Insomnia symptoms = insomnia symptoms (ISQ), higher 
scores indicating more insomnia symptoms.  
 
4.4.4 Regression analyses  
In the stepwise regression, the overall model was significant F(2,546) = 141.46, 
p < .01, and predicted 38% (adjusted R squared = .38) of the variance of insomnia 
symptoms. Sex was a significant factor (B(SE) = .77(.30); ß = .07; t = 2.59; p = .01), 
whilst age was non-significant (B(SE) = .10(.08); ß = .04; t = 1.27; p = .21). Both 
cognitive (B(SE) = .39(.03); ß = .50; t = 14.46; p < .01) and somatic pre-sleep arousal 
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(B(SE) = .68(.17); ß = .14; t = 3.97; p < .01) were significant predictors for insomnia 
symptoms.  
4.4.5 Twin/sibling analyses 
The fit statistics of the univariate models are presented in Table 4.4 and the 
results (estimates for A, C and E with 95% confidence intervals) are shown in Table 4.5 
(please refer to tables on the next pages). For somatic pre-sleep arousal, the difference 
between the MZ correlations and the DZ was substantial (somatic pre-sleep arousal: 
rMZ = .44, rDZ = .20). This suggests possible non-additive genetic effects, namely 
dominance (D). Therefore, the ADE model was also tested for this variable, but D was 
not significant in the model (95% confidence interval overlapping 0). Therefore, the 
ADE model has not been presented. Overall pre-sleep arousal and somatic pre-sleep 
arousal showed significant genetic influence (overall pre-sleep arousal: A = .47, 95% 
confidence interval = .19 - .60; somatic pre-sleep arousal: A = .49, 95% confidence 
interval = .24 - .61), no shared environmental influence, but non-shared environmental 
influence (overall pre-sleep arousal: E = .53, 95% confidence interval = .40 - .70; 
somatic pre-sleep arousal: E = .51, 95% confidence interval = .39 - .67). When the ACE 
model and the E model were compared for these variables, the fit declined significantly 
in both cases (χ2 = 6054.39, df = 834, p < .01, AIC = 43836.39 for overall pre-sleep 
arousal and χ2 = 2536.12, df = 835, p < .01, AIC = 866.12 for somatic pre-sleep 
arousal), indicating familial influence, once again confirming the results. For cognitive 
pre-sleep arousal and insomnia symptoms, non-shared environment appeared to be most 
important (cognitive pre-sleep arousal: E = .74, 95% confidence interval = .56 - .90; 
insomnia symptoms: E = .61, 95% confidence interval = .47 - .80) and familiality was 
indicated in both cases as the fit of E model declined significantly when compared to 
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the ACE model (χ2 = 5559.70, df = 838, p < .01, AIC = 3883.70 for cognitive pre-sleep 
arousal and χ2 = 5135.58, df = 837, p < .01, AIC = 3461.58 for insomnia symptoms).  
Table 4.4 Fit statistics of all univariate genetic model fitting analyses  
Variable/ 
Model 
ep -2LL df AIC ∆ -2LL ∆ df p 
Overall pre-sleep arousal       
Saturated 15 6006.78 821 4364.78 - - - 
ACE 4 6028.64 832 4364.64 21.85 11 .03 
E 2 6054.39 834 4386.39 25.75 2 < .01 
Cognitive pre-sleep arousal      
Saturated 15 5529.05 825 3879.05 - - - 
ACE 4 5547.11 836 3875.13     18.08 11 .08 
E 2 5559.70 838 3883.70 12.57 2 < .01 
Somatic pre-sleep arousal      
Saturated 15 2497.20 822 853.20 - - - 
ACE 4 2505.77 833 839.77 8.56 11 .66 
E 2 2536.12 835 866.12 30.35 2 < .01 
Insomnia Symptoms        
Saturated 15 5096.90 824 3448.90 - - - 
ACE 4 5112.43 835 3442.43 15.53 11 .16 
E 2 5135.58 837 3461.58 23.15 2 < .01 
Note: All analyses focus on the transformed data, outliers deleted with age and sex regressed out. ep = estimated 
parameters; -2LL = -2*(log likelihood); df = degrees of freedom; ∆χ2 = change in chi-square statistic; ∆df = change in 
degrees of freedom; AIC = Akaike’s Information Criterion statistic; Saturated = full model, A = additive genetic,      
C = shared environmental; E = non-shared environmental. The fit of the ACE model is relative to saturated model, 
the fit of the E model relative to ACE model.  
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Table 4.5 Estimates for A, C and E for the univariate genetic model fitting analyses  
Variable 
Parameter Estimates 
     A (CI)     C (CI)      E (CI) 
Overall pre-sleep arousal .47 (.19 - .60)  0 (0 - .17) .53(.40 - .70) 
Cognitive pre-sleep arousal .13 (0 - .44) .13 (0 - .31) .74 (.56 - .90) 
Somatic pre-sleep arousal .49 (.24 - .61) 0 (0 - .15) .51(.39 - .67) 
Insomnia Symptoms .36 (0 - .53) .03 (0 - .32) .61 (.47 - .80) 
Note: All analyses focus on the transformed data, outliers deleted with age and sex regressed out. A = additive 
genetic, C = shared environmental; E = non-shared environmental. The fit of the ACE model is relative to saturated 
model, the fit of the E model relative to ACE model. The 95% confidence intervals are presented in brackets. 
 
Fit statistics for the bivariate and trivariate analyses are presented in Table 4.6.  
Table 4.6 Fit statistics for the multivariate genetic model fitting analyses  
 ep -2LL df AIC ∆ -2LL ∆ df p 
 Model: Overall pre-sleep arousal and symptoms of insomnia 
Saturated  42 10739.18 1633 7473.18 - - - 
ACE  11 10781.59 1664 7453.59 42.41 31 0.08 
Model: Cognitive pre-sleep arousal, somatic pre-sleep arousal and symptoms of insomnia 
Saturated  81 12357.87 2435 7487.87 - - - 
ACE Correlated Factors 
Solution 
21 12427.52 2495 7437.52 69.65 60 0.18 
ACE Independent Pathway 21 12427.52 2495 7437.52 69.65 60 0.18 
ACE Common Pathway  18 12437.32 2499 7439.32 9.80 4 0.04 
Note: All analyses focus on the transformed data, outliers deleted with age and sex regressed out. ep = estimated 
parameters; -2LL = -2*(log likelihood); df = degrees of freedom; ∆χ2 = change in chi-square statistic; ∆df = change in 
degrees of freedom; AIC = Akaike’s Information Criterion statistic; Saturated = full model; A = additive genetic, C = 
shared environmental; E = non-shared environmental. The fit statistics of the ACE correlated factors model, the ACE 
independent pathway model are relative to the saturated model. The fit statistic of the ACE common pathway model 




The results of the bivariate analyses including overall pre-sleep arousal and 
insomnia symptoms are presented in Figure 4.1. There was a very high, significant 
correlation for the genetic influences on overall pre-sleep arousal and insomnia 
symptoms (rA = .88, 95% confidence interval = .61 - 1), a high but not significant 
correlation for the shared environmental factors on both traits (rC = 1, 95% confidence 
interval = -1 - 1), and a moderate, significant overlap in the non-shared environmental 
influences (rE = .42, 95% confidence interval = .27 - .55) for the two traits.  
 
 
Figure 4.1 Path diagram of the bivariate analysis, including overall pre-sleep arousal 
and insomnia symptoms  
Note: A = additive genetic, C = shared environmental; E = non-shared environmental. Significant paths are shown in 
black, see brackets for 95% confidence intervals. Paths with confidence intervals spanning 0 are depicted in grey.   
rPh = .61 (95%CI = .55 - .66). Overall pre-sleep arousal = overall pre-sleep arousal (PSAS), higher score indicating 
higher overall pre-sleep arousal; Somatic pre-sleep arousal = somatic pre-sleep arousal (PSAS subscale), higher score 
indicating higher somatic pre-sleep arousal; Insomnia Symptoms = insomnia symptoms (ISQ), higher scores 
indicating more insomnia symptoms.
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For the trivariate analyses including cognitive pre-sleep arousal, somatic pre-
sleep arousal and insomnia symptoms, the fit of the correlated factors solution and the 
independent pathway model (χ2 = 12427.52, df = 2495, p = .18, AIC = 7437.52) were 
the same. This was expected because the two models have the same number of 
estimated parameters. Two models can only be compared in fit if one model is nested in 
the other; meaning that the set of parameters of the first model is a subset of parameters 
of the second (nested) model (Rijsdijk and Sham, 2002). For a more detailed 
explanation see Chapter 2, 2.3.5.4 Models including three measured variables. 
When comparing the common pathway model to the correlated factors model, 
the fit became significantly worse (χ2 = 12437.32, df = 2499, p = .04, AIC = 7439.32). 
Therefore, the correlated factor solution and the independent pathway model were the 
two best fitting models. As this is the first study about genetic and environmental 
influences on cognitive pre-sleep arousal, somatic pre-sleep arousal and insomnia 
symptoms, both models will be presented. The correlated factor solution is presented in 
the main text (see Figure 4.2a, 4.2.b, 4.2c and 4.3 on the following pages) and the 
independent pathways model is shown additionally, in the appendix (see Appendix F, 
Figure F.4).  
From Figure 4.2a, we can see that the genetic influences on cognitive pre-sleep 
arousal, somatic pre-sleep arousal and insomnia symptoms were all highly and 
significantly correlated (ranging from .93 to 1). The shared environmental influences 
between the three traits were indicated to be high (1 respectively -1), but not significant 
(95% confidence intervals all -1 to 1) – see Figure 4.2b. As Figure 4.2c shows, the 
non-shared environmental influence between cognitive pre-sleep arousal, somatic pre-










Figure 4.2 Path diagram of the correlated factors solution, including cognitive pre-sleep 
arousal and insomnia symptoms  
Note: A = additive genetic, C = shared environmental; E = non-shared environmental.  Significant paths are shown in 
black. Paths with confidence intervals spanning 0 are depicted in grey. Cognitive pre-sleep arousal = cognitive pre-
sleep arousal (PSAS subscale), higher score indicating higher cognitive pre-sleep arousal; Somatic pre-sleep arousal 
= somatic pre-sleep arousal (PSAS subscale), higher score indicating higher somatic pre-sleep arousal; Insomnia 
Symptoms = insomnia symptoms (ISQ), higher scores indicating more insomnia symptoms; part a. shows the genetic 




For an alternative illustration of the results, the relative contribution of A, C and 
E to the phenotypic correlations is displayed in Figure 4.3. 
 
 
 Correlations between phenotypes 
Figure 4.3 Relative contributions of A, C and E to the overall phenotypic correlations 
Note: A = additive genetic, C = shared environmental, E = non-shared environmental. Cogn. Pre-sleep Arousal = 
Cognitive Pre-Sleep Arousal (PSAS subscale), higher score indicating higher cognitive pre-sleep arousal; Som. Pre-
Sleep Arousal = somatic pre-sleep arousal (PSAS subscale), higher score indicating higher somatic pre-sleep arousal; 
Insomnia Symptoms = insomnia symptoms (ISQ), higher scores indicating more insomnia symptoms 
 
4.5 Discussion 
The first aim of the current study was to consider the magnitude of the 
associations between overall pre-sleep arousal, its cognitive and somatic arousal 
subscales and insomnia symptoms. We examined whether and to what extent cognitive 
pre-sleep arousal is associated with insomnia symptoms rather than with somatic pre-
sleep arousal, and whether cognitive and somatic pre-sleep arousal are independent 
factors for predicting insomnia symptoms. A further aim was to estimate the relative 
contribution of genetic and environmental influences on overall pre-sleep arousal, 
cognitive pre-sleep arousal, somatic pre-sleep arousal and insomnia symptoms. 














associations between overall pre-sleep arousal and insomnia symptoms and cognitive 
pre-sleep arousal, somatic pre-sleep arousal and insomnia symptoms. 
4.5.1 Association between variables 
Pre-sleep arousal and cognitive and somatic pre-sleep arousal were found to be 
associated with insomnia symptoms, which is in line with the current theories of 
insomnia (see, for example, Espie 2002; Harvey, 2002; Spielman et al., 1987). The 
correlation between cognitive pre-sleep arousal and insomnia symptoms was 
significantly greater than that between somatic pre-sleep arousal and insomnia 
symptoms. The regression analysis further showed that both cognitive and somatic pre-
sleep arousal were significant, independent predictors of insomnia symptoms (with 
cognitive arousal being a slightly stronger predictor than somatic arousal) which is in 
line with previous findings (Gregory et al., 2008; Nicassio et al.,1985).  
4.5.2 Familial influences 
This was the first study to estimate the heritability of pre-sleep arousal and its 
subscales. The twin analyses revealed that overall pre-sleep arousal and somatic pre-
sleep arousal showed a significant and surprisingly high genetic influence and no shared 
environmental influence, but non-shared environmental influence. This is worth further 
investigation in future research.  
For cognitive pre-sleep arousal and insomnia symptoms, non-shared 
environment appeared to be most important, and familiality was indicated. To discover 
a substantial genetic influence for somatic pre-sleep arousal, but not for cognitive 
arousal is interesting. This gives us an insight into the concepts of somatic pre-sleep 
arousal and cognitive pre-sleep arousal and this helps us to gain a better understanding 
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of overall pre-sleep arousal, by decomposing the influences on the two subscales that 
make up overall pre-sleep arousal. 
Furthermore, there was a very high, significant association for the genetic 
influences in overall pre-sleep arousal and insomnia symptoms, a high but not 
significant correlation for the shared environmental factors in both traits and a moderate 
yet significant overlap in the non-shared environmental influences for both traits. The 
high, but not significant estimate for the overlap in C can be explained by the small and 
non-significant estimates of C for each of the variables.  
Having considered cognitive pre-sleep arousal, somatic pre-sleep arousal and 
insomnia symptoms in a trivariate analysis, high and significant genetic correlations 
were again found for all three traits. The shared environmental influences between the 
three traits were also indicated to be high but not significant (95% confidence intervals 
all -1 to 1), which again can be explained by the small and non-significant estimates of 
C for each of the variables. The non-shared environmental influence between cognitive 
pre-sleep arousal, somatic pre-sleep arousal and insomnia symptoms were moderately 
correlated. As cognitive pre-sleep arousal, somatic pre-sleep arousal and insomnia 
symptoms showed a high genetic correlation, the finings indicate that they may perhaps 
be part of the same genetic cluster (as indicated in previous research, for example, for 
sleep disturbances and depression disorders; Middeldorp et al., 2005). This also means 
that developing cognitive and/or somatic pre-sleep arousal may hint at an increased 
vulnerability to develop insomnia symptoms. 
The high, significant association of the genetic influences on overall pre-sleep 
arousal (respectively cognitive and somatic pre-sleep arousal) and insomnia symptoms 
is also an interesting finding as this helps us to gain a better understanding of the 
aetiology of insomnia and the role that pre-sleep arousal plays in insomnia. The findings 
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are in line with current theories (see Espie, 2002; Harvey, 2002; Spielman et al., 1987) 
and support the idea of pre-sleep arousal being a predisposing and maintaining factor 
for insomnia (even though we must bear in mind that the current findings cannot 
establish the direction of effects). The large overlap of genetic influences between pre-
sleep arousal and insomnia symptoms demonstrates again how closely linked pre-sleep 
arousal and insomnia are. This can help us to understand why targeting pre-sleep 
arousal is effective in the treatment of insomnia (see, for example, Ong et al., 2012; Ong 
et al., 2014). 
4.5.3 Limitations 
There are limitations which relate to the assumptions made by the twin design. 
These are discussed in detail in the methods chapter (see Chapter 2: Methods, 2.3.1 
Assumptions and associated limitations).  
Further limitations relate to the sample size and the use of self-report measures. 
For a more detailed discussion see Chapter 8: Discussion, 8.4 General limitations. 
Because of these limitations, further work using larger samples and including objective 
measures would be of value. However, there was significant genetic influence on 
overall pre-sleep arousal and somatic pre-sleep arousal. It should also be pointed out 
here that the current findings are largely in line with previous findings. For example, 
cognitive and somatic pre-sleep arousal were indicated to be independent factors for 
predicting insomnia symptoms and the magnitude of the association with insomnia 
symptoms was greater for cognitive as opposed to somatic pre-sleep arousal (Gregory et 
al., 2008; Nicassio et al.,1985). Similar estimates for the heritability of insomnia have 
been previously reported for the G1219 sample (Gregory et al., submitted) and in other 
previous findings (for example Gehrman et al., 2011, Wing et al., 2012). As heritability 




The current findings are novel and exciting as they help us to gain a better 
understanding of pre-sleep arousal, the concept of insomnia and the role that pre-sleep 
arousal plays in the aetiology of insomnia. Furthermore, this is a first step towards 
gaining a better understanding of the mechanisms underlying the link between pre-sleep 
arousal and insomnia symptoms, shedding light on the principles discussed in the 
cognitive therapies of insomnia. The results indicate that developing cognitive and/or 
somatic pre-sleep arousal may hint at an increased vulnerability for developing 
insomnia symptoms. Even though we are confident of our findings, the results need to 
be validated in a larger sample. Further research into the cognitive and somatic arousal 
within the context of insomnia would be useful as it could potentially help to prevent 
insomnia and improve the treatment of insomnia in the future as we gradually begin to 
understand the concept of insomnia in greater depth.   
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CHAPTER 5: Dysfunctional Beliefs about Sleep and Insomnia 
Symptoms in Early Adulthood: A Twin and Sibling Study 
 
5.1 Introduction and theoretical background 
The rationale behind this study is to gain insight into the aetiology of 
dysfunctional beliefs about sleep and its subscales, by considering the genetic and 
environmental influences involved. Furthermore, it is attempted to provide a better 
understanding of the concept and aetiology of insomnia symptoms by illuminating the 
association between dysfunctional beliefs about sleep (its subscales) and insomnia 
symptoms from a behavioral genetics perspective to shed light on the underlying 
mechanisms involved in the development and maintenance of insomnia. 
5.1.1 The concept of dysfunctional beliefs about sleep 
Dysfunctional beliefs about sleep play a crucial role in cognitive theories of 
insomnia. They can be described as intrusive thoughts, excessive expectations or 
mistaken beliefs about sleep. For example, it would be dysfunctional to believe that we 
need 8 hours of sleep every night to be able to function the following day or to worry 
excessively about the possible consequences of loss of sleep (for example, that one’s 
health will be affected by loss of sleep). Such beliefs can lead to a sleep disturbance 
(Espie, Inglis, Harvey, & Tessier, 2000; Harvey, 2002; Morin, Blais, & Savard, 2002).  
Considering the cognitive theories can help us understand the mechanisms 
underlying the association between dysfunctional beliefs about sleep and insomnia and 
help us explain the role dysfunctional beliefs about sleep play in the treatment of 
insomnia. For example, Harvey (2002) stated in the cognitive model of insomnia that 
dysfunctional beliefs about sleep exacerbate negative cognitions (for example, 
excessive worry), which in turn leads to safety behaviours (for example, spending an 
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excessive amount of time in bed). Safety behaviours again reinforce dysfunctional 
beliefs about sleep and exacerbate negative cognitions. According to this theory, 
dysfunctional beliefs about sleep are one of the factors that maintain and exacerbate 
insomnia. A recent literature review has shown that there is plenty of support for the 
cognitive model of insomnia as proposed by Harvey (2002; Hiller et al., 2015). Various 
studies provide support for each factor that is claimed to play a role in maintaining 
insomnia, including dysfunctional beliefs about sleep (Hiller et al., 2015). 
Prior to the ‘Cognitive Model of Insomnia’, the ‘3P model of insomnia’ 
(Spielman et al., 1987) discussed predisposing, precipitating and perpetuating factors of 
insomnia. This model claimed that dysfunctional beliefs about sleep are a crucial factor 
in maintaining insomnia. More recently, this topic has been picked up in the 
metacognitive model of insomnia (Ong et al., 2012) which notes that changing how we 
‘think about the way we think’ may be helpful when targeting dysfunctional beliefs 
about sleep in the treatment of insomnia. As dysfunctional beliefs about sleep play an 
important role in the current theories of insomnia, their association with insomnia 
should be further investigated. For a more detailed discussion of the role of 
dysfunctional beliefs about sleep in cognitive theories, see 1.3.2 Occurrence of the 
analysed traits in cognitive theories. 
To enable detailed insight into the concept of dysfunctional beliefs about sleep, 
in addition to focusing on a global score for dysfunctional beliefs, the current study will 
focus on three subscales. Firstly, beliefs about the immediate negative consequences of 
insomnia (referred to as beliefs about immediate consequences from here on). For 
example, that we need 8 hours of sleep in order to function the next day. Secondly, 
beliefs about the long-term negative consequences of insomnia (referred to as beliefs 
about long-term consequences from here on), including beliefs like chronic insomnia 
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having serious consequences for our physical health. Thirdly, beliefs about the need for 
control over insomnia (referred to as beliefs about control from here on). For example, 
when having trouble falling asleep, that it is important to stay in bed and try harder 
(Espie, et al., 2000; Morin et al., 1993). The use of the subscales has previously been 
found to be a fruitful line of enquiry. For example, one study compared ‘good sleepers’, 
‘normal sleepers’, ‘poor sleepers’ and participants with insomnia in terms of different 
aspects of dysfunctional beliefs about sleep. It was found that all four groups differed 
significantly in their beliefs about long-term consequences (Espie, et al., 2000). 
Interestingly, there were no significant differences between ‘good sleepers’ and ‘normal 
sleepers’ or ‘poor sleepers’ and participants with insomnia in terms of their beliefs 
about immediate consequences. Since there is limited research on the different aspects 
of dysfunctional beliefs about sleep, it is important to examine the role they play in the 
association with insomnia symptoms in more detail. 
5.1.2 The association of dysfunctional beliefs about sleep and insomnia 
Previous research has shown that dysfunctional beliefs about sleep and insomnia 
are associated. For example, when considering factors involved in developing and 
maintaining insomnia in a clinical sample and a healthy control group, insomnia was 
best predicted by dysfunctional beliefs about sleep and sleep quality (Palagini et al., 
2015). In a long-term, follow up study (over 6 years) which used a clinical sample, 
dysfunctional beliefs about sleep (as well as stress related sleep vulnerability) were 
found to be a good predictor of insomnia (Yang, Hung, & Lee, 2014). In line with 
previous research (see, for example, Carney et al., 2010), dysfunctional beliefs about 
sleep and sleep reactivity were found to be significantly higher in those participants 
with insomnia, compared to the good sleepers (Palagini et al., 2015). Sleep reactivity 
refers to the idea of how prone someone is to experiencing sleep disturbances as a 
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consequence of stress. This means the higher the sleep reactivity, the easier it is for that 
person’s sleep to be disturbed. Sleep reactivity was further found to be predicted by 
dysfunctional beliefs about sleep in the insomnia group. However, it can be criticised 
that because of the cross-sectional design of the study, the direction of effects could not 
be established and the relationships between dysfunctional beliefs about sleep, sleep 
reactivity and insomnia may be complex, rather than going in just one direction only 
(Palagini et al., 2015). Previous research has shown that dysfunctional beliefs about 
sleep and insomnia are associated but the mechanisms underlying this association are 
complex. This is worth to further investigate. 
5.1.3 The role of dysfunctional beliefs about sleep in the treatment of insomnia 
The crucial role that dysfunctional beliefs about sleep play in insomnia is 
underlined in research that considers the treatment of insomnia. A meta-analysis of 
randomised controlled studies has shown that cognitive-behavioural therapy is effective 
in treating insomnia (Okajima et al., 2011). However, this meta-analysis can be 
criticised for not differentiating between CBT-I delivered as group-therapy or on a one-
on one basis. Furthermore, age groups were not differentiated either (for example, 
young adults and mid-aged compared to older adults). One of the central aims of CBT-I 
(cognitive-behavioural therapy for insomnia) is to correct dysfunctional beliefs about 
sleep (Sivertsen, Vedaa, & Nordgreen, 2013). In a recent study, using a randomised 
controlled trial, the authors compared cognitive therapy, behaviour therapy and 
cognitive-behavioural therapy (CBT) as treatments of insomnia (Eidelman et al., & 
Harvey, 2016; for a detailed explanation of the different forms of therapy, see Chapter 
1: Introduction, 1.6.1 Psychotherapeutic treatment of insomnia). Irrespective of the 
therapy method applied, it was found that the greater the change in dysfunctional beliefs 
about sleep during treatment, the greater the improvement in insomnia symptoms 
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(Eidelman et al., 2016). This was the case both directly after treatment and in the 6-
month and 12-month follow-up. Dysfunctional beliefs about sleep were also found to be 
improved, but to a lesser extent, by behaviour therapy. Interestingly, behaviour therapy 
does not target dysfunctional beliefs about sleep directly as an element of therapy 
(Eidelman et al., 2016). Another meta-analysis of randomised controlled trials of CBT 
for insomnia further showed that dysfunctional beliefs about sleep could be reduced and 
insomnia could be improved significantly when CBT was administered in the form of 
self-help (Ho et al., 2015). Self-help therapy can include written material, audio-visual 
material and telephone consultation. It can be criticised that relatively few studies (20 in 
total) have been included in this meta-analysis and the included studies often excluded 
participants with comorbidities (Ho et al., 2015). 
In a longitudinal study that considered factors associated with the persistence and 
remission of insomnia, it was possible to distinguish those participants with insomnia 
from those participants with normal sleep, based on their cognitive processes (Norell-
Clarke et al., 2014). Dysfunctional beliefs about sleep (in addition to worry, somatic 
arousal, safety behaviours, selective attention, and monitoring) were a significant 
predictor of sleep status. Specifically, dysfunctional beliefs about sleep were associated 
with a greater likelihood of reporting persistent insomnia than with a normal sleep 
pattern (Norell-Clarke et al., 2014). As dysfunctional beliefs about sleep and insomnia 
remission were measured at the same time, a causal link could not be established. It is 
possible that a third factor was involved, simultaneously influencing the severity of 
insomnia and dysfunctional beliefs about sleep (for example, the link could be via pre-
sleep arousal, which is influenced by dysfunctional beliefs about sleep, and this in turn 
has an effect on insomnia) (Norell-Clarke et al., 2014). It can be criticised that the 
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response rate for this study was not very high (47%) and selective attrition occurred 
(older participants were more likely to respond). 
An earlier study, using a randomised controlled trial in a sample of older adults 
(N = 78; mean age = 64.7), compared cognitive-behavioural therapy (CBT), 
pharmacotherapy (PCT), a combination of the two (COMB) and a placebo group (PLA; 
Morin et al., 2002). It was found that dysfunctional beliefs about sleep improved with 
CBT and COMB but not with PCT or PLA. A greater improvement in dysfunctional 
beliefs about sleep was associated with greater sleep improvement following treatment. 
Furthermore, fewer dysfunctional beliefs about sleep after treatment were associated 
with a better outcome over time (in the 3-month, 12-month and 24-month follow-up; 
Morin et al., 2002). It has been speculated that the main reason why CBT-I is so 
effective might be that it corrects dysfunctional beliefs about sleep (Okajima et al., 
2011). The changes in dysfunctional beliefs about sleep were less strongly associated 
with the objective (polysomnography) than with the subjective (sleep diary) measures of 
sleep (Morin et al., 2002). It should also be noted that insomnia is often described as a 
‘subjective complaint’ and in current clinical practice insomnia patients are typically 
assessed using subjective measures rather than objective ones (American Academy of 
Sleep Medicine, 2014; American Psychiatric Association, 2013; World Health 
Organization, 1992). 
 However, in a study using a small clinical sample (64 participants with chronic 
insomnia), dysfunctional beliefs about sleep and insomnia were shown to be linked but 
reducing dysfunctional beliefs about sleep was not found to mediate an improvement in 
insomnia (Okajima, Nakajima, Ochi, & Inoue, 2014). One limitation of this study is that 
the participants were recruited from the same sleep disorder clinic. Therefore, the 
sample may not have been representative of the wider clinical population. It is possible 
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that other variables are involved in this link too. For example, Ong and colleagues 
(2012) proposed in the metacognitive model of insomnia that dysfunctional cognitions, 
arousal and maladaptive behaviours are all interacting factors and this interplay has 
influence on insomnia, rather than there being a simple one-directional link between 
dysfunctional beliefs about sleep and insomnia. In summary, plenty of previous research 
has shown that dysfunctional beliefs about sleep play a crucial role in the treatment of 
insomnia, as well as in the theory of insomnia. Therefore, this relationship is worth 
further investigating. 
5.1.4 Heritability of dysfunctional beliefs about sleep 
In spite of the extensive research interest in dysfunctional beliefs about sleep, no 
research has explored genetic and environmental influences on individual differences 
for this variable yet. Furthermore, even though the link between dysfunctional beliefs 
about sleep and insomnia symptoms is well established (see, for example, Morin et al., 
2002; Norell-Clarke et al., 2014; Palagini et al., 2015) and dysfunctional beliefs about 
sleep play a crucial role in the current theories and the treatment of insomnia (see, for 
example, Eidelman et al., 2016; Harvey, 2002; Ong et al., 2012), the role that genetic 
and environmental influences play in this association has yet to be explored. 
5.1.5 Aims of the current study 
In summary, dysfunctional beliefs about sleep are an important element in the 
development of insomnia and are therefore discussed in the cognitive theories of 
insomnia. They are known to be associated with insomnia and they are a crucial aspect 
to target in the treatment of insomnia. However, no previous study has yet considered 
the roots of dysfunctional beliefs about sleep (and its subscales) and the mechanisms 
underlying their association with insomnia symptoms. As this study is the first to 
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attempt to investigate these points, aims were formulated rather than hypotheses. The 
aims of this study were: 
1) Estimate the relative contribution of genetic and environmental influences on   
a) overall dysfunctional beliefs about sleep, b) beliefs about immediate 
consequences, c) beliefs about long-term consequences, d) beliefs about control 
and e) insomnia symptoms.  
2) Examine the magnitude of the association between overall dysfunctional beliefs 
about sleep, different aspects of dysfunctional beliefs about sleep and insomnia 
symptoms.  
3) Explore the relative contribution of genetic and environmental influences on the 
association between dysfunctional beliefs about sleep (as well as its subscales) 
and insomnia symptoms. 
 
5.2 Method  
5.2.1 Sample 
Data from Wave 5 of the G1219 longitudinal twin/sibling study was the focus of 
this study as this is the only wave at which dysfunctional beliefs about sleep have been 
measured. Wave 5 included data from 223 monozygotic (MZ) twins, 404 dizygotic 
(DZ) twins and 218 siblings (Denis et al., 2015). The participants were aged between 22 
and 32 years (mean age 25 years) and 34.3% of them were male (Denis et al., 2015). 
For a more detailed description of the sample, see Chapter 2: Methods, 2.4 The 
G1219 sample. 
5.2.2 Dysfunctional beliefs about sleep 
In the present study the DBAS-10 was utilised. It is a shortened version of the 
dysfunctional beliefs and attitudes about sleep scale (DBAS; Morin et al., 1993), 
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developed by Espie et al. (2000). It comprises only 10 items (Espie et al., 2000) and 
three subscales. Namely, beliefs about immediate negative consequences of insomnia 
(DBAS factor I), beliefs about long-term negative consequences of insomnia (DBAS 
factor II), and beliefs about the need for control over insomnia (DBAS factor III). The 
items included in the DBAS-10 were shown to be sensitive to recovery (Espie et al., 
2000; Edinger & Wohlgemuth, 2001). This means that the DBAS-10 was able to detect 
differences before and after treatment. This version of the DBAS is now widely used 
(see, for example, Ellis, Hampson, & Cropley, 2007; Norell-Clarke et al., 2014).  See 
Appendix G for the items included in each of the subscales. Each item was coded from 
1 (‘strongly disagree’) to 10 (‘strongly agree’), based on the participants’ responses. For 
the subscale beliefs about immediate consequences (DBAS factor I), items 1 to 5 were 
added, giving a theoretical range from 5 to 50. For beliefs about long-term 
consequences (DBAS factor II), items 6 to 8 were added, resulting in a theoretical range 
from 3 to 30. For beliefs about control (DBAS factor III), items 9 and 10 were added, 
therefore the theoretical range was from 2 to 20. The total scale score is the sum of all 
responses (theoretical range from 10 to 100), with higher scores indicating more 
dysfunctional beliefs about sleep. In the current sample, the Cronbach’s alpha for the 
overall DBAS is .78, the DBAS factor I is .78, the DBAS factor II is .69 (in line with 
the approach taken by Espie et al., 2000, the Cronbach’s alpha for the DBAS factor III 
was not calculated for the current sample, because it only consisted of two items).  
 
5.2.3 Insomnia symptoms  
Insomnia symptoms were measured by the Insomnia Symptoms Questionnaire 
(ISQ, Okun et al., 2009), using a 6-item version. The total scale score is the sum of 
these responses, ranging from 0 to 24, with higher scores meaning more severe  
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insomnia symptoms. For a more detailed explanation of the insomnia symptoms 
measure, see Chapter 3, 3.2.3 Insomnia symptoms. 
 
5.3 Analyses 
5.3.1 Data preparation and preliminary analyses 
The data was prepared (see 2.4.4 Data preparation for more details). None of 
the variables required transformation. SPSS (IBM, 2013; version 22) was used for a 
preliminary analysis, which included descriptive and inferential statistics. Pearson’s 
correlations between the overall DBAS, as well as its subscales (DBAS factor I, DBAS 
factor II and DBAS factor III) and insomnia symptoms were also considered 
(phenotypic correlations), focusing on twin one only to control for non-independence of 
observations. This was helpful to get a first idea of the role each variable plays in 
association with insomnia symptoms.  
5.3.2 Univariate twin and sibling analyses   
A univariate analysis was run for each variable (using OpenMX version 1, R 
version 3.0.3; Boker et al., 2011), applying maximum-likelihood model fitting analysis 
to estimate the relative contribution of genetic, shared and non-shared environmental 
influence (Neale & Cardon, 2013). For a detailed explanation of univariate analysis, see 
Chapter 2: Methods, 2.3.2 Univariate Analysis.   
Furthermore, the ACE model and E model were compared. If, by dropping A 
and C at the same time, the fit for the E model gets worse (compared to the ACE 
model), it can be concluded that familial influences (either A and/or C) must have 
played a role (Waszczuk et al., 2016).  
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5.3.3 Multivariate twin and sibling analyses   
The phenotypic correlations show a small to moderate yet significant association 
between the phenotypes considered, therefore further analyses were performed. A 
bivariate analysis was run to examine the relationship between the genetic and 
environmental factors that affect overall dysfunctional beliefs about sleep and insomnia 
symptoms. A multivariate analysis explored this association in more detail by 
examining the relationship between the genetic and environmental factors that influence 
the three subscales of dysfunctional beliefs about sleep and insomnia symptoms. For a 
detailed explanation of multivariate analysis, see Chapter 2: Methods, 2.3.5 
Multivariate analysis. It was planned to test different multivariate models (the 
correlated factors model, independent pathway model and common pathway model) and 
present the model which represented the best fit. For a detailed explanation of the model 
see Chapter 2: Methods, 2.3.5.1 The correlated factor model, 2.3.5.2 The 
independent pathway model and 2.3.5.3 The common pathway model.  The 
correlated factors model allows us to consider the correlation of the non-shared 
environment separately, while the independent pathway model and the common 
pathway model take into account a combination of genetic, shared and non-shared 
environmental influences. Based on the results of the univariate analyses (see 5.4 
Results), we deviated from the original plan and present the correlated factors model 
only. For completion, the fit statistics of the independent pathway model and common 
pathway model are presented in Appendix H, but should not be interpreted further. 






5.4.1 Descriptive statistics 
Descriptive statistics for each variable are summarised in Table 5.1 (please refer 
to table overleaf). For overall dysfunctional belief about sleep, significant sex 
differences were found (t(850) = -4.04, p < .01, d = .29), males reported fewer insomnia 
symptoms than females. There was also a significant difference between males and 
females in terms of the beliefs about immediate consequences (DBAS factor I; t(850) = 
-6.20, p < .01, d = .45), with males showing on average lower scores than females. For 
insomnia symptoms, significant sex differences were found as well (t(625) = -3.28, p = 
.01, d = .25), males reported fewer insomnia symptoms than females. 
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Table 5.1 Means (SD) of raw scores for overall dysfunctional beliefs about sleep, its 
subscales, and symptoms of insomnia 
  Means (SD)  
      Total      Males      Females 
Overall DBAS 50.26 (15.24) 47.30 (15.45)* 51.78 (14.93)* 
DBAS factor I 31.24 (9.36)  28.51 (9.31)*  32.66 (9.07)* 
DBAS factor II 9.50 (6.07)  9.57 (6.18)  9.46 (6.02) 
DBAS factor III 9.51 (4.41)  9.21 (4.31)  9.67 (4.46) 
Insomnia symptoms 6.48 (5.22)  5.65 (4.89)*  6.92 (5.33)* 
       MZ       DZ     Siblings 
Overall DBAS 49.52 (15.34) 50.49 (15.99) 50.40 (13.78) 
DBAS factor I 30.75 (9.18) 30.91 (9.92) 32.07 (8.41) 
DBAS factor II 8.86 (5.69) 9.98 (6.56) 9.26 (5.52) 
DBAS factor III 9.91 (4.48) 9.58 (4.46) 9.06 (4.26) 
Insomnia symptoms 6.09 (4.97) 6.68 (5.38) 6.61 (5.19) 
Note: * sex differences were found. Means and SD are based on the raw data (untransformed, including outliers, 
etc.); MZ = monozygotic twin; DZ = dizygotic twins; siblings = non-twin sibling pairs; Overall DBAS = overall 
dysfunctional beliefs about sleep (DBAS); DBAS factor I = beliefs about the immediate negative consequences of 
insomnia (DBAS subscales); DBAS factor II = beliefs about the long-term negative consequences of insomnia 
(DBAS subscale); DBAS factor III = beliefs about the need for control over insomnia (DBAS subscale) – higher 
scores indicating more dysfunctional beliefs about sleep; Insomnia symptoms = insomnia symptoms (ISQ), higher 
scores indicating more insomnia symptoms. 
5.4.2 Phenotypic analysis 
The phenotypic correlations are displayed in Table 5.2 (please refer to table 
overleaf). Higher overall dysfunctional beliefs about sleep were associated with more 
insomnia symptoms  
(r = .37, p < .01). Higher scores in beliefs about immediate consequences (DBAS factor 
I), beliefs about long-term consequences (DBAS factor II) and beliefs about control 




factor I: r = .18, p < .01; DBAS factor II: r = .44, p < .01; DBAS factor III: r = .44, 
 p < .01).  
Table 5.2 Phenotypic correlations for overall dysfunctional beliefs about sleep, its 











Overall DBAS 1     
DBAS factor I .84** 1    
DBAS factor II .75** .37** 1   
DBAS factor III .67** .31** .49** 1  
Insomnia 
symptoms 
.37** .18** .44** .34** 1 
Note: * p < .05; ** p < .01. Correlations were calculated on data with outliers deleted and age and sex was regressed 
out in SPSS, using twin 1 only to control for non-independence of observations. Overall DBAS = overall 
dysfunctional beliefs about sleep (DBAS); DBAS factor I = beliefs about the immediate negative consequences of 
insomnia (DBAS subscale); DBAS factor II = beliefs about the long-term negative consequences of insomnia (DBAS 
subscale); DBAS factor III = beliefs about the need for control over insomnia (DBAS subscale) – higher scores 
indicating more dysfunctional beliefs about sleep; Insomnia Symptoms = insomnia symptoms (ISQ), higher scores 
indicating more insomnia symptoms.  
 
5.4.3 MZ, DZ and sibling correlations 
The MZ, DZ and sibling within-trait and cross-trait-cross-twin correlations for 
all variables are presented in Table 5.3 (see table overleaf). The MZ and the DZ 
correlations for the overall DBAS, DBAS factor I, DBAS factor II and DBAS factor III 
were similar, hinting at the possibility that there is little or no genetic influence at work 
here. For insomnia symptoms, the difference between the MZ and DZ correlation was 
larger (although not significantly, as indicated by overlapping confidence intervals), 
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indicating a possible genetic influence. As the MZ correlations are substantially less 
than 1 for all of the traits, the importance of non-shared environmental influence (E; 
including error) is highlighted.  
Table 5.3 Twin/sibling correlations for overall dysfunctional beliefs about sleep, its 
subscales, and symptoms of insomnia 
 Correlations 
         MZ       DZ      Sibling 
Within-trait    
Overall DBAS .15 (-.04 - .34) .17 (0 -.32) -.03 (-.26 - .20) 
DBAS factor I .23 (.03 - .38) .20 (.03 - .35) -.16 (-.37 - .07) 
DBAS factor II .05 (-.15 - .24) .18 (.01 - .34) .11 (-.14 - .34) 
DBAS factor III .16 (-.05 - .36) .07 (-.10 - .23) .10 (-.15 - .33) 
Insomnia symptoms .37 (.19 - .53) .21 (.05 - .36) .12 (-.13 - .34) 
Cross-traits-cross-twins    
Overall DBAS - Insomnia symptoms .14 (-.01 - .27) .11 (-.01 - .22) -.08 (-.28 - .13) 
DBAS factor I - Insomnia symptoms .09 (-.05 - .22) .04 (-.07 - .14) -.16 (-.33 - .04) 
DBAS factor II - Insomnia symptoms .09 (-.08 - .23) .16 (.04 - .27) 0 (-.21 - .21) 
DBAS factor III - Insomnia symptoms .18 (.04 - .31) .08 (-.04 - .19) 0 (-.18 - .18) 
DBAS factor I - DBAS factor II .02 (-.14 - .17) .07 (-.04 - .18) -.17 (-.36 - .10) 
DBAS factor I - DBAS factor III .04 (-.10 - .18) -.01 (.13 - .10) -.06 (-.25 - .15) 
DBAS factor II - DBAS factor III .11 (-.07 - .26) .04 (-.08 - .16) -.02 (-.24 - .20) 
Note: The 95% confidence intervals are presented in brackets. MZ = monozygotic twins; DZ = dizygotic twins; 
Sibling = sibling pairs; Overall DBAS = overall dysfunctional beliefs about sleep (DBAS); DBAS factor I = beliefs 
about the immediate negative consequences of insomnia (DBAS subscale); DBAS factor II = beliefs about the long-
term negative consequences of insomnia (DBAS subscale); DBAS factor III = beliefs about the need for control over 
insomnia (DBAS subscale) – higher scores indicating more dysfunctional beliefs about sleep; Insomnia symptoms = 




5.4.4 Twin analysis 
Univariate analyses were run on all variables; the fit statistics and the results of 
the full ACE models are presented in Table 5.4 and the estimates of A, C and E with 
95% confidence intervals are shown in Table 5.5 (see tables following on the next 
pages). Overall dysfunctional beliefs about sleep, beliefs about long-term consequences 
(DBAS factor II) and beliefs about control (DBAS factor III) showed no significant 
genetic influence (overall DBAS: A = .09, 95% CI = 0 - .31; DBAS factor II: A = 0, 
95% CI = 0 - .32; DBAS factor III: A = .17, 95% CI = 0 - .32) and no significant shared 
environmental influence (overall DBAS: C = .05, 95% CI = 0 - .22; DBAS factor II: C 
= .13, 95% CI = 0 - .24; DBAS factor III: C = 0, 95% CI = 0 - .21), and mainly non-
shared environmental influence (overall DBAS: E = .86, 95% CI = .69 - .99; DBAS 
factor II: E = .87, 95% CI = .68 - .99; DBAS factor III: E = .83, 95% CI = .68 - .99). For 
the beliefs about immediate consequences (DBAS factor I) some significant genetic 
influence was indicated (A = .19; 95% CI = .01 -.38), no shared environmental 
influence was evident (C = 0, 95% CI = 0 - .22) and the main influence came from non-
shared environment (E = .81, 95% CI = .65 -.98). When the ACE model and the E 
model were compared for these four variables, the fit did not decline significantly in any 
of the cases (overall DBAS: χ2 = 6953.24, df = 839, p = .12, AIC = 5275.92; DBAS 
factor I: χ2 = 6106.98, df = 839, p = .07, AIC = 4428.98; DBAS factor II: χ2 = 5314.09, 
df = 832, p = .11, AIC = 3650.09; DBAS factor III: χ2 = 4882.15, df = 839, p = .11, AIC 
= 3204.15), indicating no familial influence, once again confirming the results. For 
insomnia symptoms, non-shared environment appeared to be most important and 
familiality was found, indicated by a decline in fit for the E model (χ2 = 5135.58, df = 




Table 5.4 Fit statistics of all univariate genetic model fitting analyses  
Variable/ 
Model 
ep -2LL Df AIC ∆ -2LL ∆ df p 
Overall DBAS       
Saturated 15 6933.43 826 5281.43 - - - 
ACE  4 6949.72 837 5275.72 16.29 11 .13 
E 2 6953.24 839 5275.92 4.20 2 .12 
Beliefs about immediate consequences (DBAS Factor I) 
Saturated 15 6083.25 826 4431.25 - - - 
ACE  4 6101.63 837 4427.63     18.38 11 .07 
E  2 6106.98 839 4428.98 5.35 2 .07 
Beliefs about long-term consequences (DBAS Factor II) 
Saturated 15 5275.74 819 3637.74 - - - 
ACE 4 5309.73 830 3649.73     33.99 11 < .01 
E  2 5314.09 832 3650.09 4.36 2 .11 
Beliefs about control (DBAS Factor III) 
Saturated 15 4873.04 826 3221.04 - - - 
ACE  4 4877.81 837 3203.81 4.77 11 .94 
E  2 4882.15 839 3204.15 4.34 2 .11 
Insomnia symptoms        
Saturated 15 5096.90 824 3448.90 - - - 
ACE  4 5112.43 835 3442.43 15.53 11 .16 
E  2 5135.58 837 3461.58 23.15 2 < .01 
Note: All analyses focus on transformed data, outliers deleted with age and sex regressed out. ep = estimated 
parameters; -2LL = -2*(log likelihood); df = degrees of freedom; ∆χ2 = change in chi-square statistic; ∆df = change in 
degrees of freedom; AIC = Akaike’s Information Criterion statistic; Saturated = full model. The fit of the ACE model 








    A (CI)     C (CI)     E (CI) 
Overall DBAS .09 (0 - .31) .05 (0 - .22) .86(.69 - .99) 
DBAS factor I .19 (.01 - .38) 0 (0 - .22) .81 (.65 - .98) 
DBAS factor II 0 (0 - .32) .13 (0 - .24) .87 (.68 - .99) 
DBAS factor III .17 (0 - .32) 0 (0 - .21) .83 (.68 - .99) 
Insomnia symptoms .36 (0 - .53) .03 (0 - .32) .61 (.47 - .80) 
Note: All analyses focus on transformed data, outliers deleted with age and sex regressed out. The 95% confidence 
intervals are presented in brackets. Overall DBAS = overall dysfunctional beliefs about sleep (DBAS); DBAS factor I 
= beliefs about the immediate negative consequences of insomnia (DBAS subscale); DBAS factor II = beliefs about 
the long-term negative consequences of insomnia (DBAS subscale); DBAS factor III = beliefs about the need for 
control over insomnia (DBAS subscale) – higher scores indicating more dysfunctional beliefs about sleep; Insomnia 
symptoms = insomnia symptoms (ISQ) –  higher scores indicating more insomnia symptoms.  
 
Fit statistics for the bivariate and the multivariate analyses are presented in 
Table 5.6 (see table overleaf). The results of the bivariate analyses including overall 
dysfunctional beliefs about sleep and insomnia symptoms are shown in Figure 5.1 (see 
figure on the following page). The genetic and shared environmental correlation 
between dysfunctional beliefs about sleep and insomnia symptoms were not significant 
(rA = .74, 95% CI = -1 - 1; rC = -.17, 95% CI = -1 - 1), and a moderate yet significant 
overlap in the non-shared environmental influences (rE = .32, 95% CI = .17 - .47) for 




Table 5.6 Fit statistics for the multivariate genetic model fitting analyses  
 ep -2LL df AIC ∆ -2LL ∆ df p 
 Model 1: Overall DBAS and symptoms of insomnia 
Saturated  42 11904.61 1638 8628.61 - - - 
ACE  11 11941.04 1669 8603.04 36.43 31 0.23 
Model 2: DBAS Factor I, DBAS Factor II, DBAS Factor III and symptoms of insomnia 
Saturated  132 20732.85 3223 14286.85 - - - 
ACE Correlated 
Factors Solution 
34 20865.04 3321 14223.04 132.19 98 0.01 
Note: All analyses focus on transformed data, outliers deleted with age and sex regressed out. ep = 
estimated parameters; -2LL = -2*(log likelihood); df = degrees of freedom; ∆χ2 = change in chi-square 
statistic; ∆df = change in degrees of freedom; AIC = Akaike’s Information Criterion statistic; Saturated = 
full model, A = additive genetic, C = shared environmental; E = non-shared environmental. The fit 
statistics of the ACE respectively the correlated factors solution is relative to the saturated model.  
 
 
Figure 5.1 Path diagram of the bivariate analysis, including overall dysfunctional  
beliefs about sleep (overall DBAS) and insomnia symptoms  
Note: A = additive genetic, C = shared environmental; E = non-shared environmental. Significant paths are shown in 
black, see brackets for 95% confidence intervals. Paths with confidence intervals spanning 0 are depicted in grey.  
rPh = .37 (95%CI = .31 - .43). Overall DBAS = overall dysfunctional beliefs about sleep (DBAS), higher score 
indicating more dysfunctional beliefs about sleep; Insomnia Symptoms = insomnia symptoms (ISQ), higher score 
indicating more insomnia symptoms.  
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The results of the multivariate analyses including beliefs about immediate 
consequences (DBAS factor I), beliefs about long-term consequences (DBAS factor II), 
beliefs about control (DBAS factor III) and insomnia symptoms are displayed in Figure 
5.2 (see figure overleaf). For completeness, the fit statistics for the correlated factors 
solution, the independent pathway model and the common pathway model are shown in 
Appendix H. No significant overlap for genetic or shared environmental factors was 
indicated, see Figure 5.2a and 5.2b (see figure overleaf). Furthermore, the overall 
DBAS, DBAS factor II and DBAS factor III were not found to be familial in the 
previously run univariate analyses. As Figure 5.2c shows (see figure overleaf), the non-
shared environmental influence between the subscales of the DBAS and insomnia 
symptoms were all significantly, moderately correlated (rE ranging from .24 to .46), 
except for beliefs about immediate consequences (DBAS factor I) and insomnia 










Figure 5.2 Path diagram of the correlated factors solution, including beliefs about 
immediate consequences (DBAS factor I), beliefs about long-term consequences 
(DBAS factor II), beliefs about control (DBAS factor III) and insomnia symptoms  
Note: A = additive genetic, C = shared environmental; E = non-shared environmental. Significant paths are shown in 
black. Paths with confidence intervals spanning 0 are depicted in grey; part a. shows the genetic correlations; part b. 




The rationale behind this study was to gain insight into the aetiology of 
dysfunctional beliefs about sleep and its subscales, by considering the genetic and 
environmental influences involved. Furthermore, it was attempted to gain a better 
understanding of the concept and aetiology of insomnia symptoms by illuminating the 
association between dysfunctional beliefs about sleep (its subscales) and insomnia 
symptoms from a behavioral genetics perspective to shed light on the underlying 
mechanisms involved in the development and maintenance of insomnia. 
5.5.1 Associations between variables 
Dysfunctional beliefs about sleep and its subscales were all associated with 
insomnia symptoms. However, the association between the subscale beliefs about 
immediate consequences and insomnia symptoms was only weak, but significant. This 
finding could help to improve insomnia treatment in the future, as it may be useful to 
focus on the subscales beliefs about long-term consequences and beliefs about control 
which showed stronger associations with insomnia symptoms. 
5.5.2 Factors influencing dysfunctional beliefs about sleep 
This was the first study to estimate the heritability of dysfunctional belief about 
sleep and its subscales. The twin analyses revealed that overall dysfunctional beliefs 
about sleep showed neither a significant genetic influence (except for beliefs about 
immediate consequences) nor shared environmental influence but was mainly 
influenced by the non-shared environment (including error). The results held up in the 
sensitivity analysis for all variables except for beliefs about immediate consequences. 
When re-running the analysis on the raw data (outliers still included, age and sex not 
regressed out yet), the genetic influence was not significant (95% CI spanning zero) but 
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when A and C were dropped at the same time, the fit actually got worse. Considering 
the results together with the results of the sensitivity analysis for the beliefs about 
immediate consequences, it seems likely that some familial influence was at work here, 
whilst no familial influence was indicated for overall dysfunctional beliefs about sleep, 
beliefs about long-term consequences and beliefs about control, but the results should 
be interpreted with caution. However, even though most traits have some genetic 
influence (Polderman et al., 2015), there are some findings which indicate very small 
(i.e. almost no) genetic influence on interpersonal variables. For example, interpersonal 
cognition was found to have a genetic influence of only .03 (Gregory et al., 2007). 
Interpersonal cognition refers to expectations and perceptions of others, as well as 
beliefs about oneself (Gregory et al., 2007). 
5.5.3 Factors influencing the association between overall dysfunctional beliefs 
about sleep and insomnia symptoms 
The results of the correlated factor solution showed that neither the correlations 
between the genetic influences nor the correlations between the shared environmental 
influences were significant in the multivariate model. This actually makes sense as we 
did not find any genetic or shared environmental influence either in the univariate 
analyses for overall dysfunctional beliefs about sleep and its subscales (except for 
beliefs about immediate consequences) or for these separate variables in the 
multivariate. All non-shared environmental correlations were significant except for 
beliefs about immediate consequences and insomnia symptoms, which was also the 
association with the lowest correlation in the phenotypic analysis (see Table 5.2). The 
results held up in the sensitivity analysis. It can be concluded that for the association of 
the DBAS subscales and insomnia symptoms, the non-shared environmental influences 




The twin design has some limitations which are discussed in detail in the 
methods chapter (see Chapter 2: Methods, 2.3.1 Assumptions and associated 
limitations). Whilst the results from twin studies are used to draw conclusions about 
individual differences in the general population, it is possible that twins may not be 
representative of the wider non-twin population (Plomin et al., 2013).  
Further limitations include the relatively small sample size, which meant that 
some of the confidence intervals were wide and slight inconsistencies occurred in the 
sensitivity analysis (described below). However, we did find a significant genetic 
estimate for overall and somatic pre-sleep arousal in the previous chapter, when using 
the same sample (see CHAPTER 4: Associations between pre-sleep arousal and 
insomnia symptoms in early adulthood: a twin and sibling study). Therefore, the 
small sample size may not explain the lack of genetic or shared environmental influence 
indicated for dysfunctional beliefs about sleep in the current study. For additional, 
general limitations see Chapter 8: Discussion, 8.4 General limitations. 
It should also be mentioned that the subscale beliefs about control (DBAS factor 
III) only included two items so no Cronbach’s alpha was calculated. However, the 
DBAS-10 has been evaluated previously and the subscales were found to be valid and 
useful (Espie et al., 2000). This variable was further moderately associated with 
insomnia symptoms (r = .34, p < .01). Therefore, we decided to include it in the 
analyses. Despite these limitations, the current findings were largely in line with 
previous findings - for example, with regard to the estimate for heritability for insomnia 
(Gregory et al., 2016; Wing et al., 2012; Gehrman et al., 2011). Heritability is a 





This was the first study to examine dysfunctional beliefs about sleep and its 
subscales in a twin study. The current findings give us a novel insight into the concept 
of dysfunctional beliefs about sleep, its subscales and the association between 
dysfunctional beliefs about sleep and insomnia symptoms. This helps to deepen our 
understanding of the cognitive theories of insomnia, by dissecting one of its crucial 
elements and illuminating the factors involved in its association with insomnia 
symptoms. The findings may also help to improve insomnia treatment in the future. 
These results now need to be validated in a larger sample. The current findings are 
novel, exciting and raise new questions such as ‘Which are the environmental factors 




CHAPTER 6: Non-shared Environmental Factors Associated with 
Dysfunctional Beliefs about Sleep in Early Adulthood: A 
Monozygotic Twin Differences Study 
 
6.1 Introduction 
6.1.1 Previously conducted study 
In the previous chapter ‘Dysfunctional Beliefs about Sleep and Insomnia 
Symptoms in Early Adulthood: A Twin and Sibling Study’, one of the main findings 
was that no genetic or shared environmental factors were indicated as having an 
influence on dysfunctional beliefs about sleep. Instead, non-shared environmental 
influences accounted for 86% of the variance (for a more detailed discussion of 
dysfunctional beliefs about sleep see Chapter 5, 5.1 Introduction and theoretical 
background). As a result of this previous finding, it was decided to conduct further 
analyses to attempt to identify these specific non-shared environmental influences. The 
findings will help us to gain insight in the mechanisms involved in developing insomnia 
by considering environmental factors which influence dysfunctional beliefs about sleep 
which in turn is a factor that plays a crucial role in the development of insomnia (as we 
know from the cognitive theories of insomnia). In this way the underlying mechanism is 
dissected. 
6.1.2 Background 
The present study is exploratory in nature. Currently, we do not know much 
about the environmental factors influencing dysfunctional beliefs about sleep as 
research in this area is limited. However, previous literature illustrates that there are 
certain environmental factors which are associated with insomnia or sleep quality in 
general. Since dysfunctional beliefs about sleep and insomnia symptoms and sleep 
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quality are associated (for example, Carney et al., 2010; Hiller et al., 2015; Palagini et 
al., 2015; Yang et al., 2014; see previous chapter for a detailed discussion), these 
environmental factors might also be related to dysfunctional beliefs about sleep.  
 
6.1.3 Selection of candidate ‘environmental’ factors  
In this study, data previously collected for the G1219 study is used (at wave 5, 
the only time point at which information about dysfunctional beliefs about sleep has 
been collected). Variables considered to be associated with sleep were included in the 
testing battery and are investigated here as possible non-shared environmental 
influences on dysfunctional beliefs about sleep. These variables happen to also being 
associated with insomnia, which makes them even more suitable for being possible 
candidate environmental influences on dysfunctional beliefs about sleep. 
Relationship status, relationship satisfaction, highest level of education, 
employment status and general health have all previously been found to be associated 
with insomnia and sleep quality (Arber, Bote, & Meadows, 2009; Barclay & Gregory, 
2013; Healey, Kales, Monroe, Bixler, Chamberlin, & Soldatos, 1981; Janson, Lindberg, 
Gislason, Elmasry, & Boman, 2001; Ohayon, 2002; Troxel, Buysse, & Matthews, 2009; 
Troxel, Robles, Hall, & Buysse, 2007).  
Smoking status and alcohol dependence have also been found to be associated 
with insomnia symptoms (Janson et al., 2001). However, it can be criticised that this 
study focused only on males. Furthermore, alcohol use has been found to be related to 
sleep disturbance (see, for example, Kenney, LaBrie, Hummer, & Pham, 2012; 
Sivertsen, Skogen, Jakobsen, Hysing, 2015; Valerio, Kim, & Sexton-Radek, 2016). For 
example, sleep quality was found to be lower in nights after alcohol use (Lydon et al., 
2016). The study by Lydon and colleagues (2016) could have been improved by 
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including a more precise measure for alcohol use (highest amount recorded here was 5 
or more drinks). Previous studies have also found that drug use/misuse is associated 
with various sleep-related parameters, such as sleep quality, sleep duration, sleep deficit 
and insomnia (see, for example, Ogeil, Phillips, Rajaratnam, & Broadbear, 2015; 
Sivertsen et al., 2015). It can be criticised that the study by Ogeil and colleagues (2015) 
mainly focused on marijuana and did not include hard drugs such as cocaine or heroin. 
Negative life events were shown to be related to insomnia and sleep quality 
(Barclay, Eley, Rijsdijk, & Gregory, 2011; Bernert, Merrill, Braithwaite, Van Orden, & 
Joiner, 2007; Vahtera et al., 2007) and the number of stressful life events experienced 
was associated with the onset of insomnia (Healey et al., 1981). Life events are 
commonly divided into dependent and independent life events. Dependent life events 
refer to events that the individual has to some extent influence on (for example, getting 
divorced), whist independent life events are beyond their control (for example, the death 
of a close relative) (Brown & Harris, 1978). The distinction between dependent and 
independent life events has been included in our analyses from this sample previously 
(Barclay et al. 2011). In particular dependent negative life events appear to have the 
strongest association with sleep quality which was found to be explained to some extent 
by a gene-environment correlation (Barclay et al. 2011). However, it is possible that life 
events also act as non-shared environmental factors un-confounded by genetic influence 
influencing dysfunctional beliefs about sleep. Therefore, both dependent and 
independent life events are included in the analyses. Based on the previous literature as 
discussed above, all these variables are useful to consider as potential environmental 
influences un-confounded by genetic factors in the analyses for the current study.  
 
189 
6.1.4 Aims of the current study 
In summary, the current study is exploratory in nature and aims to specify 
general ‘environmental’ factors which influence dysfunctional beliefs about sleep for 
the first time. Therefore, no hypotheses were formulated and an overall aim was 
provided instead. We acknowledge that these candidate ‘environmental’ influences 
themselves may in part also be influenced by genes and/or shared environment. By 
adopting a MZ differences design, we attempt to identify those factors that can be 
considered to have a non-shared environmental influence un-confounded by genetic 
factors influencing dysfunctional beliefs about sleep. Based on the previous literature 
the following candidate ‘environmental’ factors were included in the analyses: 
relationship status, relationship satisfaction, relationship cohesion, highest level of 
education, employment status, general health, smoking status, alcohol use, drug use, 
dependent life events and independent life events. 
 
6.2 Method  
6.2.1 Sample 
Data from Wave 5 of the Genesis 12-19 (G1219) longitudinal twin/sibling study 
was the focus of this study as this is the only wave at which dysfunctional beliefs about 
sleep have been measured. Wave 5 included data from 223 monozygotic (MZ) twins, 
404 dizygotic (DZ) twins and 218 siblings (Denis et al., 2015). The participants were 
aged between 22 and 32 years (mean age 25 years) and 34.3% of them were male 
(Denis et al., 2015). For the 88 MZ twin pairs who both completed the overall DBAS 
(dysfunctional beliefs about sleep scale), which were the main focus in the analyses 
conducted, the age range was 23 to 27 (mean age = 24.66, SD = 1.27), 74% of the MZ 
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twin pairs were female. For a more detailed description of the sample, see Chapter 2: 
Methods, 2.4 The G1219 sample. 
6.2.2 Measures 
6.2.2.1 Dysfunctional beliefs about sleep (DBAS) 
The DBAS-10 comprises ten items tapping into dysfunctional beliefs about sleep 
(Espie et al., 2000). The total scale score is the sum of all responses (theoretical range 
from 10 to 100), with higher scores indicating more dysfunctional beliefs about sleep. 
For a more detailed discussion of the DBAS see Chapter 5, 5.2.2 Dysfunctional 
beliefs about sleep.  
6.2.2.2 Relationship (status, satisfaction, and cohesion) 
Relationship status was assessed by asking the question “Are you…? (single, 
living with a partner, married, legally separated/divorced or ‘other’)” (Spanier, 1976). 
For the response ‘other’, it was possible for the participants to add their own text. 
Combining the additional information added under ‘other’ resulted in the following 
categories: married, living together, engaged, in a serious relationship, ‘just casual’ and 
single. Thirty-five per cent (302 cases) of the participants of the overall sample were 
single, 12% married (102 cases), 23% were living together (195 cases), 7% were 
engaged (59 cases), 19% were in a serious relationship (164 cases), and 4% were ‘just 
casual’ (31 cases).  
Looking just at the MZ sub-sample, the ‘just casual’-group was too small to be 
analysed (4 cases) and was therefore excluded from all analyses (using a cut-off of 
minimum 5 cases for the MZ sub-sample). Of the remaining categories, the MZ sub-
sample had the following distribution: 38% (65 cases) were single, 10% of the 
participants were married (17 cases), 20% were living together (34 cases, excluding the 
married couples), 9% were engaged (15 cases), and 24% were in a serious relationship 
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(41 cases). For the total sample, this means that 37% (65 cases) were single and 63% 
(111 cases) in some kind of relationship. 
The Dyadic Adjustment Scale (Spanier, 1976) was used to measure relationship 
satisfaction and cohesion (see Appendix I for a list of items included in the two scales). 
Responses were given on a 5-point Likert scale ranging from ‘all the time’ (coded as 1) 
to ‘rarely/never’ (coded as 5) for relationship status and from ‘daily’ (coded as 1) to 
‘never’ (coded as 5) for relationship cohesion. The scores of each of the items were 
summed. The higher scores indicated less relationship satisfaction and cohesion. This 
measure has previously been reported to show good levels of reliability (see for 
example Busby, Christensen, Crane, & Larson, 1995, relationship satisfaction 
Cronbach’s alpha = .85, cohesion Cronbach’s alpha = .80). However, in the current 
sample, the Cronbach’s alpha for relationship satisfaction was only .40, while the 
Cronbach’s alpha for relationship cohesion was .73.  
6.2.2.3 Education 
The highest level of education was assessed using just one item, namely asking 
the participants to “Please write how many of each of these qualifications you have 
achieved…”. The variable was coded as a continuous variable as follows: None = 0, 
GCSEs (other grades) = 1; GCSEs (A* - C) = 2; GNVQ/NVQ = 3; AS Level = 4; A 
Levels = 5; City and Guilds or BTEC = 6; National Cert/Diploma (e.g. HND) = 7; 
Degree (e.g. BA, BSc) = 8; and Postgraduate Degree (e.g. MA, MSc, PhD) = 9. 
Consequently, higher scores indicate a higher level of education.  
6.2.2.4 Employment 
Employment was determined by asking the question “At the moment are 
you…?:”. The possible answers were ‘studying at college’, ‘studying at university’, 
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‘full-time parent’, ‘on government benefit’, ‘working full-time’, ‘working part-time’ or 
‘other’ (free text could be added here). The ‘full-time parent’ (7 cases in the overall 
sample, but only 2 in the MZ sub-sample), ‘unemployed’ (5 cases in the overall sample, 
but none in the MZ sub-sample) and ‘on government benefit’ (6 cases in the overall 
sample, but none in the MZ sub-sample) categories were too small (less than 5 cases in 
the MZ sub-sample) to be considered in the analyses. A similar approach was also 
adopted in previous studies using this variable for the G1219 sample (Barclay et al., 
2012; Barclay et al., 2013). The remaining categories were summarised as follows: 
‘studying’ (66 cases; 8% of the total sample), ‘working’ (695 cases; 88% of the total 
sample) and ‘working and studying’ (27 cases; 3% of the total sample). For the MZ 
twins, this resulted in the categories: ‘studying’ (14 cases; 8% of the MZ twins), 
‘working’ (147 cases; 87% of the MZ twins) and ‘working and studying’ (8 cases; 5% 
of the MZ twins).  
6.2.2.5 General health 
The participants indicated the state of their general health by responding to a 
single question (“In general, how good would you say your health is now?”). Responses 
were given on a 5-point Likert scale, ranging from poor (5) to excellent (1), where the 
higher scores indicated poorer health (see Ware Jr & Sherbourne, 1992). This approach 




6.2.2.6 Smoking status 
Whether or not the participants smoked was established by asking the question: 
“Do you smoke?”. Possible answers were ‘yes’, ‘used to, given up’ and ‘never’ (Currie, 
Samdal, Boyce, & Smith, 2001). In the overall sample 15% (130 cases) replied ‘yes’, 
12% (103 cases) ‘used to, given up’ and 72% (620 cases) ‘never’, while in the MZ 
twins 9% (16 cases) responded ‘yes’, 14% (24 cases) ‘used to, given up’ and 77% (135 
cases) ‘never’. 
6.2.2.7 Alcohol use  
Alcohol use was established by asking the following question: “Do you drink?” 
(Currie et al., 2001).  A simple yes/no answer was required here. Of the overall sample 
94% of the participants (799 cases) indicated that they drank and 6% of the participants 
(55 cases) indicated that they did not drink. For the MZ twins 93% of the participants 
(163 cases) actually consumed alcohol whilst 7% of them (13 cases) drank no alcohol at 
all. See 6.3.3 Sensitivity analysis for additional alcohol related variables that were not 
included in the results. 
6.2.2.8 Drug use 
Illicit drug use was established by responding to one statement, taken from the 
Youth Self-Report (Achenbach, 1991): “I use drugs (other than alcohol and nicotine) for 
non-medical purposes”. The possible answers were ‘not true’ (784 cases; 92% of the 
total sample), ‘somewhat true’ (42 cases; 5% of the total sample) and ‘very true’ (28 
cases; 3% of the total sample). After considering the frequencies of scores for this 
measure in the MZ twins produced the following categories:  94% participants replied 




6.2.2.9 Life events 
Life events were measured using items from the Coddington Stressful Life 
Events Scale (Coddington, 1984) and the List of Threatening Experiences (Brugha, 
Bebbington, Tennant, & Hurry, 1985). See Appendix J for a list of the items that were 
included. The participants were asked to respond with a ‘yes’ or ‘no’ to a list of 
negative life events to indicate whether or not they had experienced a particular 
negative life event during the past year. The higher scores indicate more negative life 
events. Thirteen of the items were coded as dependent negative life events (i.e. events 
influenced to some extent by the participant’s behaviour), eight items were coded as 
independent life events (i.e. events which were not really a consequence of the 
participants’ behaviour). The scores are the sum of all dependent life events, 
respectively independent life events. This approach has been taken in previous studies 
(see, for example, Silberg, Rutter, Neale, & Eaves, 2001), including studies that used 
the G1219 sample (see, for example, Barclay et al., 2012; Barclay et al., 2013). 
 
6.3 Analyses 
6.3.1 Data preparation and preliminary analyses 
The data was prepared (see 2.4.4 Data preparation for more details). SPSS 
(IBM, 2013; version 22) was used for a preliminary analysis which included descriptive 
and inferential statistics.  
6.3.2 MZ differences analysis  
The idea behind the MZ differences analysis design is that we know that MZ 
twins share 100% of their genes, as well as 100% of their shared environment (Plomin 
et al., 2013). Hence any discrepancy between MZ twins must be due to non-shared 
environmental influence (which includes measurement error). This means that, when 
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using MZ differences scores, we are controlling for genetic and shared environmental 
influences, which allows us to identify non-shared environmental components, un-
confounded by genetic factors, which influence the outcome variable (Barclay et al., 
2013; Vitaro, Brendgen, & Arseneault, 2009). MZ differences scores were calculated 
for each variable by subtracting the score of twin 2 from that of twin 1 (the co-twin). 
Note that for the current sample, twins were entered in random order to control for birth 
order effects. 
Two series of regression analyses were run in STATA (StataCorp, 2015; version 
SE 14.0), controlling for the non-independence of observations and the effects of sex 
and age. The first series investigated the extent to which various factors contributed to 
the overall DBAS score, considering the full sample. This gives us an idea about 
‘environmental’ factors that generally influence dysfunctional beliefs about sleep 
(which could be influenced by genetic and/or shared environment as well).  
The second series of regression analyses used MZ differences scores to examine 
whether any of the MZ differences in candidate non-shared environmental influences 
could predict the differences between the MZs for the overall DBAS score (in the 88 
full MZ pairs). This provides information about which factors have a non-shared 
environmental influence, un-confounded by genetic factors, influencing dysfunctional 
beliefs about sleep. All regression analyses controlled for age and sex.  
The regressions were run separately instead of using one model including all 
variables in order to avoid the problem of multicollinearity, which had occurred. 
Bonferroni correction was applied, multiplying the p-value by the number of analyses 
run (11 analyses), to correct for multiple testing.  
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6.3.3 Sensitivity analyses 
Sensitivity analyses were performed for all analyses as outlined under 2.5 
Sensitivity analyses. For additional sensitivity analyses, the categorical variables drug 
use and smoking status were re-coded into simple yes/no answers to check whether or 
not different results were obtained. Additional variables for alcohol use were also 
considered (‘How often?’, ‘Number of drinks?’) but the results were in line with the 
results presented for variable alcohol use and did not add to the findings and have 




6.4.1 Descriptive statistics 
The key variable dysfunctional beliefs about sleep had a mean of 50.26 (SD = 
15.25) for the overall sample and a mean of 50.14 (SD = 15.83) for the MZ twins. The 
theoretical range was 10 - 100, with higher scores indicating more dysfunctional beliefs 
about sleep. For overall dysfunctional belief about sleep significant sex differences were 
found (t(850) = -4.04, p < .01, d = .29), males reported fewer overall dysfunctional 
belief about sleep than females. 
6.4.2 MZ differences analyses   
As discussed previously, significant difference between males and females was 
found for the overall DBAS but not when considering the MZ sub-sample, which was 
the main focus of the analysis (for the MZ sub-sample t(174) = -1.09). Therefore, the 
regression analysis was run on all MZs and not on males and females separately, as 
elsewhere (Barclay et al., 2012). The distribution of the MZ differences of the DBAS 
score is presented in Figure 6.1 (see figure overleaf). As twins within each pair were 
 
197 
entered into the dataset in a random order, the calculation of the MZ differences scores 
produces a mean difference score approximating zero. The deviation away from the 
mean of zero in the current sample illustrates that there are MZ differences in 
dysfunctional beliefs about sleep. 
 
 
Figure 6.1 Histogram of distribution of MZ differences for the overall DBAS score 
Note: DBAS difference scores = difference in the overall dysfunctional beliefs about sleep (DBAS) score between 
twin 1 and twin 2 for the MZ twins, scores further away from 0 (the mean) indicating greater difference in 
dysfunctional beliefs about sleep. 
 
The results of the first series of univariate linear regressions are presented in part 
a) of Table 6.1 (see table overleaf). This shows the extent to which the measured 
variables in the full sample predict absolute dysfunctional beliefs about sleep. 
Relationship satisfaction, general health, dependent and independent life events were all 
correlates of overall dysfunctional beliefs about sleep. However, the variable 
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independent life events did not remain significant after controlling for multiple 
comparisons.  
Part b) of Table 6.1 shows the results of the MZ differences analyses (see table 
overleaf). Various univariate linear regressions were run on the MZ sub-sample, using 
the MZ differences scores to control for genetic and shared environmental influences, 
revealing associations with a non-shared environmental component which is un-
confounded by genetic influence. Drug use was the only variable that was found to have 
a non-shared environmental component un-confounded by genetic influence in the 




Table 6.1 Regression analyses predicting a) Absolute DBAS scores and b) MZ 
differences, controlling for genetic influence and shared environmental influence on the 
environmental measures 
 a) Absolute DBAS  
score analysis 
b) MZ differences  
analysis 
 R2 ß t R2 ß t 
Relationship status  .02 -.12 -.23 .04 1.32 .56 
Relationship 
satisfaction  
.04 -2.14 -3.34** .04 -3.48 -.81 
Relationship 
cohesion 
.02 -.72 -.98 .02 -.25 -.07 
Education .02 .54 .87 .04 -2.77 -.91 
Employment .02 -.64 -1.14 .04 -.58 -.34 
General health .05 2.60 4.88** .07 4.19 1.69 
Smoking status .02 -1.03 -1.92 .02 -.56 -.18 
Alcohol use .02 -.30 -.62 .04 -.49 -.30 
Drug use .02 .19 .32 .08 -4.83 -3.20** 
Dependent life 
events 
.06 2.99 6.26** .04 -2.57 -.95 
Independent life 
events 
.02 1.21 2.24* .04 .86 .32 
Note: * p < .05; ** p < .01. Significant values are displayed in bold. Values shown in grey did not remain significant 
after controlling for multiple testing. Analyses under a) are focusing on the full sample. Analyses under b) are 
focusing on the MZ twins only. 
 
6.5 Discussion 
In the previous chapter, non-shared environment was found to be key in 
explaining the variance in dysfunctional beliefs about sleep (for more details see 
Chapter 5). The literature about environmental factors that influence dysfunctional 
beliefs about sleep is limited. The aim of the current study was therefore to find those 
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factors that influence dysfunctional beliefs about sleep. It was then attempted to identify 
which of these factors can be considered to have a non-shared environmental 
component, un-confounded by genetic factors, influencing dysfunctional beliefs about 
sleep, by adopting a MZ differences design. In this way, a deeper insight into the 
mechanisms involved in the development of insomnia symptoms was gained, by 
attempting to find the roots of dysfunctional beliefs about sleep, which is, according to 
the cognitive theories, a crucial element associated with insomnia (see Harvey 2002, 
Morin, 1993; Ong et al., 2012).  
6.5.1 Factors influencing dysfunctional beliefs about sleep 
In the absolute measure analysis relationship satisfaction, general health and 
dependent life events were all associated with dysfunctional beliefs about sleep, 
showing that these were general ‘environmental’ influences on dysfunctional beliefs 
about sleep. Importantly, these were no longer significant in the MZ differences 
analyses, suggesting that the association between those variables and dysfunctional 
beliefs about sleep was to some extent also influenced by genes and/or shared 
environment and not just a non-shared environmental influence un-confounded by 
genetic influence (Barclay et al., 2013).  
In MZ differences analysis, only drug use was significant (and remained 
significant when correcting for multiple comparisons). This means that drug use was a 
non-shared environment influence un-confounded by genetic factors, which had an 
influence on dysfunctional beliefs about sleep, with no genetic or shared environmental 
influences being directly involved. 
It is interesting that, in the current study, the difference in drug use was 
associated with difference in dysfunctional beliefs about sleep between MZ twins; but 
there was no association between the phenotypes in the full sample. One possible 
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explanation is that, in the absolute measure analysis, our analyses included differences 
between families (therefore introducing between family variance), whilst in the MZ 
differences analysis, we examined differences within families. Decreasing variance 
increases statistical power (Scherbaum & Ferreter, 2009). Therefore, the effects of drug 
use might have been washed out in the absolute measure analysis. However, when using 
the MZ sub-sample instead of the full sample, sample size was also decreased, which 
also lowers power again at the same time (Scherbaum & Ferreter, 2009). This means 
that the results do make sense but they need to be interpreted with caution. It is true that 
illicit drug use might have quite a strong impact on the individual (for example on their 
sleep, see Sivertsen et al., 2015), so it also makes sense that this might cause MZ 
differences in dysfunctional beliefs about sleep. It may be that the more drugs the 
individual uses, the more dysfunctional beliefs he/she has. However, we did not 
quantify drug use for the current sample but this would be an interesting point to 
investigate further in future research. It would also be interesting to know which drugs 
were used by the participants to better understand how they might have been affected, 
but this was not asked so is a further topic for future investigation. 
6.5.2 The link between drug use and dysfunctional beliefs about sleep 
Research on the association between dysfunctional beliefs about sleep and drug 
use is limited. There are various possible mechanisms underlying this link. It is possible 
that the link between dysfunctional beliefs about sleep and drug use is direct or via a 
third variable. One idea is that dysfunctional beliefs about sleep and drug use are linked 
via another sleep-related variable. For example, previous studies have found that drug 
use/misuse is associated with sleep disturbances including poorer sleep quality, shorter 
sleep duration, sleep deficit and insomnia (see, for example, Ogeil et al., 2015; 
Sivertsen et al., 2015). Dysfunctional beliefs about sleep were also found to be 
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associated with sleep variables and insomnia (see, for example, Ho Park, An, Sook 
Jang, & Chung, 2012; Morin et al., 2002). It can be criticised that the study by Ho Park 
and colleagues (2012) used a cross sectional design and did not control for possible 
gender effects. When controlling for insomnia symptoms results remained robust, but it 
is possible that one or various sleep-related parameters mediate or moderate the 
association between dysfunctional beliefs about sleep and drug use. In case of a 
mediation effect, this would mean that it is possible that drug use may only affect sleep 
duration and sleep quality, which in turn may lead (indirectly) to the development of 
dysfunctional beliefs about sleep. This would mean that sleep duration and sleep quality 
would explain the relationship between drug use and dysfunctional beliefs about sleep. 
However, it should be kept in mind, that this kind of relationship is less likely to be one-
directional. Another possibility would be a moderation effect, which means that the 
strength of association between drug use and dysfunctional beliefs about sleep is 
moderated (or affected) by sleep parameter variables, such as sleep duration or sleep 
quality. 
6.5.3 Limitations 
The twin design has some limitations, and it is possible that twins may not be 
representative of the wider non-twin population (Plomin et al., 2013). These limitations 
relating to the twin method are discussed in detail in the methods chapter (see Chapter 
2: Methods, 2.3.1 Assumptions and associated limitations).  
Further additional limitations, for example, the sample size and the use of self-
report measure are discussed in detail under Chapter 8: Discussion, 8.4 General 
limitations. The relatively small sample size may have explained the low Cronbach’s 
alpha of .40 reported for relationship satisfaction (only 63% of the participants in the 
total sample were in a relationship). However, relationship cohesion produced a 
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satisfactory Cronbach’s alpha of .73 while it also focused exclusively on a sub-sample 
of participants in a relationship. 
Another issue to consider is that non-shared environmental candidates such as 
drug use are also genetically influenced to some extent (see, for example, van den Bree, 
Johnson, Neale, & Pickens, 1998; Barclay, Eley, Buysse, Rijsdijk, & Gregory, 2010). 
While accepting that most if not all of the candidate influences included in this study are 
likely to be influenced by genes and/or shared environment, here it was considered 
whether they can also identify as non-shared environmental component, un-confounded 
by genetic factors, influencing dysfunctional beliefs about sleep.  
Additionally, it should be kept in mind that drug use had a low prevalence in the 
sample. In the whole sample, 92% had not used any drugs. Therefore, the results should 
be interpreted with caution. It can further be questioned how robust the reporting of 
drug use was, as the use of the drug itself may have influenced the ability to report it. 
Despite these limitations, the current findings were largely in line with previous 
findings. For example, previous studies using the same sample but from an earlier wave 
(wave 4), showed that dependent life events and general health were among the factors 
that influenced other sleep-related variables (absolute measures analysis), namely, sleep 
quality and chronotype (Barclay et al., 2012, Barclay et al., 2013). Drug use was further 
found to have a non-shared environmental component un-confounded by genetic factors 
influencing chronotype (this variable was not considered in the study of sleep quality), 
in the MZ differences analysis in the previous study (Barclay et al., 2013).  
6.5.4 Conclusion 
The current findings give us a novel insight into the concept of dysfunctional 
beliefs about sleep as this is the first study that attempts to identify environmental 
factors un-confounded by genetic influence. Relationship satisfaction, general health, 
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dependent life events, were found to be associated with dysfunctional beliefs about 
sleep. Drug use was identified to have a non-shared environmental component un-
confounded by genetic factors influencing dysfunctional beliefs about sleep. The exact 
mechanisms underlying the link between drug use and dysfunctional beliefs about sleep 
are not clear yet. It would be interesting to explore this further in the future. These 
results now need to be validated in a larger sample. The results also help us to better 
understand the cognitive models of insomnia by providing a deeper insight into the 
mechanisms involved in the development of insomnia symptoms, attempting to find the 






CHAPTER 7: Self-reports of insomnia with short versus normal 
sleep duration: comparing the subtypes in terms of heritability, 
associated phenotypes and persistence over time 
 
7.1 Introduction 
In order to gain a deep insight into the concept of insomnia symptoms the current 
study adds a further analytical level by testing a current theory about the existence of 
two subtypes of insomnia. The theory of interest, states that insomnia with objective 
short sleep length and insomnia with objective normal sleep length can be differentiated 
as two distinct subtypes of insomnia (Vgontzas et al., 2013). 
 
7.1.1 Background 
Previous research and theory suggests that insomnia with objective short sleep 
duration (SSD, typically referring to < 6h of sleep per night) differs importantly from 
insomnia with normal sleep duration (NSD, typically referring to >= 6h of sleep per 
night) (Vgontzas et al., 2013; American Academy of Sleep Medicine, 2014). This 
theory has been well-cited (Carroll, Irwin, Merkin, & Seeman, 2015; Irwin, 2015), has 
been discussed in the ICSD-3 (American Academy of Sleep Medicine, 2015) and has 
also gained support from previous investigation (see, for example, Fernandez-Mendoza 
et al., 2015; Sivertsen, Harvey, Lundervold, & Hysing, 2014). Despite this, certain 
aspects of the theory are yet to be tested.  
The following assumptions are made by the theory. The theory states that there 
is a biological vulnerability to insomnia SSD, in contrast to a mainly psychological 
vulnerability to insomnia NSD, which may cause a difference in heritability for the two 





differences between the two insomnia subtypes in terms of associations with certain 
psychological factors. This means that while both subtypes are associated with 
cognitive arousal, insomnia SSD is assumed to be associated with physiological 
hyperarousal and stress, while insomnia NSD is associated with a lack of physiological 
hyperarousal and an anxious-ruminative profile (Vgontzas et al., 2013). Furthermore, 
the theory claims that there are differences in persistence over time between the two 
subtypes of insomnia, with insomnia SSD being more likely to persist, while insomnia 
NSD is more likely to remit (Vgontzas et al., 2013).   
Previous research has found support for this theory. For example, it has been 
suggested that those individuals with insomnia SSD are at an increased risk of 
cardiometabolic morbidity and mortality and are more likely to have impaired 
neurocognitive functioning as compared to those individuals with insomnia NSD 
(Fernandez-Mendoza et al., 2017b; Lin, Tsai, & Yeh, 2016). Furthermore, it was found 
that insomnia with short sleep duration (but not normal sleep duration) predicted 
depression and anxiety disorders (Fernandez-Mendoza et al., 2016; Fernandez-Mendoza 
et al., 2015; van Mill, Vogelzangs, van Someren, Hoogendijk, & Penninx, 2014). 
Insomnia with short sleep duration was further found to be associated with increased 
rates of inflammation (Fernandez-Mendoza et al., 2017a; Irwin, 2015). However, it is 
important to note that different cut-off values have been used in previous research for 
defining short and normal sleep time in context with insomnia (Fernandez-Mendoza et 
al., 2014; Irwin, 2015; van Mill, Vogelzangs, van Someren, Hoogendijk, & Penninx, 
2014). It can be criticised that the cut-off seems to be set rather arbitrarily in some of 
the previous studies, even though the theory by Vgontzas and colleagues (2013) is 
mentioned which suggests a cut off of >= 6h for normal sleep (see, for example, 





different cut-offs for defining normal and short sleep duration, even when some of the 
same researchers were involved in the study (see, for example, Fernandez-Mendoza et 
al., 2017a; Fernandez-Mendoza et al., 2017b; Fernandez-Mendoza et al., 2016).  
While the theory clearly focuses on objectively defined sleep length, there is 
some evidence that differences between insomnia SSD and insomnia NSD are indicated 
even when sleep length is assessed subjectively (Chandola, Ferrie, Perski, Akbaraly, & 
Marmot, 2010). This is noteworthy because, in current clinical practice, insomnia 
patients are typically assessed using subjective measures (American Academy of Sleep 
Medicine, 2015; APA, 2013; WHO, 1992). This being the case, it makes sense to also 
assess whether differences between the two insomnia subtypes are found when using 
subjective reports.  
7.1.2 Predictions of the theory to be tested in the current study 
Given widespread interest in this theory and the need to understand more about 
the distinctions between these subtypes when they are assessed using subjective 
measures, the aim of this study was to assess three predictions, which can be made from 
the theory: 
1) Difference in heritability: The theory states that there is a biological 
vulnerability for insomnia SSD, in contrast to a mainly psychological 
vulnerability for insomnia NSD (Vgontzas et al., 2013). The hypothesis that 
insomnia symptoms are more heritable for those with SSD versus NSD will 
therefore be tested. 
2) Difference in associated traits: The theory states that both subtypes are 
associated with cognitive arousal. Insomnia SSD is assumed to be associated 
with physiological hyperarousal and stress, while insomnia NSD is 





ruminative profile (Vgontzas et al., 2013). It is hypothesised that there will 
be no significant mean difference in cognitive pre-sleep arousal between the 
insomnia SSD group and the insomnia NSD group but that somatic arousal 
will be significantly higher in insomnia SSD compared to NSD. Furthermore, 
life events (as an indicator of stress) will be significantly lower in SSD 
compared to NSD and anxiety symptoms will be significantly lower in 
insomnia SSD compared to NSD. Also, the insomnia SSD and insomnia NSD 
groups should show higher cognitive pre-sleep arousal, somatic pre-sleep 
arousal, and more life events and anxiety symptoms than the no insomnia 
group. 
3) Difference in persistence over time: The theory states that insomnia SSD is 
more likely to persist, while insomnia NSD is more likely to remit (Vgontzas 
et al., 2013). It is hypothesised that a significantly higher proportion of those 
with insomnia SSD at Time 1 will have insomnia at Time 2 as compared to 




Data from wave 4 (which, from here on, will be called Time 1 for ease of 
presentation) and 5 (which, from here on, will be called Time 2) of the G1219 
longitudinal twin study was the focus of this study as they were the only waves in which 
sleep has been assessed (McAdams et al., 2012). At wave 4 a total of 1,556 individuals 
from 896 families took part. The sample was 61% female with an age range of 18 - 27, 
and a mean age of 20 (McAdams et al., 2012). Data from wave 5 was also used for this 





(MZ) twins, 404 dizygotic (DZ) twins and 218 siblings (see Denis et al., 2015). 
Participants were aged between 22 and 32 (with a mean age of 25) and 34.3% of them 
were male. For a more detailed description of the sample, see Chapter 2: Methods, 2.4 
The G1219 sample. 
7.2.2 Definition of sleep length for the insomnia SSD and insomnia NSD group 
For all analyses, short sleep duration (SSD) was defined as < 6 hours per night, 
while normal sleep duration (NSD) was defined as >= 6 hours of sleep per night, as 
specified in the theory of focus (Vgontzas et al., 2013). For the twin analyses, splitting 
the sample in this way resulted in only a very few full twin pairs experiencing short 
sleep duration (i.e. insomnia SSD: N = 5, of which 2 are MZs and 3 are DZs, and 0 
sibling pairs). For this reason, it was not possible to run the twin analyses.  
7.2.3 Subjective sleep duration 
Subjective sleep duration was assessed using the Pittsburgh Sleep Quality Index 
(PSQI; Buysse et al., 1989), as has been done in previous research (Carroll et al., 2015). 
Participants were asked the following question: “During the past month, how many 
hours of actual sleep did you get at night? (This may be different than the number of 
hours you spend in bed.)”. 
7.2.4 Insomnia and insomnia symptoms 
In the previous chapters, insomnia symptoms were measured using the Insomnia 
Symptoms Questionnaire (ISQ, Okun et al., 2009) and coded as a continuous variable. 
The continuous variable insomnia symptoms was needed for the twin analysis. In order 
to be able to split the participants into the following groups: no insomnia, insomnia SSD 
and insomnia NSD, the ISQ measure was also coded as a dichotomous variable, as 





positively (i.e. ‘sometimes’, ‘frequently’ or ‘always’) to one or more of the first 5 items 
and positively (i.e. ‘moderate’, ‘quite a bit' or ‘extreme’) to the last item (which was a 
necessary criterion to be met in addition), then the score was coded as meeting the 
diagnostic criteria for insomnia (coded as ‘1’). Not meeting the diagnostic criteria was 
coded as ‘0’. For a more detailed explanation of the insomnia symptoms measure, see 
Chapter 3, 3.2.3 Insomnia symptoms. For a list of items included in the measure see 
Appendix C. 
7.2.5 Cognitive and somatic pre-sleep arousal  
Pre-sleep arousal was measured using the pre-sleep arousal scale (PSAS, 
Nicassio et al., 1985). For the somatic arousal subscale, the scores have a theoretical 
range from 8 to 40. For cognitive pre-sleep arousal subscale, the scores also have a 
theoretical range from 8 to 40. Higher scores indicate more pre-sleep arousal. See 
Chapter 4, 4.2.2 Pre-sleep arousal for a more detailed discussion of the measure. As 
pre-sleep arousal was only measured in the most recent wave of data collection, it was 
only possible to include wave 5 data for those two variables.  
7.2.6 Life events 
Life events were measured using items from the Coddington Stressful Life 
Events Scale (Coddington, 1984). The participants were asked to respond with a ‘yes’ 
or ‘no’ to a list of negative life events to indicate whether or not they had experienced a 
particular negative life event during the past year. The scores are the sum of all life 
events. The higher scores indicate more negative life events. The theoretical range of all 
life events (including dependent and independent ones) is 0 to 21. See Appendix J for a 
list of the items that were included and see Chapter 6, 6.2.2.9 Life events for a more 





the number of participants was higher for wave 4 than it was for wave 5, wave 4 data 
was included for the analysis of this variable to maximise power. 
7.2.7 Anxiety symptoms 
Symptoms of anxiety were measured by an age-adapted version of the Revised 
Children Anxiety and Depression Scale (RCADS; Chorpita et al., 2000; Willis, 2007). 
This scale comprises 36 items for assessing symptoms of anxiety as described by the 
DSM-IV (APA, 2000). The scores have a theoretical range from 0 to 108. See Chapter 
3, 3.2.5 Anxiety symptoms for a more detailed discussion of the measure. Anxiety 
symptoms were also assessed in wave 4. As the number of participants was higher for 
wave 4 than it was for wave 5, wave 4 data was included for the analysis of this variable 
to maximise power. 
 
7.3 Analysis 
7.3.1 Data preparation  
The data was prepared (see 2.4.4 Data preparation for more details). The 
variable somatic pre-sleep arousal (wave 5) was skewed (skewness = 1.82, std. error = 
.08; kurtosis = 4.16, std. error = .17) and was therefore log-transformed, which 
successfully reduced the skewness (skewness = 1.03, std. error = .08; kurtosis = .63, std. 
error = .17). The variable life events (wave 4) was also skewed (skewness = 1.67, std. 
error = .06; kurtosis = 3.71, std. error = .13), log-transformation successfully reduced 
the skewness (skewness = .18, std. error = .06; kurtosis = -.85, std. error = .13).  
Splitting the insomnia symptoms variable into insomnia symptoms SSD and 
insomnia symptoms NSD resulted in the loss of some of the complete twin/sibling pairs, 
in some cases, as one twin had a sleep duration of 6 hours or less (SSD), while the other 





different groups. There were no complete sibling pairs were in the insomnia symptoms 
SSD group. Therefore, siblings were excluded from the twin analyses.  
7.3.2 Twin analysis  
Due to the very small number of twins for insomnia SSD, a formal twin analysis 
(using OpenMX; Boker et al., 2011) could not be performed. Furthermore, it would not 
be sensible to draw larger conclusions based on the comparison of MZ and DZ 
correlations for insomnia SSD as very few participants were included in this group.  
7.3.3 Regression analysis  
The mean differences for the insomnia SSD, insomnia NSD and no insomnia 
groups were compared for the following variables: cognitive pre-sleep arousal (wave 5), 
somatic pre-sleep arousal (wave 5), life events (wave 4) and anxiety symptoms (wave 
4). All regressions were run in Stata/MP version 14.0 (StataCorp, 2015), controlling for 
non-independence of observations, age and sex. 
7.3.4 Sensitivity analyses  
Sensitivity analyses were performed as outlined under 2.5 Sensitivity analyses. 
As additional sensitivity analyses, the mean differences for the insomnia SSD, insomnia 
NSD and no insomnia group were compared for the variables life events (as assessed in 
wave 5) and anxiety symptoms (as assessed in wave 5). Again, similar results were 
obtained (unreported).  
 
7.4 Results 
7.4.1 Descriptive statistics 
Descriptive statistics for each variable are summarised in Table 7.1 (see table 





found (t(655) = -3.33, p < .01, d = .23). Males reported less somatic pre-sleep arousal 
than females. The variable life events (wave 4) also showed significant sex differences 
(t(1123) = 2.84, p < .01, d = .15). Males reported more life events than females. There 
was also a significant sex difference for anxiety symptoms (wave 4) t(1439) = -9.11, p < 
.01, d = .26). Males showed fewer anxiety symptoms than females. Splitting the sample 
by sex would have resulted in very small groups for some of the analyses. To maximise 
power and to be consistent across all the analyses, all of the following analyses were run 
on the full sample (not splitting the sample by sex). 
Table 7.1 Means (SD) of raw scores for cognitive pre-sleep arousal, somatic pre-sleep 
arousal, life events and anxiety symptoms   
 Means (SD) 
     Total     Males     Females 
Cognitive pre-sleep arousal  17.09 (6.76) 16.60 (6.32)  17.34 (6.98) 
Somatic pre-sleep arousal  11.30 (3.84) 10.72 (3.54)* 11.60 (3.96)* 
Life events  1.85 (1.98)  2.04 (2.14)*  1.73 (1.87)* 
Anxiety symptoms  25.06 (14.88)  21.00 (12.77)*  24.65 (14.99)* 
 No insomnia Insomnia SSD  Insomnia NSD 
Cognitive pre-sleep arousal  15.96 (5.94) 25.90 (7.98)  23.65 (7.27) 
Somatic pre-sleep arousal  10.70 (3.19) 16.38 (7.19) 14.71 (4.74) 
Life events  1.68 (1.87)  3.54 (2.57) 2.87 (2.30) 
Anxiety symptoms  23.06 (13.20) 36.70 (18.24) 38.65 (18.59) 
Note: * sex differences were found. Means and SD were obtained from SPSS and are based on the raw data 
(untransformed, including outliers, etc.); Cognitive pre-sleep arousal (wave 5) = cognitive pre-sleep arousal (PSAS 
subscale), higher score indicating higher cognitive pre-sleep arousal; Somatic pre-sleep arousal (wave 5) = somatic 
pre-sleep arousal (PSAS subscale), higher score indicating higher somatic pre-sleep arousal; Life events (wave 4) = 
Life events (List of Threatening Experiences), higher score indicating more life events experienced; Anxiety 






Using the 6-hour cut-off for the SSD group resulted in the following groups: 
participants without insomnia (Time 1: 1323 cases, 87%; Time 2: 732 cases 86%), 
participants with insomnia SSD (Time 1: 38 cases, 3%; Time 2: 21 cases, 2%), and 
participants with insomnia NSD (Time 1: 159 cases, 10%; Time 2: 102 cases, 12%).  
7.4.2 Twin analyses/MZ and DZ correlations 
The MZ and DZ correlations for all variables are presented in Table 7.2. At 
Time 1, the MZ correlation for insomnia symptoms SSD was 1 (N = 2, p < .01) and the 
DZ correlation was .10 (N = 3, p < .01), while for insomnia symptoms NSD the MZ 
correlation was .40 (N = 163, p < .01) and the DZ correlation was .24 (N = 279, p < 
.01). As the twin analysis scripts (OpenMX) did not run stable, results were obtained 
from SPSS. The number of cases included for each of the correlations is also presented 
in the table in order to illustrate the problems with running the twin analysis. The MZ 
correlations for both variables were greater than the DZ correlations, indicating possible 
genetic influence. However, it would not be sensible to draw larger conclusions for 
insomnia SSD as this group was very small. 
Table 7.2 MZ and DZ correlations for insomnia SSD and insomnia NSD 
 Correlations 
        MZ        DZ 
Wave 4   
Insomnia SSD 1** (N = 2) .10** (N = 3) 
Insomnia NSD .40** (N = 163) .24** (N = 279) 
Note: * p < .05; ** p < .01. MZ = monozygotic twins; DZ = dizygotic twins. Correlations were obtained from SPSS. 
Insomnia SSD = Participants meeting the insomnia criteria and having a sleep duration < 6 hours per night; Insomnia 






7.4.3 Phenotypic analyses 
The results of the regressions and the mean scores of participants with no 
insomnia, insomnia SSD and insomnia NSD for all variables included in the analyses 
are shown in Figures 7.1 to 7.4. Note that for ease of presentation in the figure, all 
mean scores were converted to z-scores.  
There was no significant mean difference between insomnia SSD and insomnia 
NSD for cognitive pre-sleep arousal but both insomnia SSD and insomnia NSD were 
significantly higher in cognitive pre-sleep arousal (wave 5) than in the no insomnia 
group (F(2, 549) = 80.42, p < .01; R2 = .19; Scheffe’s post-hoc no insomnia vs. 
insomnia SSD p < .01; no insomnia vs. insomnia NSD p < .01; insomnia SSD vs. 




 Type of insomnia 
Figure 7.1 Mean differences in cognitive pre-sleep arousal between the no insomnia, 
insomnia SSD and insomnia NSD group 
Note: * Significant mean difference; variables were transformed, outliers +/ - 3 SD away from the mean deleted; 
standardised values (z-scores) are presented here; No insomnia = group of participants, who did not experience 
insomnia; Insomnia SSD = group of participants, who did have insomnia with a sleep duration of < 6h; Insomnia NSD 
= group of participants, who did have insomnia with a sleep duration of >= 6h; Cognitive pre-sleep arousal (wave 5) = 












There was no significant mean difference between insomnia SSD and insomnia 
NSD for somatic pre-sleep arousal (wave 5), but both insomnia SSD and insomnia NSD 
were significantly higher in somatic pre-sleep arousal than in the no insomnia group 
(F(2, 550) = 61.46, p < .01; R2 = .15; Scheffe’s post-hoc no insomnia vs. insomnia SSD 
p = .01; no insomnia vs. insomnia NSD p < .01; insomnia SSD vs. insomnia NSD p = 




 Type of insomnia 
Figure 7.2 Mean differences in somatic pre-sleep arousal between the no insomnia, 
insomnia SSD and insomnia NSD group 
Note: * Significant mean difference; variables were transformed, outliers +/ - 3 SD away from the mean deleted; 
standardised values (z-scores) are presented here; No insomnia = group of participants, who did not experience 
insomnia; Insomnia SSD = group of participants, who did have insomnia with a sleep duration of < 6h; Insomnia 
NSD = group of participants, who did have insomnia with a sleep duration of >= 6h; Somatic pre-sleep arousal (wave 
5) = somatic pre-sleep arousal (PSAS subscale), higher score indicating higher somatic pre-sleep arousal 
 
There was no significant mean difference between insomnia SSD and insomnia 
NSD for life events (wave 4). However, both insomnia SSD and insomnia NSD 
reported significantly more life events than the no insomnia group (F(2, 882) = 32.21, p 
< .01; R2 = .05; Scheffe’s post-hoc no insomnia vs. insomnia SSD p < .01; no insomnia 















 Type of insomnia 
Figure 7.3 Mean differences in life events between the no insomnia, insomnia SSD and 
insomnia NSD group 
Note: * Significant mean difference; variables were transformed, outliers +/ - 3 SD away from the mean deleted; 
standardised values (z-scores) are presented here; No insomnia = group of participants, who did not experience 
insomnia; Insomnia SSD = group of participants, who did have insomnia with a sleep duration of < 6h; Insomnia 
NSD = group of participants, who did have insomnia with a sleep duration of >= 6h; Life events (wave 4) = Life 
events (List of Threatening Experiences), higher score indicating more life events experienced 
 
There was no significant mean difference between insomnia SSD and insomnia 
NSD for anxiety symptoms (wave 4) but both insomnia SSD and insomnia NSD were 
significantly higher in anxiety symptoms than the no insomnia group (F(2, 884) = 
91.00, p < .01; R2 =  .10; Scheffe’s post-hoc no insomnia vs. insomnia SSD p < .01; no 
insomnia vs. insomnia NSD p < .01; insomnia SSD vs. insomnia NSD p = .83) – see 














 Type of insomnia 
Figure 7.4 Mean differences in anxiety symptoms between the no insomnia, insomnia 
SSD and insomnia NSD group 
Note: * Significant mean difference; variables were transformed, outliers +/ - 3 SD away from the mean deleted; 
standardised values (z-scores) are presented here; No insomnia = group of participants, who did not experience 
insomnia; Insomnia SSD = group of participants, who did have insomnia with a sleep duration of < 6h; Insomnia 
NSD = group of participants, who did have insomnia with a sleep duration of >= 6h; Anxiety symptoms = symptoms 
of anxiety (RCADS), higher scores indicating more anxiety symptoms. 
 
One point to note is that, when controlling for multiple testing, applying 
Bonferroni correction (multiply the p-value by the number of tests undertaken), the 
results of the regression analyses all remained significant. Similar results were obtained 
in the sensitivity analysis.  
7.4.4 Persistence over time 
Only 17 participants with insomnia SSD at Time 1 also participated at Time 2. 
Of these, 5 participants (29%) were considered to have insomnia at Time 2. Eighty-
seven participants with insomnia NSD at Time 1 also participated at Time 2. Of these 
19 (22%) were considered to have insomnia at Time 2.   
There was high attrition between waves 4 and 5 (45% dropped out). However, 











to be selective attrition in any of the key variables assessed at Time 1 (e.g. insomnia 
symptoms, life events, etc.). No formal analysis was run, because of the small sample 
size and the high attrition rate between the two waves considered. 
 
7.5 Discussion 
The rationale behind this study was to gain a deep insight into the concept of 
insomnia symptoms by adding a further analytical level, testing a current theory about 
the existence of two subtypes of insomnia. The theory of interest states that insomnia 
with objective short sleep length and insomnia with objective normal sleep length can 
be differentiated as two distinct subtypes of insomnia (Vgontzas et al., 2013). It was 
therefore attempted to test the hypotheses which can be derived from the theory 
(Vgontzas et al., 2013). No previous study has yet attempted to test all aspects of the 
theory at once. While the theory clearly focuses on objectively defined sleep length, the 
aim was to examine whether differences between the two insomnia subtypes could be 
found when using subjective reports. The theory was tested based on three assumptions 
that were made, which allowed testable hypotheses to be formulated. The first 
assumption is that insomnia symptoms are more heritable for those individuals with 
SSD compared to those individuals with NSD. The second assumption is that a 
difference between insomnia SSD and insomnia NSD can be found in relation to 
associated traits (somatic pre-sleep arousal, life events and anxiety symptoms). The 
third assumption is that there is a difference between insomnia SSD and NSD in 





7.5.1 Hypothesis 1: Insomnia is more heritable for those with SSD versus those 
with NSD 
It was not possible to run any univariate analyses as errors occurred when 
running the script because of the very small sample size. Furthermore, comparing the 
the difference between the MZ twins and the DZ twins correlations for insomnia SSD to 
the one for insomnia NSD, it would not be sensible to draw larger conclusions as very 
few full twin pairs were included in the insomnia SSD group. Further research is needed 
in order to run the twin analyses in a larger sample so that this claim can be tested 
thoroughly.  
7.5.2 Hypothesis 2: There are differences between insomnia SSD and NSD in 
associated traits 
According to the theory, it was hypothesised that there will be no significant 
mean difference in cognitive pre-sleep arousal between the SSD group and the NSD 
group but somatic arousal will be significantly higher in insomnia with SSD compared 
to insomnia with NSD, life events (as an indicator of stress) will be significantly lower 
in SSD compared to NSD and anxiety symptoms will be significantly lower in insomnia 
with SSD compared to NSD. For cognitive pre-sleep arousal, the mean scores of 
insomnia SSD and insomnia NSD were similar but were significantly higher than for 
the no insomnia participants, which is in line with the theory (Vgontzas et al., 2013). 
Contrary to the expectations, no significant differences were found in the mean scores 
between insomnia SSD and insomnia NSD for somatic arousal, life events and anxiety 
symptoms. However, the scores were higher for both insomnia groups in comparison to 





7.5.3 Hypothesis 3: There are differences between insomnia SSD and NSD in 
persistence over time 
The final hypothesis to be tested was that a higher proportion of those 
individuals with insomnia SSD at Time 1 will have insomnia at Time 2 as compared to 
those individuals with insomnia NSD at Time 1. It was not possible to formally test this 
hypothesis as the sample size was too small and the attrition rate between Time 1 and 2 
was relatively high.  
7.5.4 Limitations 
The results of this study need to be considered along with the limitations. The 
general limitations are discussed under Chapter 8: Discussion, 8.4 General 
limitations. Focusing on a larger sample would have allowed to formally test for 
heritability differences and to test for differences in persistence over time between the 
two subtypes of insomnia. Nevertheless, the lack of power is not able to explain the 
non-significant phenotypic results, as the effect sizes were very small. Note that 
significant differences between the two insomnia groups were found, compared to the 
no insomnia group. Furthermore, a subjective rather than an objective measure of sleep 
length was used in the current study. This made it possible to examine whether simply 
asking about sleep length (when this has not yet been measured objectively) may be 
informative during case conceptualization. It is perhaps unsurprising that certain 
differences were not possible to be identified when using this approach, as it is known 
that people with insomnia struggle to estimate their sleep length correctly (Vgontzas et 
al., 2013; Silva et al., 2007), but this approach has been used in previous research 
(Carroll et al., 2015). It should also be mentioned that in chronic insomnia, there is a 
tendency to underestimate sleep length and general sleep misperception is mentioned as 






In summary, it can be said that the current findings are only preliminary and 
cannot provide sufficient support for the theory that insomnia subtypes (insomnia SSD 
versus insomnia NSD) exist. As the sample size was too small, it was not possible to 
thoroughly test all of the hypotheses. As far as the one hypothesis that could be tested is 
concerned, no substantial support was found for the theory as no mean differences in 
somatic pre-sleep arousal, life events and anxiety symptoms could be found between 
those individuals with insomnia SSD and those with NSD when using subjective 
measures. It is interesting to note that, for the ICSD-3 it was decided not to include 
insomnia SSD, as not sufficient evidence was found to support this construct (American 
Academy of Sleep Medicine, 2015). However, some later findings have since confirmed 
the existence of the two subtypes since and the theory has been quoted frequently (see, 
for example Fernandez-Mendoza et al., 2015; Lian et al., 2015; Carroll et al., 2015; 
Irwin, 2015). Further research on larger samples, including subjective as well as 
objective measures of sleep length and additionally more detailed measures of 
associated phenotypes is needed to confirm and extend the current findings. If it can be 
confirmed that two subtypes of insomnia exist, one with SSD and the other with NSD 
and that differences between these subtypes can only be found when using an objective 
measure for sleep length, this could call into question the common practice of 
diagnosing insomnia, which currently relies on subjective measures of sleep length. 
Furthermore, if support for this theory is found in the future, this could potentially help 
to optimize insomnia treatment since Vgontzas and colleagues (2013) claim that the two 





CHAPTER 8: Discussion 
 
8.1 Goals of this PhD thesis 
The rationale of this PhD thesis was to gain a better understanding of the concept 
and aetiology of insomnia symptoms by illuminating the key elements involved in the 
development and maintenance of insomnia symptoms and by testing current theory. We 
know from the cognitive (and arousal) models of insomnia that mindfulness, pre-sleep 
arousal and dysfunctional beliefs about sleep may all play a role in insomnia symptoms 
in one way or the other. However, why these traits develop was not yet clear, nor was 
the underlying mechanisms of their association with insomnia symptoms. This is an 
important topic of investigation as it helps to deepen our understanding of the concept 
of insomnia and the roots of its development. It was therefore attempted to examine the 
principles outlined in the cognitive theories using a behavioural genetics framework to 
examine the traits involved and their association with insomnia symptoms. To achieve 
this, the genetic and environmental influence on each of these elements was assessed 
separately and the genetic and environmental influence on their association with 
insomnia was estimated. To add a further level of detail, the genetic and environmental 
influences on the subscales of those variables and their association with insomnia 
symptoms were also estimated, which helped us to dissect the relationship of those 
variables with insomnia in more detail. As one of these key elements (dysfunctional 
beliefs about sleep) did not show any genetic influence, environmental influences on 
this variable were investigated, which added another layer of insight. As a final step 
towards enriching our understanding of models of insomnia, a further theory was tested 





on sleep duration (i.e. insomnia with short sleep duration and insomnia with normal 
sleep duration) was considered.  
  
8.2 The current findings within the context of cognitive theories and 
the treatment of insomnia 
8.2.1 The current findings within the context of the cognitive theories 
The discussion of the cognitive models of insomnia has shown that mindfulness, 
pre-sleep arousal and dysfunctional beliefs about sleep play an important role in 
insomnia (see 1.3.1 Theories most relevant to this thesis – Cognitive models of 
insomnia for a detailed discussion). Expanding on the cognitive theories, it can be said 
that mindfulness was found to be familial, pre-sleep arousal showed moderate, 
significant genetic influence and dysfunctional beliefs had no familial influence. These 
elements were further decomposed by estimating genetic and environmental influence 
on their subscales, thus deepening our knowledge of the concept of insomnia by 
developing the cognitive theories further. Another level of understanding was added by 
considering the environmental influences on dysfunctional beliefs about sleep, which 
was found to have no familial influence. Drug use was the only variable to have a non-
shared environmental influence un-confounded by genetic factors. 
The mechanisms underling the development and maintenance of insomnia 
symptoms were illuminated by considering the association of the key traits (and their 
subscales) with insomnia symptoms phenotypically. Mindfulness, pre-sleep arousal and 
dysfunctional beliefs about sleep (and their subscales) were all found to be associated 
with insomnia symptoms. In order to gain an even deeper insight into the aetiology of 
insomnia symptoms, the genetic and environmental influences on these associations 





symptoms was evident. Neither was any genetic overlap found between overall 
dysfunctional beliefs about sleep and insomnia symptoms or the subscales of 
dysfunctional beliefs about sleep (beliefs about immediate consequences, beliefs about 
long-term consequences and beliefs about control) and insomnia symptoms. However, 
cognitive and somatic pre-sleep arousal overlapped highly and significantly with 
insomnia symptoms in genetic influence. The current findings add another layer to the 
cognitive theories by drilling down into the details of the associations of the key 
elements associated with insomnia symptoms. 
8.2.2 The results of this thesis within the context of the metacognitive model of 
insomnia 
In the metacognitive model of insomnia, Ong and colleagues (2012) reviewed 
some of the cognitive (and behavioural) models and added metacognitive processes to 
pre-sleep arousal and the cognitive aspects that had already been included. Ong and 
colleagues attempted to identify the way in which metacognition (or mindfulness and 
acceptance) could enhance the regulation of emotions and reduce the distress caused by 
insomnia. For a more detailed outline of all aspects in which metacognitive processes 
help to improve insomnia, see Ong and colleagues (2012). It should be noted here that 
this theory of how mindful-based approaches work to improve insomnia still needs to 
be tested thoroughly. However, the current findings shed light on various aspects of this 
theory. Going back to the first study conducted, ‘nonjudging’ and ‘acting with 
awareness’ were the only mindfulness subscales associated with insomnia symptoms 
after controlling for the effect of the other subscales (‘nonreactivity’, ‘observing’ and 
‘describing’). This is noteworthy because ‘acting with awareness’ relates to the step that 
has to be taken before a change in metacognitive stance is possible (as described in the 





mindfulness. In fact, this is so important that some of the mindfulness research focusses 
exclusively on this aspect (see, for example, Waszczuk et al., 2015). Hence, it is not 
surprising that this aspect is key and that it is associated with insomnia symptoms. 
‘Nonjudging’ may be considered to be related to equanimity in terms of being less 
attached to the negative thoughts and emotions and also as being part of ‘balance’ – i.e. 
allowing thoughts just to be thoughts without avoiding them or being overly drawn to 
them. This is also related to other cognitive theories, suggesting that people with 
insomnia may interact with their thoughts in a counter-productive way. For example, 
excessive worrying and telling oneself not to think in certain way can act as a sleep-
interfering process as discussed in the hybrid cognitive-behavioural model (Lundh & 
Broman, 2000). For a detailed discussion of the hybrid cognitive-behavioural model see 
1.3.1 Theories most relevant to this thesis – Cognitive models of insomnia. 
Furthermore, the finding of the second study, i.e. that cognitive pre-sleep arousal 
is more strongly associated with insomnia symptoms than somatic pre-sleep arousal, is 
in line with previous literature (Gregory et al., 2008; Nicassio et al.,1985) and gives rise 
to the idea that mental arousal might be a particularly good target for the treatment of 
insomnia. This is also in line with Ong and colleagues’ theory (2012) and the principle 
of primary and secondary arousal as it underscores the idea that dealing differently with 
our thoughts might be a good angle to adopt in order to change other aspects of arousal. 
This finding also works well within the context of Harvey’s cognitive model of 
insomnia (2002) which emphasises that it is the cognitive arousal which reinforces the 
somatic arousal and that this would, therefore, be a useful point to address in the 
treatment of insomnia. Therefore, the current findings do, to some extent, support the 
hybrid cognitive-behavioural model (Lundh & Broman, 2000), the metacognitive model 





possible to combine the various cognitive models into one and thus extend the new 
model by adding genetic and environmental influences to the cognitive variables. 
However, the current findings should be re-evaluated first. 
8.2.3 The relevance of the results to the treatment of insomnia 
In terms of the development of the treatment of insomnia, different approaches 
have been adopted over time. As already discussed in detail in Chapter 1: 
Introduction, 1.6.1 Psychotherapeutic treatment of insomnia, assuming that the 
main problem with insomnia is increased arousal, early treatments adopted a 
behavioural approach, using relaxation techniques, behavioural intention, stimulus 
control or biofeedback to reduce arousal (Ong et al., 2012). The second wave of 
treatment approaches (CBT-I) included addressing cognitive arousal, i. e.  targeting 
sleep-related cognitions by adding a cognitive therapy component (see, Espie, 2002; 
Lundh & Broman, 2000; for the distinction between cognitive and behavioural therapy, 
see Chapter 5). The more recent third wave of treatments for insomnia includes aspects 
of metacognition by adding elements of mindfulness-based cognitive therapy (MBCT), 
mindfulness-based stress reduction (MBSR) and acceptance and commitment therapy 
(ACT) to the previous approaches, effectively treating insomnia (see, for example, 
Dalrymple, Fioentino, Politi, & Posner, 2010; Garland, Zhou, Gonzalez, & Rodriguez, 
2016; Gong et al., 2016; Hofmann et al., 2010; Khusid, Vythilingam, 2016; Ong, 2017). 
For a more detailed discussion, see, 1.6.1 Psychotherapeutic treatment of insomnia. 
The findings of this PhD thesis could help to refine those third wave approaches. For 
example, the results of the first study showed that certain aspects of mindfulness seem 
to be more strongly related to insomnia than others. ‘Nonjudging of inner experiences’ 
and ‘acting with awareness’ may be particularly useful in treating insomnia and should 





challenge them may be particularly helpful for improving ‘Nonjudging of inner 
experiences’. For example, noting the thought “Of course I am not able to sleep now. I 
am incapable of doing the simplest task!” and then challenging it by saying to oneself 
“This is just a thought; this is not reality!” (Perlis, 2011). It may also be particularly 
helpful to include mindfulness exercises that practice focusing on the here and now 
during the day, as well as at bedtime in order to practice ‘acting with awareness’. For 
example, mindful eating or mindful walking during the day and simple exercises such 
as focusing on one’s breathing or performing a body scan (i.e. mentally scanning trough 
the body from head to toe, noticing how it feels without sticking to any of the areas) (for 
more details, see Kabat-Zinn, 1994; Kabat-Zinn, 2003, Kabat-Zinn, 2013). This could 
give rise to new, more specific mindfulness-based approaches for treating insomnia. 
Cognitive pre-sleep arousal also showed a particularly strong association with insomnia 
symptoms and therefore may also be very useful to focus on even more intensely in the 
treatment of insomnia. Adopting a mindfulness and acceptance approach or a 
metacognitive stance towards cognitive arousal, i.e. noticing it without judging or being 
attached to it or attempting to force a change in cognition, may help to improve this 
aspect (Ong et al., 2012).  
The theory that two subtypes of insomnia exist, i.e. one with short sleep duration 
and the other with normal sleep duration, was not supported when using subjective 
measures. However, due to the small sample size, it was not possible to formally test for 
differences in heritability, or differences in persistence over time. If we had found 
support for this theory, this could potentially have helped to further optimize insomnia 
treatment, as Vgontzas and colleagues (2013) claimed that the two subtypes may 
respond different to different types of treatment. They suggested that insomnia SSD 





increase sleep duration using pharmacological treatment, while insomnia NSD may be 
better treated by focusing on decreasing cognitive arousal and sleep misperception using 
CBT-I (Vgontzas et al., 2013). 
 
8.3 Future directions 
8.3.1 Re-evaluation of the results 
Many of the findings of this PhD are novel. The genetic and environmental 
influences on overall mindfulness and its subscales (in an adult sample), overall pre-
sleep arousal and its subscales cognitive and somatic pre-sleep arousal, as well as 
dysfunctional beliefs about sleep (and its subscales beliefs about immediate 
consequences, beliefs about long-term consequences and beliefs about control), have, 
for the first time, been estimated in an adult sample. In addition, the genetic and 
environmental influences on the association of these variables with insomnia symptoms 
and the environmental factors that influence dysfunctional beliefs about sleep were 
examined for the first time. Therefore, future research should re-evaluate the current 
results in different (and preferably larger) twin samples. Furthermore, it would be very 
interesting to consider all of these variables together in one large model – which would 
be possible in a much larger sample. To consider all variables together in one large 
model would be interesting because it would allow us to consider all associations of the 
key variables at once. If power was sufficient, this would give us more exact estimates. 
Furthermore, it would be possible to test in a common pathway model if there is a 
higher order latent variable via which the genetic, shared environmental and a non-
shared environmental factors influence all these key variables. This latent variable 
would be in addition to the specific genetic, shared environmental and non-shared 





If the common pathway model was be the best fitting model, then this would tell us 
something about the structure of the association between all of the elements which are 
considered to be crucial in the development and maintenance of insomnia, as outlined in 
the meta-cognitive model of insomnia. In this way, a direct bridge would be built 
between the cognitive theories and behavioural genetics findings. 
8.3.2 Adding an objective measure of sleep 
One idea for being able to explore new and interesting research questions would 
be to add an objective measure of sleep. One suggestion for future work would be to 
invite back those participants who meet the criteria for insomnia (according to the ISQ) 
so that their sleep can be assessed using an objective measure. Depending on the 
funding available, this could either be done in a sleep laboratory using a PSG or in their 
own homes using actigraphy (as the research team already owns actigraphs). 
8.3.3 Testing the theory of subtypes of insomnia (SSD versus NSD)  
Adding an objective level to the existing data would also allow to assess the 
theory that two separate subtypes of insomnia (insomnia SSD and insomnia NSD) exist 
as independent subtypes on a new level. No previous study has yet considered testing 
the theory on an objective and a subjective level at the same time. This could enhance 
our knowledge of the concept of insomnia and would also help us to evaluate whether 
or not it would be useful to apply an objective measure in the context of diagnosing 
insomnia and whether or not it may be useful to include the two subtypes of insomnia in 
future diagnosis. 
8.3.4 Adding treatment intervention 
Members of the G1219 team have been working on a project examining genetic, 





SLEEPIO program (Denis et al., 2017). For future work, members of the team plan to 
include a CBT-I in a twin study to examine this question further. In addition, it would 
also be possible to test to what extent any improvement in insomnia symptoms were 
driven by an improvement in the variables crucial to insomnia, as assessed in this PhD 
thesis: overall mindfulness (and its subscales), overall pre-sleep arousal (and its 
subscales), overall dysfunctional beliefs about sleep (and its subscales), and in addition, 
maladaptive behaviours. Even though previous research has considered how some of 
those elements are improved when insomnia is treated (see, for example, Eidelman et 
al., 2016), a comprehensive study including all those elements would be interesting 
from the point of view of gaining a more holistic understanding. 
8.3.5 Adding sleep hygiene 
If more data on the G1219 is collected, it would be useful to include a measure 
of sleep hygiene such as the Sleep Hygiene Index (SHI; Mastin, Bryson, & Corwyn, 
2006), as this is another element mentioned in the cognitive models of insomnia that 
was not assessed in wave 5 of the G1219 study (see, Espie, 2007; Harvey, 2002; 
Harvey, 2005; Lundh & Broman, 2000; Ong et al., 2012). This would be another 
interesting area of research that could help provide a better understanding of the concept 
of insomnia symptoms in the G1219 sample in the future. 
8.3.6 Re-evaluation of mindfulness, ideas for a new measure  
The FFMQ (Baer et al., 2006) that was used in the research conducted within the 
framework of this PhD is currently considered to be the most useful questionnaire for 
measuring mindfulness in a detailed way. However, it should be kept in mind that we 
have used an abbreviated version of the questionnaire. Furthermore, as already 





opinions in terms of the understanding of the concept of mindfulness and how it should 
be measured. In spite of having reviewed a great deal of mindfulness literature at the 
beginning of this PhD, no clear picture emerged of what mindfulness actually is – the 
concept remained ambiguous. Reviewing literature related to the topic mindfulness 
from a Buddhist perspective (see, for example, Gutoski, 2011; Hesse, 1922; Rinpoche, 
2008) helped to enhance the understanding of the topic by adding a philosophical level. 
The reviewed literature gives rise to the idea that the discrepancy in the concept and 
measures of mindfulness may be rooted in the issue that different ‘signs of mindfulness’ 
are measured rather than mindfulness itself. To illustrate this point, mindfulness is 
described (from a Buddhist perspective) as a deeper level of thinking that provides us 
with more profound thoughts and feelings and allows us to have some control over our 
mind and our emotions (Gyatsho & Alt, 2016). This change of thinking will inevitably 
lead to a shift of perspective when reflecting on our own behaviour, thoughts and value 
system which will in turn lead to a change in experience (for the ‘inner world’ as well as 
for the ‘world outside’) (Rinpoche, 2008). Considering the complexity and depth of the 
concept from this point of view, it seems challenging to be captured by a self-measure 
questionnaire. However, this does not mean that mindfulness, as it is conceptualised 
within Western research literature, is not valid or useful. It just represents a different 
approach which attempts to integrate a complex concept into a format that can be 
applied in research. It would be useful to try to broaden our knowledge by conducting 
even more research in this area. To acknowledge the complexity of this topic, it may be 
better to refer to it as ‘signs of mindfulness’ in context with assessment. Instead of 
avoiding the topic because of its complexity, effort should be made to further improve 





For example, Rinpoche (2008) mentions that empathy and kindness towards 
ourselves and others are part of being mindful. This is only partially captured by the 
subscale ‘non-judging’. It does not, for example, cover whether or not the inner 
dialogue is positive and empathic or rather more negative. This idea is supported by 
recent literature which confirms the association between positive effects and sleep but 
was mainly based on cross-sectional studies (Ong, Kim, Young, & Steptoe, 2016). It 
was pointed out that limited research in this area has been conducted on clinical 
populations and one criticism was that some of the studies included had methodological 
weaknesses (Ong et al., 2016). 
Another important concept to consider in relation to mindfulness is that of ‘not 
grabbing’ or ‘non-striving’, in contrast to ‘being grateful’ for what we have or for what 
is happening (Rinpoche, 2008). This is related to the ‘nonreactivity’ subscale or to a 
general acceptance in a broader sense but it also shows some differences. It basically 
describes the inner attitude that things could be better. For example, we could achieve 
more, be better looking or have more money, etc. This attitude or feeling is completely 
independent of what we actually have. For example, a model could feel that he/she 
could be prettier or a rich person could feel that he/she needs more money – there are 
numerous examples of ‘grabbing’ or ‘striving’. If we apply this to the concept of 
insomnia, this would be reflected in thoughts such as “I woke up several times tonight, 
but I should be able to sleep better. Everyone else sleeps better than me. I should try 
harder.”, etc. Alternative thoughts of gratefulness would be reflected in thought patterns 
such as “Thankfully, I was able to sleep for a couple of hours. Even though I woke up 
several times, I was able to fall asleep again”. 
Also, the realisation that everything is constantly changing and nothing stays the 





Gutoski, 2011). This is also reflected in the fact that we hold on to the present and is 
evident in thoughts such as “I have insomnia right now and it is probably chronic. I will 
never be cured. I will always have insomnia…”. This is also reflected in the concept of 
equanimity in the metacognitive model which underlines the importance of adopting a 
beginners’ mind and to consider every night as a new night and detaching oneself from 
the sleep outcome (Ong et al., 2012). 
Furthermore, the general focus on the self seems to be over-emphasised in 
individuals who are less mindful (Gutoski, 2011; Rinpoche, 2008). Therefore, this 
concept may also be usefully incorporated into the measure of ‘signs of mindfulness’. 
This would be reflected in thoughts such as “I am the only person who has insomnia.” 
or “Why am I sleeping so badly, while everyone else sleeps well?”. 
The topic of how mindfulness could be better conceptualised and be better 
measured is substantial enough to fill another PhD thesis. Further research is needed to 
evaluate whether or not the elements suggested here (‘empathy/kindness’, ‘non-
striving’, ‘acceptance of change’ and ’letting go of the self/ego’) would be a useful 
addition to the ‘signs of mindfulness’ measure. 
 
8.4 General limitations 
8.4.1 Self-report measures 
Some criticism has been levelled in relation to the use of self-measures (see, for 
example, Haeffel & Howard, 2010). For example, it could be questioned to what extent 
mindfulness can be measured by self-report (Grossman, 2011; Sauer et al., 2013).  
However, with the amount of data collected, it would have been difficult to try to get a 
more ‘objective measure’ of mindfulness (e.g. rating of behaviour by an experienced 
meditator) or to have used other methods such as interview methods, which may 





Sauer et al., 2013). It should also be mentioned here that being mindful may in itself 
enhance the ability to self-reflect. This means that an experienced meditator who is very 
mindful may estimate his/her mindfulness to be lower than a rather 
inexperienced/‘mindless’ person would (Grossman, 2011; Sauer et al., 2013). Being 
aware of this issue, all analyses conducted here (which include the mindfulness 
measure) have controlled for meditation experience. Furthermore, to date, 
questionnaire-based measures are still the standard for measuring mindfulness 
(Grossman, 2011). Also, some researchers have argued that the FFMQ is the most 
comprehensive measure for measuring mindfulness within the general population as it 
covers various facets of mindfulness (Baer et al., 2006; Bergomi, Tschacher, & Kupper, 
2013).  
In relation to measuring insomnia symptoms, it should be pointed out that 
insomnia is a subjective complaint rather an objective one (see discussion below). Some 
researchers may still argue that sleep or insomnia symptoms were assessed by using 
self-report measures and not by also using an objective measure such as PSG in 
addition. For example, individuals with insomnia generally have a tendency to 
underestimate their sleep length (American Academy of Sleep Medicine, 2015; Feige et 
al., 2008). However, various studies have shown that subjective reports are very 
valuable in the context of insomnia, particularly when considering associated cognitive 
traits. For example, a study that compared different treatments for insomnia showed that 
changes in dysfunctional beliefs about sleep were less strongly associated with the 
objective (polysomnography) and more strongly associated with the subjective (sleep 
diary) measures of sleep (Morin et al., 2002). In a different study which used a clinical 
sample, dysfunctional beliefs about sleep were also found to improve following 





al., 2015). Again, while no improvement in the objective sleep measure was found, a 
subjective improvement in sleep and insomnia symptoms was reported and was 
maintained in the 3-month follow-up (Larouche et al., 2015). It should be emphasised 
again that insomnia is often described as a ‘subjective complaint’ and, in current clinical 
practice, insomnia patients are typically assessed using subjective measures rather than 
objective ones (American Academy of Sleep Medicine, 2014; APA, 2013; WHO, 1992). 
The discrepancy between subjective and objective measures of sleep is not exclusive to 
insomnia symptoms; it can also be found in other disorders. For example, when 
measuring sleep duration in overweight individuals, the total sleep time measured by 
actigraphy differed by more than an hour from the subjective sleep time for one-third of 
the participants (O’Brien, Hart, & Wing, 2016). 
Despite the criticism of self-report measures discussed, this approach of data 
collection was necessary, given the scope of the study (assessing numerous variables in 
a sample of many hundreds of participants) and is also currently considered to be the 
optimal approach to assessing certain phenotypes (e.g. insomnia symptoms). It should 
also be mentioned that all the self-report measures chosen for the analyses have 
frequently been used in previous studies and have been thoroughly evaluated (see 
Chapter 1: Introduction and the methods sections of Chapters 3 to 7). As the self-
report measures could have artificially inflated the associations, future work should 
attempt to incorporate additional information (e.g. symptoms rated by other reporters, 
objective measures of sleep, etc.).  
8.4.2 Age  
The current findings are based on a sample of young adults (wave 5 of G1219 
which includes individuals aged between 22 and 32 years, with a mean age of 25) and 





(Plomin et al., 2013).  
Age is a risk factor for insomnia as it is more common in older individuals (in 
terms of an increased prevalence in older adults) than in younger ones (APA, 2013; 
Lichstein et al., 2003; Ohayon, 2002). However, there is some inconsistency in these 
findings because some studies have found that the prevalence rate between the different 
age groups remains quite stable (see, for example, Chevalier et al., 1999). Furthermore, 
sleep changes over the course of a lifetime, which means that sleep duration decreases 
and subjective quality and sleep becomes more fragmented over the years (Blackwell et 
al., 2014; Chee, 2016; Lo, Groeger, Cheng, Dijk, & Chee, 2016; Sivertsen et al., 2015). 
Therefore, future research should consider other age groups as well. 
8.4.3 Twin sample 
The twin design has some limitations (Plomin et al., 2013), which are discussed 
in detail in Chapter 2: Methods, 2.3.1 Assumptions and associated limitations. 
8.4.4 Non-clinical sample 
The current findings are based on a population-based sample and not on a 
clinical sample and they focus on insomnia symptoms rather than on the clinical 
diagnosis of insomnia (except for the last study conducted, see Chapter 7). This makes 
the findings applicable to the general population. Insomnia symptoms are highly 
prevalent in the general population (see, for example, Ohayon, 2002; Roth et al., 2011), 
therefore research in this area is needed. The term ‘insomnia symptom’ was used rather 
than just referring to insomnia in order to underline the fact that the sample was a non-
clinical one. The term ‘Insomnia’ was used only when participants actually met the 
diagnostic criteria of the DSM-IV (APA, 2000) as identified by the self-measure – the 





DSM version at the time). Future research should re-evaluate the results in a clinical 
sample. It would also be informative to use a mindfulness treatment intervention (see 
also description under 8.4.4 Adding treatment intervention) when considering a 
clinical sample. 
8.4.5 Sample size 
A further limitation relates to the sample size. Wave 5 of the G1219 sample was 
relatively small for a twin study. This meant that some of the confidence intervals were 
wide so further work using large samples would be of value. However, the results 
presented here were largely in line with previous research (see discussion sections of 
the empirical Chapters 3 to 7). Furthermore, using methods such as comparing the 
ACE model to the E model allowed us to draw conclusions about familial influence on 
the traits analysed when it could not be determined whether the influence was due to 
additive genetic or shared-environmental factors. 
8.4.6 Cross-sectional data 
Except for the last study, all analyses focused exclusively on wave 5 of the 
G1219 sample. The reason for this is that the key variables (mindfulness, pre-sleep 
arousal and dysfunctional beliefs about sleep) were only assessed during that wave. The 
conclusions that can be drawn from cross-sectional data are limited in terms of direction 
of effects or causality. In order to establish causality, longitudinal-data and/or treatment 
intervention (for example, by using a wait list control) would be needed in order to 
allow to conclude to what extent an improvement in one or more of the parameters 
would result is an improvement in insomnia symptoms (see description under 8.4.4 
Adding treatment intervention). According to the counterfactual model of causal 





need to be measureable), the best approach is to conduct an experiment and measure the 
baseline and the outcome after the manipulation (such as treatment intervention, ideally 
with random allocation to the groups) has happened (for a more detailed discussion see 
Höfler, 2005). It should be pointed out that measuring ‘real life’ (also including 
confounding variables) in research does not always provide us with the perfect 
conditions and that we have to work within the constraints that are provided in the given 
situations (Hill, 1965).  
According to the cognitive theories as discussed earlier, we also have to keep in 
mind that the various factors are likely to interact and influence each other rather than 
being linked in a one-directional way (see, Harvey, 2002; Morin, 1993; Ong et al., 
2012). Therefore, it would be less likely to find a straightforward, one-directional 
causality between the different traits considered in the model anyway.  
8.4.7 Additional factors 
Additional factors likely to be important in insomnia symptoms (see, for 
example, Figure 1.1 in the Introduction Chapter). The list of other possible candidates 
that could influence insomnia is long and includes, for example, stress and factors 
associated with mental health in general (see, for example, Dewa et al., 2017; Elder et 
al., 2014; Ohayon, 2002; Roth et al., 2011; Roth & Roehrs, 2003). Nevertheless, the 
current results do add to our understanding of the key elements involved in developing 
and maintaining insomnia. In order to establish direction of effects and possible causal 
links, longitudinal-data of a treatment intervention (preferably conducted with a wait list 
control) would be needed to allow for conclusions to be drawn about which parameters 
are related to an improvement in insomnia symptoms. This type of study has been 
conducted in the past but research typically focuses on single elements rather than 





method applied, it was found that the greater the change in dysfunctional beliefs about 
sleep during treatment, the greater the improvement in insomnia symptoms (Eidelman 
et al., 2016). 
 
8.5 Conclusion 
This PhD thesis represents one of the very first pieces of work aimed at 
advancing our knowledge about cognitive models of insomnia by examining key 
variables in a genetically sensitive design. The G1219 sample provided the opportunity 
to conduct a series of original studies that investigated the concept and aetiology of 
insomnia by illuminating the genetic and environmental influences on the key traits that 
play an important role in developing and maintaining insomnia (including overall 
mindfulness, overall pre-sleep arousal and overall dysfunctional beliefs about sleep) and 
their subscales, as well as their association with insomnia symptoms. In addition, the 
work conducted in this thesis aimed to test the theory about short versus normal sleep 
length insomnia using a subjective measure of insomnia but could not be confirmed.  
The findings show that nature and nurture play an important role in influencing 
insomnia, once more underlying the importance of behavioural genetics research. The 
findings also demonstrate how valuable it is to illuminate current theory from different 
angles and to integrate new approaches in order to gain a deeper understanding of the 
concept of insomnia. Future research would benefit from using an objective measure of 
sleep, considering other age groups, exploring additional factors likely to be important 
in insomnia symptoms and using longitudinal data to advance our knowledge of 
insomnia even further. Researchers should also feel inspired to test the theory by 
Vgontzas and colleagues (2013) in a systematic and comprehensive way (by using a 





Working on this PhD thesis has brought forward a whole range of interesting and 
novel findings. The results make a valuable contribution to the field of sleep research by 
providing insight into the roots of insomnia symptoms and the mechanisms underlying 
the development and maintenance of insomnia symptoms. The findings have helped to 
broaden our understanding of the concept and the current cognitive theories of 
insomnia. They will stimulate further research and will hopefully help to improve the 
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APPENDIX A: Comparison of the correlated factors solution and the independent 
pathway model for three variables 
 
Figure A.1 Correlated factors solution, three variables 
 
 





APPENDIX B: Items included from the FFMQ 
Table B.1 Items included from the FFMQ (Baer et al., 2006, pp. 34-35) to measure the 
five sub-scales of mindfulness  
Sub-scale Items included 
‘Nonreactivity’ 
 
1. “I perceive my feelings and emotions without having to react to them” 
2. “I watch my feelings without getting lost in them” 
3. “Usually when I have distressing thoughts or images, I am able just to notice 
them without reacting” 
4. “Usually when I have distressing thoughts or images, I “step back” and am 
aware of the thought or image without getting taken over by it” 
5. “Usually when I have distressing thoughts or images, I just notice them and 
let them go” 
‘Observing’ 
 
6. “When I’m walking, I deliberately notice the sensations of my body moving” 
7. “When I take a shower or a bath, I stay alert to the sensations of water on my 
body” 
8. “I pay attention to sensations, such as the wind in my hair or sun on my face” 





10. “I find it difficult to stay focused on what’s happening in the present” 
11. “It seems I am “running on automatic” without much awareness of what I’m 
doing” 
12. “I rush through activities without being really attentive to them” 
13. “I find myself doing things without paying attention” 
‘Describing’ 
 
14. “I’m good at finding the words to describe my feelings” 
15. “I can easily put my beliefs, opinions, and expectations into words” 
16. “It’s hard for me to find the words to describe what I’m thinking” 





18. “I believe some of my thoughts are abnormal or bad and I shouldn’t think that 
way” 
19. “I make judgments about whether my thoughts are good or bad” 
20. “I tell myself I shouldn’t be thinking the way I’m thinking” 
21. “I think some of my emotions are bad or inappropriate and I shouldn’t feel 
them” 
Note: The original version of the FFMQ (Baer et al., 2006) contains 39 items, for the current study it was shortened 
to 21 items. The four items with the highest factor loading for each subscale were selected. Sub-scale ‘nonreactivity 





APPENDIX C: Comparison of the ISI and the ISQ 
Table C.1 Comparison of the ISI (Morin et al., 2011) and the ISQ (Okun et al., 2009) 
 ISI (Morin et al., 2011, Bastien et al., 
2001, p. 299)  
ISQ (Okun et al., 2009, p. 50) 
Items  1. “Difficulty falling asleep”
2. “Difficulty staying asleep”
3. “Problems waking up too early”
4. “How satisfied/dissatisfied are you 
about your current sleep pattern?”
5. “How noticeable to others do you 
think your sleep problem is in terms 
of impairing the quality of your life?”
6. “How worried/distressed are you 
about your current sleep problem?”
7. “To what extent do you consider 
your sleep problem to interfere with 
your daily functioning currently?” 
1. “Difficulty falling asleep” 
2. “Difficulty staying asleep”
3. “Frequent awakenings from 
sleep”
4. “Feeling that your sleep is not 
sound”
5. “Feeling that your sleep is 
unrefreshing”
6. “Have your sleep difficulties 
interfered with your daily life?” 
Note: In the published version of the ISQ, eight additional items relating to the effect on daily life are also included, 





APPENDIX D: The correlated factors solution for overall mindfulness and 







Figure D.1 Path diagram of the correlated factors solution, including overall 
mindfulness, insomnia symptoms, depression and correlations 
Note: A = additive genetic, C = shared environmental; E = non-shared environmental. Significant paths are shown in 
black. Paths with confidence intervals spanning 0 are depicted in grey. Overall mindfulness = overall score of 
mindfulness (FFMQ), reverse coded, higher score indicating lower mindfulness; Insomnia Symptoms = insomnia 
symptoms (ISQ), higher scores indicating more insomnia symptoms; Depression Symptoms = symptoms of 
depression (MFQ), higher scores indicating more symptoms of depression; Anxiety Symptoms = symptoms of 
anxiety (RCADS), higher scores indicating more symptoms of anxiety; part a. shows the genetic correlations; part b. 







Figure D.2 Relative contributions of A, C and E to the overall phenotypic correlations 
Note: Overall mindf. = overall score of mindfulness, (FFMQ), reverse coded, higher score indicating lower 
mindfulness; Insom. S. = insomnia symptoms (ISQ), higher scores indicating more insomnia symptoms; Depress. S. 
= symptoms of depression (MFQ), higher scores indicating more symptoms of depression; Anxiety S. = symptoms of 





APPENDIX E: Items included in the PSAS 
Table E.1 List of items included in the PSAS (Nicassio et al., 1985, p. 266) 
Items included in Somatic Pre-sleep Arousal 
1. “Heart racing, pounding or beating irregularly” 
2. “A jittery, nervous feeling in your body” 
3. “Shortness of breath or labored breathing” 
4. “A tight, tense feeling in your muscles” 
5. “Cold feeling in your hands, feet or body in general” 
6. “Have stomach upset (knot or nervous feeling in stomach, heartburn, nausea, gas 
etc.)” 
7. “Perspiration in palms of your hands or other parts of your body” 
8. “Dry feeling in mouth or throat” 
Items included in Cognitive Pre-sleep Arousal 
9. “Worry about falling asleep” 
10. “Review or ponder events of the day” 
11. “Depressing or anxious thoughts” 
12. “Worry about problems other than sleep” 
13. “Being mentally alert, active” 
14. “Can’t shut off thoughts” 
15. “Thoughts keep running through your head”  
16. “Being distracted by sounds, noise in the environment (e.g. ticking of clock, 






APPENDIX F: The independent pathway model for cognitive pre-sleep arousal, 
somatic pre-sleep arousal and symptoms of insomnia 
 
Figure F.1 Path diagram of the independent pathway model, including cognitive pre-
sleep arousal, somatic pre-sleep arousal and symptoms of insomnia 
Note: Significant paths and estimates are presented in bold, see brackets for 95% confidence intervals. A = additive 
genetic influence; C = shared environmental influence; E = non-shared environmental influence; Cognitive pre-sleep 
arousal = cognitive pre-sleep arousal (PSAS subscale), higher score indicating higher cognitive pre-sleep arousal; 
Somatic pre-sleep arousal = somatic pre-sleep arousal (PSAS subscale), higher score indicating higher somatic pre-






APPENDIX G: Items included in the DBAS-10 
Table G.1 Items included in the DBAS-10 (Morin et al., 1993; Espie et al., 2000, 
p.145) 
DBAS factor I – Beliefs about the immediate negative consequences  
1. (Item 1) “I need 8 hours of sleep to feel refreshed and function well during the 
day.” 
2. (Item 2) “When I don't get the proper amount of sleep on a given night, I need to 
catch up on the next day by napping or on the next night by sleeping longer.” 
3. (Item 10) “After a poor night’s sleep, I know that it will interfere with my daily 
activities on the next day.”   
4. (Item 12) “When I feel irritable, depressed, or anxious during the day, it is 
mostly because I did not sleep well the night before. “ 
5. (Item 21) “When I feel tired, have no energy, or just seem not to function well 
during the day, it is generally because I did not sleep well the night before.” 
DBAS factor II – Beliefs about the long-term negative consequences  
6. (Item 5) “I am concerned that chronic insomnia may have serious consequences 
on my physical health.”    
7. (Item 8) “I am worried that I may lose control over my abilities to sleep.” 
8. (Item 17 )”When I sleep poorly on one night, I know it will disturb my sleep 
schedule for the whole week.” 
DBAS factor III – Beliefs about the need for control  
9. (Item 7) “When I have trouble falling asleep or getting back to sleep after night-
time awakening, I should stay in bed and try harder.”  
10. (Item 22) “I get overwhelmed by my thoughts at night and often feel I have no 





APPENDIX H: Fit statistics of additional multivariate analyses  
Table H.1 Full table of fit statistics for all multivariate genetic model fitting analyses  
 ep -2LL df AIC ∆ -2LL ∆ df p 
 Model 1: Overall DBAS and symptoms of insomnia 
Saturated  42 11904.61 1638 8628.61 - - - 
ACE  11 11941.04 1669 8603.04 36.43 31 0.23 
Model 2: DBAS factor I, DBAS factor II, DBAS factor III and insomnia symptoms 
Saturated  132 20732.85 3223 14286.85 - - - 
Correlated Factors 
Solution 
34 20865.04 3321 14223.04 132.19 98 0.01 
Independent Pathway 28 20871.19 3327 14217.19 6.15 6 0.41 
Common Pathway  23 20883.69 3333 14217.69 12.51 6 0.05 
Note: All analyses focus on transformed data, outliers deleted with age and sex regressed out. ep = estimated 
parameters; -2LL = -2*(log likelihood); df = degrees of freedom; ∆χ2 = change in chi-square statistic; ∆df = change in 
degrees of freedom; AIC = Akaike’s Information Criterion statistic; Saturated = full model, A = additive genetic,      
C = shared environmental; E = non-shared environmental. Model 1: The fit statistics of the ACE model is relative to 
the saturated model. Model 2: The fit statistics of the correlated factors solution is relative to the saturated model. The 
fit statistics of the independent pathway model is relative to the correlated factors solution. ACE common pathway 
model is relative to the independent pathway model. Phenotypes: Overall DBAS = overall dysfunctional beliefs about 
sleep; DBAS factor I = beliefs about the immediate negative consequences of insomnia (DBAS subscale); DBAS 
factor II = beliefs about the long-term negative consequences of insomnia (DBAS subscale); DBAS factor III = 
beliefs about the need for control over insomnia (DBAS subscale) – higher scores indicating more dysfunctional 
beliefs about sleep. Please note that the fit of the independent pathway model and the common pathway model cannot 
be interpreted as valid results, because the univariate analyses of the overall DBAS, beliefs about immediate 





APPENDIX I: Items included in the measure of relationship satisfaction and 
relationship cohesion 
Table I.1 Items included in the measure of relationship satisfaction and relationship 
cohesion (Spanier, 1976, p.14-15) 
Relationship satisfaction  
1. “How happy are you in your relationship?” 
2. “You think that, in general, things between you and your partner are going 
well?” 
3. “You and your partner get on each other’s nerves?” 
4. “You and your partner have an argument?” 
5. “You regret you started the relationship?” 
6. “You and your partner discuss or consider divorce, separation, or ending 
your relationship?” 
Relationship cohesion 
7. “Have a stimulating exchange of ideas”  
8. “Laugh together”  
9. “Calmly discuss something”  
10. “Work together on a project”  







APPENDIX J: Items included in the measure of negative life events 
Table J.1 Items included in the measure of negative life events (Coddington, 1984; 
Brugha et al., 1985, p.194) 
Dependent negative life events  
1. “Separation due to marital difficulties” 
2. “Serious problem with a close friend, neighbor or relative” 
3. “Problems with police or court appearance” 
4. “Unemployed or seeking work for more than one month” 
5. “Suspension/expulsion from college or university” 
6. “Have become involved in drugs” 
7. “Had a major financial crisis” 
8. “Break up of a steady relationship” 
9. “Failed end of year exams” 
10. “Start of a new problem between you and your parents” 
11. “Been sacked from job” 
12. “Been invited by a friend to break the law” 
13. “Have failed to achieve something you really want” 
Independent negative life events 
1. “Been in hospital with a serious illness or injury”  
2. “A parent hospitalized for a serious illness or injury” 
3. “Death of a second degree relative (e.g. grandparent)” 
4. “A sibling hospitalized for a serious illness or injury” 
5. “Death of a parent” 
6. “Had something valuable lost or stolen” 
7. “Death of a sibling” 
8. “Death of a close friend” 
9. “Death of a child or spouse” 





APPENDIX K: Additional regression analyses 
Table K.1 Additional regression analyses predicting a) Absolute DBAS score (full 
sample) and b) MZ differences, controlling for genetic influence and shared 
environmental influence on the environmental measures – run for sensitivity analyses  
 a) Absolute DBAS score 
analysis 
b) MZ differences  
analysis 
 R2 ß t R2 ß t 
Alcohol  
(How often?)  
.02 -.13 -.25 .05 -2.74 -.96 
Alcohol  
(no. of drinks) 
.02 .58 .96 .04 -1.51 -.55 
Drug use  
(yes/no only) 
.02 .41 .76 .08 -6.56 -3.41** 
Smoking status 
(yes/no only) 
.02 -.94 -1.76 .06 5.49 1.81 
Note: * p < .05; ** p < .01. Significant values are displayed in bold. Multiply p-value by 11, to control for multiple 
testing using Bonferroni correction.  
 
